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Summary 
 
The contemporary public and economic awareness for sustainable and ecological technologies drive 
the industrial development of superior biotechnological processes for bulk and fine chemicals. 
Regarding top-value compounds within this context, production of bio-based succinate is a highly 
anticipated industrial process due to its wide industrial applicability. In this work, naturally succinate 
producing Basfia succiniciproducens was systematically evolved towards improved production and 
tolerance properties. Small scale CO2-enriched sequential batch cultivations enabled for successful 
adaptation, evaluated by cell growth and production performance. Evolved phenotypes exhibited 
improved abilities to cope with the applied stress such as growing at 42 °C, at a pH of 5.2 and with 
25 g L
-1
 succinate – conditions not feasible for the wild-type strain. In addition, they outperformed the 
parent strain at standard conditions in respect to growth and succinate production reaching a maximum 
productivity of 2.9 g L
-1
 h
-1
. Systems biology approaches were then applied to identify the underlying 
genotype-phenotype correlations. Most promising targets thereof were selectively introduced into 
defined production hosts and demonstrated clear improvements regarding temperature tolerance, 
productivity and cell separation. Taken together, this work is an important contribution to the breeding 
of superior cell factories of B. succiniciproducens for bio-based succinate production.  
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Zusammenfassung 
 
Das öffentliche und wirtschaftliche Interesse an nachhaltigen, ökologischen Technologien ist Antrieb 
für die Entwicklung innovativer biotechnologischer Prozesse für Bulk- und Feinchemikalien. Ein 
Schwerpunkt liegt hier auf der biobasierten Herstellung von Succinat, einem Produkt mit vielfältigen 
Anwendungsbereichen. In dieser Arbeit wurde Basfia succiniciproducens, ein natürlicher Succinat-
Produzent, zur Verbesserung der Produktions- und Toleranzeigenschaften systematisch adaptiert. Ein 
sequentielles Kultivierungsverfahren unter CO2-Atmosphäre ermöglichte die erfolgreiche Adaption, 
mit Zellwachstum und Produktivität als Indikatoren. Die generierten Phänotypen zeichneten sich 
durch verbesserte Stresseigenschaften gegenüber erhöhter Temperatur und Produktkonzentration 
sowie niedrigerem pH-Wert aus (42 °C, 25 g L
-1
 Succinat, pH 5.2) – Bedingungen, unter denen der 
Wildtyp kein Wachstum aufweist. Zudem übertrafen Wachstums- und Produktionseigenschaften unter 
Standardbedingungen die des Ausgangsstamms (Pmax = 2.9 g L
-1
 h
-1
). Zur Identifizierung der 
zugrundeliegenden Genotyp-Phänotyp Beziehungen wurden systembiologische Methoden 
herangezogen. Erfolgsversprechende Targets wurden in definierte Produktionsstämme eingebracht und 
führten zu signifikanter Verbesserung von Temperaturtoleranz, Produktivität und Zellseparation. 
Diese Arbeit stellt somit einen wichtigen Schritt auf dem Weg zur Etablierung von 
B. succiniciproducens als Zellfabrik für die biobasierte Succinatproduktion dar. 
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1 Introduction 
 
Nowadays, the global chemical industry is continuously challenged by decreasing oil reserves and 
increasing public demand for green chemicals and additional products. These emerging ecological and 
undeniably economic aspects triggered the concept of bioeconomy that comprises the development of 
new and innovative biotechnological processes. The processes will then provide attractive alternatives 
to common industrial routes by conversion of renewable resources to e.g. platform chemicals. Among 
several petrochemically produced building blocks, succinate is described as a top value-added 
chemical (Werpy and Peterson 2004) and attracted growing attention by various global players of the 
chemical market in the last few years (Beauprez et al. 2010). It is projected that the succinate market 
reaches about 250.000 tons by the year 2018 with a potential market value of $ 840 Mio. 
(MarketsandMarkets 2012; Transparency Market Research 2013). These numbers can be easily 
explained by the myriad of applications of succinate. Sustainably produced commodity chemicals like 
1,4-butandiol or tetrahydrofuran or various specialty and fine chemicals promote this high demand in 
the chemical industry sector. A combination of succinate with biotechnologically produced diamines 
can be applied to synthesize commercially profitable bio-based polymers (Kind and Wittmann 2011). 
Further application fields comprise the pharmaceutical, neutraceutical and agrochemical industry 
sector (McKinlay et al. 2007). From a metabolic viewpoint, succinate is a ubiquitous intermediate in 
almost all organisms. In this line, genetic engineering of well-known platform organisms seemed 
encouraging. However, naturally succinate producing microorganisms were isolated throughout the 
last two decades (Guettler et al. 1999; Lee et al. 2002; Scholten and Dägele 2008) and currently 
represent the most auspicious production hosts. Among them, Basfia succiniciproducens shows 
promising features in terms of a future bioprocess application (Scholten and Dägele 2008; Scholten et 
al. 2009; Stellmacher et al. 2010). 
Establishing a competitive bioprocess for succinate production is obviously linked to key challenges 
regarding a successful implementation into the industrial landscape. The most challenging features 
comprise the overall productivity of a production host, its ability to convert supplemented carbon 
sources to the desired product with high titers and the specific yield in doing so (Werpy and Peterson 
2004; Patel et al. 2006) as well as its robustness concerning the bioprocess. Most of these goals can be 
achieved using widely applied metabolic engineering strategies. However, an integral process 
consideration also recommends the contemplation of further microbial physiology associated 
characteristics. The applied fermentation plants are mostly running semi-sterile, which increases the 
contamination risk. High substrate and product titers demand for strong tolerances. Some up- or 
downstream processes require presettings to enable economic feasibility. In this line, evolutionary 
adaptation represents a promising approach regarding tolerance and performance improvements.  
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2 Objectives 
 
The present work aimed for the generation of B. succiniciproducens phenotypes, featuring optimized 
characteristics regarding their tolerance against fermentation associated perturbance, i.e. high 
temperature, high succinate levels and low pH and their overall production performance. For this 
purpose, evolutionary adaptation should be used to gain evolved phenotypes. In this line, strain 
specific physiologic limitations served as starting points. Initially, the double mutant 
B. succiniciproducens DD3 was chosen as starting strain. It harbors deletions of the genes ldh and 
pflD, i.e. the pathways for lactate and formate production, respectively. This yields a minimized 
degree of freedom on which the strain could adapt evolutionary. State-of-the-art systems biology tools, 
combined with sophisticated cultivation experiments should be applied to shed some light into the 
metabolic response regarding the adaptation approaches. Obtained phenotype profiles, consisting of 
fluxomics, transcriptomics and genomics should help to identify promising targets for rational strain 
improvement. The final objective was the implementation of identified targets into production strains 
and to validate their contribution to observed tolerance and performance improvements of the adapted 
strains. Additionally, this work should provide a promising starting point, based on the establishment 
of evolutionary adaptation as valid tool in industrial strain development and encourage further 
approaches to achieve sustainable and competitive bioprocesses in context with the bioeconomy. 
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3.1 From amber to bio-succinic acid 
 
Succinic acid, a well-known chemical that was already described in the 16
th
 century when it was 
obtained from amber (Agricola 1955), is a four carbon dicarboxylic acid, systematically denoted as 
butanedioic acid. Throughout the past centuries, the compound was extensively used in medical 
treatment for joint pain, arthritic symptoms or teething (Amber Artisans 2013; Markman 2009). 
Nowadays it is known to represent a ubiquitous substance in the metabolism of almost all living 
organisms, where it serves as intermediate in cellular processes or as metabolic end-product of 
fermentative growth. Beyond its widespread biochemical occurrence, succinic acid has received 
increasing interest during the last decades by ranking it as “Top 12 Candidate” for high value added 
chemicals from biomass (Werpy and Peterson 2004). So far it was preferably used for food and 
pharmaceutical applications (Hayes et al. 2006; USDA 2009; Transparency Market Research 2013). 
For these purposes, petrochemical based processes provided 15.000 tons of succinic acid per year (Lee 
et al. 2005). The primary production route involves catalytic hydrogenation of maleic acid, a derivate 
of maleic anhydride, which is obtained during the oxidation of butane, a cracking product of fossil oil 
(Patel et al. 2006; Bechthold et al. 2008). However, this dependency on ultimate fossil resources 
shortens the succinic acid production volume by directly coupling it to increasing oil prices thus 
limiting the opportunities for further industrial application. Alternatively, succinic acid can be 
produced by microbial fermentation employing renewable feedstocks while fixing external carbon 
dioxide. This meets the growing demand for ecological substitutes of chemicals or building blocks and 
the development of a clean and efficient industry regarding the progressing climate change. Lately, 
these ecologic and undoubtedly economic concerns have raised global companies interest in a 
competitive succinic acid bioprocess based on stable feedstock costs and optimal availability, efficient 
succinic acid recovery and purification and process optimized microorganisms (Bastidon 2012). The 
accomplishment of these key challenges will boost the economic viability of bio-succinic acid as a 
mainstay of the biorefinery concept and points out the major driving force for upvaluing the 
introduction of a sustainable bio-succinic acid market. In this line, bio-succinic acid’s rising popularity 
has tremendously increased the potential of its market position accompanied by an excellent and 
innovative portfolio of renewable and sustainable products (Tweel 2010). 
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Figure 3.1 Application routes for bio-based succinic acid and its respective derivatives in various industrial sectors. 
 
Current reports predict a market value of about $ 840 Mio by 2018, linked to a strong growth rate of 
19 % reaching an annual market volume of 250,000 tons per year until 2018 (MarketsandMarkets 
2012; Transparency Market Research 2013). This is particularly driven by the various possible 
applications of succinic acid in the chemical sector. Obviously, the compound displays a versatile C4 
building block with outstanding industrial potential (Figure 3.1) due to its molecular character as a 
dicarboxylic acid. It might partly replace maleic anhydride with a total market share of 210,000 tons 
per year (Sauer et al. 2008) or maleic acid which is constantly increasing in both, demand and price 
(Cukalovic and Stevens 2008). In this line, succinic acid can serve as precursor for different 
commodity and specialty chemicals. Among them, 1,4-butanediol and its derivatives tetrahydrofuran 
or γ-butyrolacton cover a cumulated market volume of about 500,000 tons. Their application fields 
include the production of polyurethane, polyesters, adhesives, or coating resins (Paster et al. 2004; 
Müller 2005). They are further used as raw materials for pharmaceuticals and as components of 
herbicides and rubber additives (Cukalovic and Stevens 2008). Synthesis of the derivative N-methyl-
2-pyrrolidone could further extend possible applications of succinic acid towards chemical synthesis 
and process solvents, with additional application in the pharmaceutical industry. Adipic acid, 
synthesized with succinic acid as ligand in combination with hydrogen peroxide or from 1,4-
butanediol by carbonylation could facilitate the access to a polymer market for e.g. PA 6.6 (nylon) 
with a production volume of about 900,000 tons (Paster et al. 2004). Furthermore, succinic acid is an 
alternative monomer for the bio-polymer chemistry, e.g. for bio-based polyamides like PA 5.4 (Kind 
and Wittmann 2011) that involve an annual production volume of 3.5 Mio tons (Becker et al. 2012) or 
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for polyesters like polyethylene succinate (PES) or polybutylene succinate (PBS) (Fujimaki 1998; 
Oishi et al. 2006). Regarding these refining products, succinic acid’s economic feasibility additionally 
depends on optimization and innovation of chemical engineering approaches to competitively 
synthesize the above mentioned compounds from fermentation derived succinic acid. However, its 
acid residue anion succinate, which represents the physiologically occurring variant and will thus be 
used as term instead of succinic acid throughout the following chapters, can also be applied as salt and 
contribute to the application in the fields of pharmacology, toxicology and for medical purposes as 
well as in the food industry sector as pH-modifier, flavoring or antimicrobial agent (Cukalovic and 
Stevens 2008). 
 
Table 3.1 List of bio-succinate joint-ventures formed in the last years, the respectively applied strain and estimated 
production volumes for future bio-based succinate production. 
Strategic alliance Year Microorganism Product volume 
BioAmber / Mitsubishi Chemicals (in JV with 
Ajinomoto since 2006) 
2008 Yeast biocatalyst (BioAmber) / 
B. flavum or C. glutamicum 
(Mitsubishi Chemicals)  
34,000 tons per year 
(Canada) / 65,000 tons 
per year (Thailand) 
Succinity (BASF SE and Corbion Purac) 2009 B. succiniciproducens 50,000 tons per year 
(Spain) 
Myriant / ThyssenKrupp Uhde & Showa Denko 2009 E. coli 77,000 tons per year 
(US) 
Reverdia (Royale D.S.M & Roquettes) 2010 Yeast biocatalyst 30,000 tons per year 
(Italy) 
Information according to Ajinomoto 2007; Beauprez et al. 2010; BioAmber 2011; BASF SE and CSM 2012; Bastidon 2012; 
Jansen et al. 2012; Myriant 2013a; Myriant 2013b; Roquette 2013 
 
The brilliant properties have meanwhile driven the formation of different industry joint ventures 
(Table 3.1). These collaborations comprise prestigious global companies (Beauprez et al. 2010). 
Apparently, these strategic alliances aim at innovative and commercially competitive bioprocesses 
based on renewable feedstocks. For successful industrial scale production several benchmarks have to 
be reached. The key criteria involve a minimal productivity of 2.5 g L
-1
 h
-1
, minimal nutrient supply 
combined with cheap substrates and high titers of 50 – 100 g L-1 (Werpy and Peterson 2004; Warnecke 
and Gill 2005). In particular, tailored production strains are needed that efficiently convert the raw 
material into succinate in a robust and reproducible process. Different microorganisms have been 
considered over the last years as potential succinate producers. Two strategies seemed most promising. 
First, bacteria from animal rumen such as  B. succiniciproducens, M. succiniciproducens or 
A. succinogenes (Guettler et al. 1999; Lee et al. 2002; Scholten and Dägele 2008) have a high natural 
potential to synthesize succinate. On the other hand, recombinant strains of industrial well-known cell 
factories like E. coli, C. glutamicum or S. cerevisae can be built on excellent knowledge and synthetic 
biology methods for cellular engineering (Okino et al. 2008; Beauprez et al. 2010; Otero et al. 2013). 
 
Theoretical Background 
6 
Table 3.2 Potential industrial hosts for bio-based succinate production.  
Strain Production host specific characteristics 
Escherichia coli Physiology  Facultative anaerobic, Gram-negative, rod-shaped, mesophile 
 Genome Completely sequenced; 4.6 Mb (Blattner et al. 1997) 
Advantages Short doubling time  
Wide substrate variety and well-studied nutrition requirements 
Fully established engineering tool-box 
Disadvantages No natural producer (typically low anaerobic yields)  
Catabolite repression and strong regulation patterns 
PTS mediated substrate uptake 
Corynebacterium 
glutamicum 
Physiology  Aerobic, Gram-positive, pleomorphic, mesophile 
Genome Completely sequenced; 3.3 Mb (Kalinowski et al. 2003) 
Advantages GRAS-status  
Broad industrial feasibility 
Fully established engineering tool-box 
Disadvantages No natural producer (biotransformation of succinate under oxygen 
deprivation (Okino et al. 2005; Inui et al. 2007)) 
Saccharomyces 
cerevisiae 
Physiology  Eukaryotic, aerobic, round to ovoid cells, reproduction via budding, 
mesophile 
Genome Completely sequenced; 12.2 Mb  
Advantages GRAS-status 
High product tolerances 
Wide pH operation range 
Well-established engineering tool-box 
Disadvantages No natural producer  
Lacking growth on pentose sugars (Hong and Nielsen 2012) 
Compartmented synthesis pathway 
Actinobacillus 
succinogenes 
Physiology  Facultative anaerobic, Gram-negative, pleomorphic, mesophile, 
capnophilic 
Genome Completely sequenced; 2.3 Mb (McKinlay et al. 2010) 
Advantages Natural producer of high succinate titers,  
PEP-carboxykinase mediated carbon dioxide fixation,  
Disadvantages Auxotrophies for glutamate, cysteine and methionine  
Missing engineering tools 
No complete TCA cycle 
Mannheimia 
succiniciproducens 
Physiology  Facultative anaerobic, Gram-negative, pleomorphic, mesophile, 
capnophilic 
Genome Completely sequenced; 2.3 Mb (Hong et al. 2004) 
Advantages Natural producer of high succinate titers 
PEP-carboxykinase mediated carbon dioxide fixation  
Ferments wide variety of substrates and hydrolysates 
Specifically developed engineering tools 
Disadvantages Pyrimidine auxotrophy  
Missing links in vitamin pathways and in methionine and cysteine pathway 
Basfia 
succiniciproducens 
Physiology  Facultative anaerobic, Gram-negative, pleomorphic, mesophile, 
capnophilic 
Genome Partially sequenced (Kuhnert et al. 2010) 
Advantages Natural producer of high succinate titers 
PEP-carboxykinase mediated carbon dioxide fixation  
Ferments wide variety of substrates and hydrolysates, e.g. glycerol 
No Auxotrophies 
 Disadvantages Poor availability of genetic tool knowledge 
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3.2 Succinate production by Basfia succiniciproducens 
 
3.2.1 Physiology and basic properties 
 
B. succiniciproducens strains were first isolated from bovine rumen juice during a selective study, 
aiming at succinate producing microorganisms (Scholten and Dägele 2008; Kuhnert et al. 2010). The 
BASF proprietary isolate B. succiniciproducens DD1 is a Gram-negative and facultative anaerobic 
bacterium characterized by a pleomorphic shape and tending to accumulate in clusters. It belongs to 
the family Pasteurellaceae a bacteria species primarily associated with the normal flora of vertebrate 
mucosal membranes. Multilocus sequence analysis revealed a strong genetic similarity to the patent 
strain Mannheimia succiniciproducens MBEL55E with a total of 2006 homologous ORFs and a 
comparable genome size of 2.3 Mb (Kuhnert et al. 2010). In contrast to other Pasteurellaceae 
members such as strains belonging to the genus Haemophilus or Actinobacillus, this bacterium is 
neither toxic nor pathogen enabling an unrestricted application in industrial production processes. 
 
 
Figure 3.2 Scanning electron microscope picture of B. succiniciproducens DD1 (kindly provided by BASF SE) 
 
B. succiniciproducens DD1 thrives under capnophilic conditions (Scholten and Dägele 2008; 
Stellmacher et al. 2010) based on the incorporation of the environmentally significant gas carbon 
dioxide into its metabolism. This preference is caused by the natural environment, since the bovine 
rumen contains about 65.5 mol % carbon dioxide in its gas atmosphere (Hong et al. 2004). Under 
these carbon dioxide rich conditions, the strain naturally produces substantial amounts of succinate, 
hence representing an ideal host for the rising bio-based succinate market. Primary production studies, 
based on several carbon sources such as glucose, sucrose or xylose, described a standard anaerobic 
fermentation product portfolio in addition to succinate containing lactate, formate and acetate 
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(Scholten and Dägele 2008) without production of gas (Kuhnert et al. 2010). Further approaches using 
crude glycerol as carbon source in continuously driven cultivations described highly anticipated yields 
(Scholten et al. 2009). This broad substrate utilization emphasizes the promising applicability of this 
strain in industrial production processes.  
 
3.2.2 Biochemistry of succinate synthesis 
 
The biosynthesis of succinate is a biological widespread process as the compound is an intermediate of 
the tricarboxylic acid (TCA) cycle, an almost ubiquitous pathway to provide cellular energy and 
building blocks. Succinate can generally be formed by three pathways, the oxidative branch and the 
reductive one, respectively and via the glyoxylate shunt. Under aerobic conditions succinate appears as 
intermediate of the oxidative TCA cycle and supplies electrons for the oxidative phosphorylation or 
regenerates the oxaloacetate pool (Cox et al. 2006) with a theoretical stoichiometric maximum yield of 
1 mol succinate per mol glucose. Typically, it is not secreted in the medium to maintain cyclic 
operation of this pathway. Alternatively, succinate derives from the glyoxylate shunt by the cleavage 
of isocitrate to succinate and glyoxylate while by-passing decarboxylation steps (Raab et al. 2010). 
This pathway mainly serves to support growth on carbon two substrates and is found in different 
bacteria and in yeasts. In natural succinate producers the anaerobic pathway is favored while fumarate 
acts as final electron acceptor. This fermentative growth leads to substantial succinate release, thus 
exhibiting a tremendous potential to produce succinate.  
Based on glucose, B. succiniciproducens predominantly runs the glycolytic pathway to convert the 
substrate to cellular building blocks and energy. However, some carbon is metabolized through the 
pentose phosphate pathway to serve for anabolic precursors while recycling excess carbon back into 
glycolysis (Becker et al. 2013). At the pyruvate node, supplied carbon is distributed towards the 
reductive TCA cycle by carboxylation of phosphoenolpyruvate (PEP). Obviously, it represents an 
integral part of the succinate synthesis by delivering required precursors. When supplemented with 
carbon dioxide the carboxylation is optimally driven by PEP carboxykinase as observed with other 
natural succinate producers (Van der Werf et al. 1997; Lee et al. 2006) and directly coupled to ATP 
formation. Additionally, this reaction affects the carbon flux towards pyruvate itself as secreted by-
product or as precursor for other mixed fermentation by-products. Acetate and formate production 
particularly occurs synchronized as they both derive from formate C-acteyltransferase activity and 
growth coupled, while lactate accumulates during stationary phase (Stellmacher et al. 2010). This 
behavior can be presumably explained by growth associated gene expression and protein abundance 
(Lee et al. 2006) and unveils a high metabolic flexibility of B. succiniciproducens regarding the 
reallocation of carbon depending on the metabolic state of the cell. The TCA cycle is operated in a 
separated, bifurcated manner.  
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Figure 3.3 Overview of B. succiniciproducens carbon core metabolism involving glycolysis, pentose phosphate pathway, 
pyruvate node and TCA cycle. Glucose uptake is performed by (1) glucokinase. The enzymes coping with succinate 
precursor demand via glycolysis are (2) glucose-6-phosphate isomerase, (3) phosphofructokinase, (4) fructose-bisphosphate 
aldolase, (5) triosephosphate isomerase, (6) glyceraldehyde-3-phosphate dehydrogenase, (7) phosphoglycerate kinase, (8) 
phosphoglycerate mutase and (9) pyruvate kinase. At the pyruvate node, mixed fermentation products are generated via (10) 
lactate dehydrogenase, (11) formate C-actetyltransferase and (12) pyruvate dehydrogenase. Additionally, lactate can derive 
from (27) methylglyoxal pathway. Acetyl-CoA serves as precursor for the TCA cycle by its integration through (13) citrate 
synthase and for acetate and ethanol formation via (14) phosphate acetyltransferase, (15) acetate kinase and (16), (17) alcohol 
dehydrogenase, respectively. The oxidative TCA branch is further conducted by (18) aconitase, (19) isocitrate 
dehydrogenase, (20) 2-oxoglutarate dehydrogenase complex and (21) succinyl-CoA synthetase. Anaerobic succinate 
synthesis is primarily facilitated through (22) phosphoenolpyruvate carboxykinase, with (23) phosphoenolpyruvate 
carboxylase, and (24) malate dydrogenase, (25) fumarate hydratase and (26) fumarate reductase.  
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The reductive branch is exclusively used to synthesize succinate, while the oxidative part revealed 
only low utilization in B. succiniciproducens strains (Becker et al. 2013). Considering the redox 
balance and cofactor management of succinate synthesis, generation of succinate requires 2 molecules 
of reductants. In general NADH supply exceeds NADH consumption, while the Pasteurellaceae genus 
seems to struggle with sufficient NAPDH supply. Apparently, this likely suggest additional NADPH 
sources in B. succiniciproducens (Becker et al. 2013) as documented for A. succinogenes that employs 
a transhydrogenase or the malic enzyme, closing this gap in redox balancing (McKinlay et al. 2007). 
Unfortunately, the malic enzyme withdraws carbon from the reductive TCA branch and formed 
pyruvate is usually not converted back to oxaloacetate. The observed excess in ATP production is 
addressed to cellular maintenance and transport processes (McKinlay et al. 2007; Becker et al. 2013). 
 
3.2.3 Optimal production performance 
 
The primary desired feature of an industrial host is the efficient conversion of substrate to product. 
Therefore, the natural, in general non-optimal distribution of applied substrates throughout the 
metabolism can be externally affected by introduction of heterologous pathways or targeted regulation 
of cellular metabolic routes. Nevertheless, it is inevitable to gain information on these routes and their 
corresponding fluxes. Elementary flux mode analysis was used to search probable succinate producing 
phenotypes with a distinctive ratio of succinate production and biomass formation based on glucose 
(Becker et al. 2013). Applying a flux balance approach the phenotype with optimal succinate yield 
showed the ideal carbon distribution for succinate production, while rejecting any by-product or 
biomass formation (Figure 3.4). Obviously, the complete glucose is metabolized through glycolysis 
generating 2 mols PEP per mol glucose. At the pyruvate node, optimal flux distribution for succinate 
production revealed a branched TCA whereas 86 % of the carbon is carboxylated and subsequently 
used in the reductive TCA cycle. The rest is applied in the oxidative TCA cycle via pyruvate 
dehydrogenase and citrate synthase to generate sufficient NADH for running the reductive part. This is 
essential, since glycolysis produces 1 NADH per PEP, but reduction of OAA towards succinate 
requires 2 NADH. A maximal theoretical succinate yield of 1.71 mol per mol glucose under carbon 
dioxide atmosphere recommends the consideration of this network for innovative optimization 
approaches by e.g. metabolic engineering. Furthermore, the combination with additional reducing 
power such as hydrogen can yield 2 mol succinate per mol glucose (McKinlay et al. 2007). 
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Figure 3.4 Metabolic fluxes of B. succiniciproducens for optimum succinate production by elementary flux mode analysis, 
based on a network model, containing all reactions for succinate production (Melzer et al. 2009; Becker et al. 2013). The 
fluxes are given as relative molar fluxes to the glucose uptake.  
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3.3 Key criteria for successful industrial production of succinate 
 
Recent years upgraded the concept of biorefinery to become a mainstay of the future industrial 
landscape, considering valuable and innovative green products as substitutes for currently 
petrochemically derived compounds. The concept is similar to the traditional petroleum refinery, 
except its objective to convert biomass feedstocks into a myriad of applicable and industrial 
competitive products (Paster et al. 2004; Sauer et al. 2008; Cherubini 2010). This approach is 
forwarded to stepwise replace the global economy by a sustainable bioeconomy with bio-based 
products as one backbone among others. However, several key criteria have to be fulfilled to obtain an 
industrial platform for bio-based production processes, reaching competitive price margins. Succinate 
was reported with a selling price between $ 6 and 9 per kg and with production costs of about $ 1.1 per 
kg which have to be further reduced to $ 0.55 per kg in the future (Patel et al. 2006; Song and Lee 
2006). This financial aspect has to be considered in terms of upstream and downstream sections as 
well as the fermentation part itself. Regarding the complete bioprocess costs, upstream processing 
covers 40 % of the overall succinate production costs, based on a raw sugar price of $ 0.40 per kg in 
2013 (USDA), and desired succinate yields of about 90 %. Since downstream processes generally 
accounts for 50 % of the process costs, due to insufficient high product titers, complex mixtures of cell 
material and chemicals in the broth and desired final product purity (Wisbiorefine; Cheng et al. 2012), 
fermentation contributes to approximately 10 %. However, these three steps are closely intertwined 
(Figure 3.5), since substrate application specifies fermentation performance and subsequent recovery 
processes. The fermentation part affects both upstream and downstream processing by nutrition 
requirements of employed microorganisms and their respective product – by-product portfolio. 
Additionally, recovery strategies influence fermentation development, e.g. yield and productivity and 
the complexity of unit-operations (van Hoek et al. 2003). In this line, the effective cost allocation to 
each step is directly linked to decisions made for the other two process parts and represents major 
elements for improving the competitiveness of a bioprocess. Microbial hosts exhibit substrate 
preferences, limited tolerances towards components resulting from substrate pretreatment or need 
essential additives for cellular growth. Thus, low-cost media must be developed, preferably based on 
inexpensive raw material such as glycerol or lignocellulose hydrolysate. The fermentation process 
must feature high product yields and titers of above 100 g L
-1
 combined with efficient productivities of 
at least 2.5 g L
-1
 h
-1
, while by-product formation must be kept to a minimum (Werpy and Peterson 
2004; Patel et al. 2006). Efficient succinate recovery strategies have to be installed in an integrated 
bioprocess (Kurzrock and Weuster-Botz 2010; Cheng et al. 2012). Therefore, low pH fermentation 
will be advantageous considering cost savings for e.g. acidifying agents that are necessary for succinic 
acid recovery. 
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Figure 3.5 Schematic bioprocess model, considering the key criteria as dependencies and interactions between the 
fermentation and the pre- and post-fermentative phases. Dashed lines and respective arrows indicate prerequisites between 
the process parts. 
 
 
3.4 Towards superior succinate production strains  
 
3.4.1 Systems biotechnology approaches 
 
Recently, industrial biotechnology broadened the field of study concerning optimization of bio-based 
production towards a holistic approach involving several biological disciplines. The generation of 
propitious cell factories is directly linked to evolving targets, unraveled by techniques like genomics 
(DNA), transcriptomics (RNA), proteomics (proteins), metabolomics and fluxomics (metabolites) 
(Kohlstedt et al. 2010), and phenomics (phenotype) (Bochner 2009). For optimization purposes 
regarding industrial aspects, it is not necessary to examine all levels of the omics-family to reveal 
beneficial modifications. Nevertheless, it can be helpful to combine various omics-techniques to draw 
a more accurate picture of the phenotype and its underlying interactions among functional layers.  
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In case of succinate production optimization, only few approaches combined two or more techniques. 
Most studies were built on in silico or in vitro tracking of carbon metabolism, accompanied by 
metabolic engineering of relevant targets to redistribute the carbon flux towards succinate (Lee et al. 
2006; McKinlay et al. 2007; McKinlay and Vieille 2008; Becker et al. 2013). The underlying networks 
obviously derived from genome knowledge and annotations. This genomics tool is essential for the 
understanding of the nuts and bolts of the observed production phenotypic. By analysis of sequenced 
genomes, targets could be identified, that would contribute to an optimized phenotype by their 
amplification, deletion or introduction.  
One level above, the adjustment of cellular metabolite synthesis and distribution can be mediated by 
two underlying regulatory mechanisms. On the one on hand, cells can probably switch on proteins or 
rather specify their activation state to direct fluxes towards desired metabolites. In this case, fluxes 
change according to varied conditions or modification implementation while gene expression patterns 
remain the same. The second option includes the fine tuning of RNA transcripts that has to be 
recruited for flux adjustment. Custom-made DNA microarray based gene expression analysis provides 
the possibility to gain a global view on the gene expression pattern of microorganisms. Thereby, 
different strains can be screened for global regulatory responses on various implemented genetic 
modifications. Furthermore, transcriptomic changes can be revealed under various conditions, e.g. 
high or low temperature. It is thus possible to unravel hindering metabolic bottlenecks that are mainly 
caused by non-optimal expression profiles of specific genes. On the other hand, modification based 
specific expression responses can be concluded from these datasets. A further approach allows for 
elucidation of gene expression concerning their participation in functional groups. This gene set 
enrichment analysis shows transcriptional responses according to several clustered genesets that share 
common biological function (Subramanian et al. 2005).  
Metabolite fluxes represent the level above transcriptomics and proteomics and thus define the cellular 
metabolite state. The technique to visualize these fluxes, metabolic flux analysis (MFA), is a vital and 
widespread applied method throughout the industry related biotechnological landscape. MFA, 
combining an experimental part applying 
13
C-carbon sources and a computational part with a genome-
scale molecular network (Wittmann 2007), serves to gain information on metabolic turnover rates. The 
quantification of intracellular fluxes is realized by tracing the 
13
C-carbon distribution throughout the 
network. It thus allows for the design of industrial valuable production hosts by pin-pointing specific 
targets like bottlenecks that cannot be clearly determined by phenotype observations. Successful 
industrial application of MFA was widely documented throughout recent literature, whereas a product 
spectrum was covered including relevant industrial products like amino acid, organic acids, vitamins, 
ethanol and antibiotics (Iwatani et al. 2008; Feng et al. 2010; Kohlstedt et al. 2010). 
Cellular phenotypes are the most comprehensive features of microorganisms, since their biochemical 
and physiological properties are easily observable and the phenotype consequently results from gene 
expression and environmental influences. The recently described method of phenotypic microarray 
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analysis allows for specific phenotypic characterization of microorganisms with the aid of phenotypic 
microarrays (Bochner 2009). Based on the understanding of bacterial characterization through simple 
growth assays this approach is justified to describe various phenotypic alterations. Every 
microorganism is specially adapted towards its niche. Thus, the pattern of nutrient consumption or 
toxicity tolerance, based on this niche, varies between and defines them. Another interesting aspect in 
case of optimization approaches is the determination of loss of function or gain of function events. 
While gain of function is mostly beneficial and thus represents a desired feature of adapted 
phenotypes, loss of function can involve industrial detrimental characteristics, like the inability to 
metabolize a common substrate (Blaby et al. 2012).  
 
3.4.2 Metabolic engineering of succinate production strains 
 
Rational analysis, based on accessible knowledge of cellular pathways and kinetics, provides the 
opportunity for optimization that can be realized by molecular biological techniques. This systems 
metabolic engineering enables target-oriented implementation of genetic modifications thus leading to 
increased carbon fluxes and improved metabolite product yields (Stephanopoulos et al. 1998) while 
reconfiguring metabolic bottlenecks. Regarding succinate production the major engineering approach 
deals with increasing the succinate yield. In this line, the primary group of targets blatantly derives 
from the mixed fermentation characteristics of almost all microorganisms during anaerobic growth. 
For each industrial host, specific targets arise from their inherent set of by-products and their ratio to 
succinate. Since the metabolic optimization involves complete channeling of provided carbon towards 
succinate, targeted gene deletion is the most preferred method to realize the desired fluxes. Genes that 
were preferentially considered for this strategy encoded lactate dehydrogenase, formate C-
acetyltransferase, acetate kinase or alcohol dehydrogenase (Bunch et al. 1997; Lee et al. 2006; Okino 
et al. 2008; Becker et al. 2013). Completing these tasks, succinate yields could be increased in natural 
succinate producing hosts. In primary aerobic industrial platform hosts, this strategy partially caused 
growth defects mainly due to the effect of completely linking cellular growth to succinate production 
and thus unbalancing the redox and energy capacities (Bunch et al. 1997; Stols and Donelly 1997; 
Sánchez et al. 2005; Jantama et al. 2008). Encouragingly, the introduction of the NAD generating 
malic enzyme in the respective host strain increased growth performance and succinate production 
(Stols and Donelly 1997). Considering the succinate biosynthesis pathway as target, the key reaction 
under optimal and thus anaerobic conditions is the carbon fixation step. Theoretically, three enzymes 
are capable of that reaction, whereas natural producers exhibit high specific enzyme activities for and 
carbon fluxes through the PEP carboxykinase (Podkovyrov and Zeikus 1993; Van der Werf et al. 
1997; Kim et al. 2007; Becker et al. 2013). On the other hand, studies revealed the potential of non-
ATP coupled PEP- and pyruvate carboxylase as carboxylation step (Vemuri et al. 2002; Sánchez et al. 
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2005; Litsanov et al. 2012), the latter one especially in context with PEP dependent substrate uptake 
systems, due to no losses in precursor supply (Shanmugam and Ingram 2008), while keeping in mind 
that carbon dioxide is essential to catalyze these thermodynamically unfavored reactions (Samuelov et 
al. 1991). Continuing with this pathway, the reductive TCA cycle directly emerges as target for 
pushing the carbon flux from oxaloacetate towards succinate by engineering the synthesis steps (Wang 
et al. 1998; Hong and Lee 2004; Lee 2009). This strategy is emphasized by observed accumulation of 
malic acid as pathway intermediate in engineered strains (Hong and Lee 2004; Lee et al. 2006). The 
additionally accumulating pyruvate represents an essential node in almost every metabolism (Sauer 
and Eikmanns 2005), but it is predestined to redirect its carbon via parts of the oxidative TCA cycle 
accompanied by the glyoxylate shunt (Lin et al. 2005; Raab et al. 2010; Scholten et al. 2010; Litsanov 
et al. 2012; Skorokhodova et al. 2013). Another crucial target comprises the balancing of the cellular 
redox capacities by e.g. implementation of heterologous genes (Hong and Lee 2001) or enzyme 
specific co-factor engineering (Wang et al. 2013). In this line, fine-tuned design approaches have to be 
followed by balancing the redox benefits and carbon loss, with e.g. the malic enzyme. Having in mind 
that all these strategies are mainly conducted regarding glucose based succinate production, it is 
inevitable to design microbial host that efficiently convert industrial desired raw materials, like 
molasses, hydrolysates or waste products into succinate. First studies elaborated the possibilities of 
glycerol conversion, exploiting the advantage of the higher reduced substrate for optimized redox 
balance (Blankschien et al. 2010; Scholten et al. 2009). Other approaches targeted the application of 
these mixed substrates in bioprocess refinements using both natural succinate producers and 
engineered platform microorganisms (Kim et al. 2004; Liu et al. 2008; Jiang et al. 2010; Chan et al. 
2011; Borges and Pereira Jr 2011; Liu et al. 2012). However, these complex compounds often contain 
inhibitory substances to some extent that complicate optimization tasks. Overall, the sophisticated 
approach of understanding intracellular fluxes in combination with strain specific genome-scale 
models and molecular biology methods is highly suitable in context to industrial objectives like 
product formation, volumetric production or yield. Thus, rational analysis, based on accessible 
knowledge of metabolic pathways and their kinetics, provides the opportunity for optimization 
strategies. Nevertheless, engineering strategies for succinate production have to be exclusively 
adjusted to the respective microbial hosts, their specific networks and their physiological 
characteristics as natural producer or platform host. Thus, systems metabolic engineering indeed 
specifically alters basic production phenotypes that are mediated by just a few genes, but lacks the 
ability to select for robust strains (Blaby et al. 2012) and complex phenotypes. Moreover, many of 
these phenotypes remain largely inaccessible to this method due to difficulties in predicting the 
genotype-phenotype relationship. 
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3.5 Creating robust industrial phenotypes through evolutionary engineering 
 
Under industrial aspects it is not very likely to design bioprocesses to the employed microorganisms. 
Nowadays, the development process is strongly interwoven with the capability of producing 
microorganisms that tolerate industrial preferred settings. Additionally, the industry is continuously 
searching for microorganisms that allow for a process, which features already existing facilities 
accompanied by low development costs. An answer to these driving forces is the application of multi-
tolerant phenotypes that exhibit high tolerances for various stress triggers like temperature, product 
tolerances, pH, shear stress, osmolarity, nutrient supply, or toxicity (Table 3.3), called complex 
phentotypes. 
 
Table 3.3 List of process step assigned industrially desired properties for competitive bioprocesses with their required 
complex phenotype. 
Process step Industrial requirements Complex phenotype 
Substrate supply 
Implementation of substrate pre-processing 
(saccharification) 
Temperature tolerance, tolerance towards 
impurities 
Application of industrial waste products 
and renewable ressources 
Substrate metabolism 
Fluctuating substrate quality, impurities Toxic residue tolerance 
Plant facilities  
Efficient energy policy Temperature tolerance 
Spatial inhomogenities High substrate tolerance, temperature tolerance, 
mechanical stress tolerance, pH tolerance, 
osmolarity tolerance, starvation tolerance  
 Decrease contamination risk Temperature tolerance, Phage tolerance 
Fermentation process 
High product titers High substrate tolerance, product tolerance 
No by-product formation Re-balancing of cellular redox metabolism 
Downstream processing 
Simple cell separation Cell composition 
High product purity Product tolerance 
Application of less purification agent pH tolerance, solvent tolerance 
 
These complex phenotypes distinguish themselves by their advanced polygenic response to stress 
triggers, since a single innovative product and its producing microorganism are not anywhere near 
sufficient to meet the overall criterions for an economic feasible and competitive production process. 
On that account, the last decades delivered various approaches to achieve methods for generating these 
specific microorganisms.  
A classical method to forward these issues is mutagenesis (Figure 3.6), where the genetic material is 
iteratively exposed to mutagens. Surviving clones of this procedure are then selected for the 
specifically desired phenotype (Patnaik 2008). This method convinces by its simplicity but lacks the 
ability to modify microorganism target-oriented. Nonetheless, it gets attention due to the rapid and 
extensive development of high-throughput screening systems that enables quick and reliable 
phenotype characterization (Patnaik 2008). Considering industrial requirements for cultivation 
stability at high/low temperature or osmolarity or at mechanical stress, these complex or polygenic 
phenotypes need multiple coordinated changes to retain special features (Patnaik 2008). An option to 
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cope with these problems is nature itself with its most efficient method, the evolution. Evolution 
mimicking optimization strategies were already followed throughout the last years to gain new 
variants of proteins. This approach, called directed evolution, is performed in three steps: 
diversification, selection and amplification. In most cases, several rounds are conducted to achieve an 
improved feature. 
 
Figure 3.6 Several methods can be applied to generate industrially valuable phenotypes. The arrows depict that methods like 
systems metabolic engineering and genome shuffling emerged from the classical approach through increasing metabolic 
knowledge or more extensive recombination options. The evolutionary engineering developed from the combination of 
evolutionary adaptation with metabolic engineering strategies.   
 
Based on this knowledge, further methods evolved in the last years, e.g. genome shuffling (Zhang et 
al. 2002) and were successfully applied to lactic acid production (John et al. 2010), respectively. 
However, most methods combine the need for separate screening steps and suffer the disadvantages of 
unspecific implementation of mutations or inaccessible genotype-phenotype knowledge. This will lead 
us to a straightforward, but very potent phenotype tailoring approach. During evolutionary adaptation 
in sequential batch or chemostat experiments, industrial conditions can be applied that specifically 
trigger the evolution to favorable phenotypes, which, naturally exhibit beneficial mutations. In 
combination with standard techniques of metabolic engineering, the evolutionary engineering can 
easily generate auspicious candidates for biotechnological processes. In a first step, known by-product 
pathways will be eliminated to restrict evolutionary adaptation towards desired products. Then, cells 
will be cultured under desired conditions to evolve potential phenotypes. At several time-points, single 
colonies will be isolated to access knowledge of genomic, transcriptomic or phenomic changes. Since 
most beneficial mutations mediate fitness advantage within the population, screening of these 
phenotypes is very efficient. Another great advantage is the convergence of developed phenotypes, 
whereby 6 out of 7 independently adapted E. coli lines were shown to exhibit similar phenotypic 
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characteristics, while the gene expression differed from each other (Fong et al. 2005). It was also 
shown that adapting genomes evolve in a near-linear fashion by accumulating mutations, while 
vigorously fitness improvements occur in the beginning of adaptive processes and distinctly decreases 
over time (Barrick et al. 2009). Combining these two facts, it is obvious that a parallel adaptation 
approach will yield highly efficient phenotypes in short time. Considering this method to be applied in 
strain optimization, four facts have to be kept in mind. First, the physiological limitations of the 
microorganism have to be studied to draw a picture of the complete criterion dependent performance 
space. This information will then be used to set up adaptation starting points, where growth is affected 
by the stressor, but still present. Second, the engineering level of the applied microorganism must be 
determined. Here, the wild-type easily comes to mind, but strains exhibiting definite genetic 
modifications, like gene deletion, will serve as a better host. Their metabolism is channeled to a 
specific product and often includes redox balance inconsistencies. This will narrow down the degrees 
of freedom for evolution and thus raise the odds on succeeding in desired phenotype improvement. 
Extensively modified production strains are unfavorable adaptation hosts. Indeed, a large number of 
implemented genetic changes like point mutation or promoter exchanges direct fluxes into product 
channels, but engender detrimental growth characteristics. However, the main crux lies in the 
evolutionary ability to remove these cellular undesired modifications and switch back to the wild-type 
allele. Thus phenotype generation is still possible but involves loss of industrial relevant production 
features. The third fact includes the question for the adaptation medium. Complex media facilitate 
faster growth but cause the accumulation of auxotrophies. Moreover these auxotrophies remain 
undetected during adaptation while increasing microbial fitness due to less metabolic costs for the 
cellular growth. As a consequence it is highly appreciated to apply minimal media, while their 
composition has to be adjusted for each approach. Fourth, it is necessary to setup the adaptation 
approach, which comprises the question for sequential batch or continuous cultivation, as well the 
fashion of stress induction. While batch experiments are simple structured, their effort for iteratively 
media preparation and inoculation exceeds continuous approaches, while they are running. Prior to the 
adaptation their configuration is much more elaborate. Considering the stress application, continuous 
approaches allow for constant cellular response documentation and subsequent counteracting. During 
sequential batches in small volume, these results can only be determined in between iterations. All 
things considered, evolutionary adaptation has to be well prepared to create conspicuous new 
phenotypes. 
 
Temperature 
The biological significance of temperature is undeniable. All organisms and their vital surroundings 
are directly or subtly influenced by it. The industrial interest in temperature adapted phenotypes can be 
easily linked to economic matters. Concerning specific enzymes, cold adapted proteins that exhibit 
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highest activities at low temperatures are state of the art nowadays in the detergent industry and rule 
the sales figures of companies. In contrast, the development of adapted whole cells for cultivation 
purposes is in its early stages. Improved microbial temperature stability is highly appreciated in 
fermentation processes to keep the cooling costs down. Furthermore, the extension of the growth 
optimum decreases the probability of external contamination that occur due to impracticalities in 
vessel sterilization, since the adapted strain exceeds in growth performance compared to standard 
contamination seeds. Another economic aspect is the combination of substrate pre-treatment steps 
with the following fermentation to a single step process (Turner et al. 2007). Along with it, enzyme 
kinetics, basically chemical reactions can be described by the Arrhenius equation. A generalization of 
this equation describes doubled reaction rate per 10 °C increased temperature. Thus, the industry aims 
for better growth and production performance of temperature adapted microorganisms at elevated 
temperatures. Interestingly, the Arrhenius equation was shown to be applicable for bacterial growth in 
their temperature optimum (Herendeen et al. 1979). However, rational approaches to design 
temperature tolerant microorganism were mainly based on random findings. In case of E. coli, the 
addition of methionine to a cultivation medium enabled for growth at a lethal temperature (Ron and 
Davis 1971). On closer inspection two specific amino acid sites were revealed in homoserine o-
succinyltransferase, the first enzyme in methionine synthesis that stabilized the protein and thus E. coli 
growth at higher temperature. In general, the bacterial heat stress response is just partly understood 
caused by its magnitude of involved regulatory pathways. Since temperature represents a pervasive 
challenge for microorganisms, they developed a successful adaptation scheme to overcome this stress 
called heat shock response. This mechanism is mediated by organism specific transcription factors that 
are directly activated by the perturbant before damage or by the damage itself (DNA, mRNA, 
proteins). Afterwards ubiquitous existing chaperons and proteases are activated that deal with 
unfolded or misfolded proteins to preserve the protein homeostasis (Lim and Gross 2011). Other 
predicted strategies describe the maintenance of physiological rates achieved by a quantitative 
approach, where the concentration of enzymes is increased throughout adaptation. A qualitative 
approach comprises more stable enzyme variants, whereas the modulation approach minimizes the 
temperature effect by modifying the protein environment (Clarke 2003). Concluding this, it is 
inevitable to acquire tolerant phenotypes to facilitate the strategic tailoring of temperature tolerant 
microorganisms. 
 
Product Tolerance 
A common claim of biorefinery is a fermentation process yielding maximal titers, a key performance 
indicator. The crux in this claim is the fact that even though some industrial microorganisms show the 
potential of producing organic acids in extremely high titers they exhibit intolerances against the 
produced compounds to some extent (Loubiere et al. 1997; Song et al. 2008; Urbance et al. 2004), 
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which limits the commercial application. During a mixed organic acid fermentation secreted acids 
dissociate and cause a rapid decrease in pH. In case of non-regulated cultivation media the pH drops 
below the corresponding pKa and the organic acids remain undissociated. These acids can then directly 
diffuse across cellular membranes (Warnecke and Gill 2005). They enter the cell unimpeded and 
accumulate intracellular. The neutral pH of the cytosol promotes the dissociation of these organic 
acids resulting in a severe pH decrease and thus decreased integrity of purine bases and severe protein 
denaturation (Warnecke and Gill 2005). At a neutral pH instead, the nearly equilibrium between 
intracellular and extracellular pH prevents from toxic accumulation of organic acids in the cell. 
Furthermore, at neutral pH organic acids dissociate into protons and acid residues, which can only be 
taken up via secondary transport. Anyhow, the rational understanding of these complex networks is 
limited by its broad spectrum. Microorganisms have developed several strategies to compensate for 
the problem of acid shock that is accompanied by a decrease of cytosolic pH. The proton permeability 
of membranes can be triggered through their composition (Booth 1999). A further response can be 
observed on the level of transport mechanisms. As recently reported, a succinate adapted E. coli 
exhibited strong changes on the level of transcriptomics for genes that contributes to several transport 
mechanisms. Additionally, higher expression patterns could be observed for genes that are involved in 
osmoprotectant biosynthesis (Kwon et al. 2011). Nevertheless, it was shown that not only growth 
associated organic acid production, but also organic acid salts impede cellular growth, both, for natural 
succinate producers and engineered microorganisms, when added to the medium prior to cultivation 
(Lin et al. 2008; Li et al. 2010; Hoon et al. 2010). Besides, organic acid tolerance depends on the 
respective organic acid. While succinate seems to be a mild stressor with high critical concentrations, 
formate severely ceases cell proliferation (Loubiere et al. 1997; Lin et al. 2008). It is therefore crucial 
to understand intracellular regulation pathways towards industrial oriented improvements in bio-
succinate production. This effort can be minimized by creating and evaluating evolutionary derived 
complex phenotypes with beneficial features (Buschke et al. 2013).  
 
pH Tolerance 
Industrial bioprocesses are closely connected to economic production procedures and down-stream 
treatments. Considering the succinate production, a classic recovery method comprises the application 
of calcium salts and the subsequent acidification with sulfuric acid (Kurzrock and Weuster-Botz 
2010), which accounts for a process relevant cost factor. Lower cultivation pH comprises lower 
investment costs due to less salt processing operations and lower variable costs caused by less salt 
acquisition. Thus regarding process sustainability, acidic pH increases the carbon footprint of 
succinate production (Jansen et al. 2012). Furthermore, applied calcium carbonate combines lower 
cultivation pH with buffer effect and carbon dioxide source. It is thus recommended to employ acidic 
pH tolerant microorganisms for production processes. By default, many microorganisms exhibit an 
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optimum at neutral pH with decreasing tolerance toward acidic pH, belonging to the neutralophilics. 
For organic acid producing bacteria the fermented products decrease extracellular pH that causes a 
transmembrane pH gradient shift. In the end organic acids accumulate in the cytosol and directly 
perturb the intracellular pH (Booth 1985). The response to that event is mediated by a passive and an 
active regulated homeostasis. The first one comprises low membrane permeability to protons and a 
cytoplasmic buffer capacity. The active mechanisms include controlled transport of cations across the 
membrane (Booth 1999). An additional response is the synthesis of proteins that forms neutral 
compounds from acidic ones or converts neutral ones to alkaline substances, in respect to the pH 
stress. Taking together, pH tolerance and organic acid tolerance are somewhat intertwined and cannot 
be clearly treated individually.  
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4 Material and Methods 
 
4.1 Chemicals 
 
Yeast extract, peptone and BHI (brain heart infusion) were purchased from Becton Dickinson 
(Heidelberg, Germany). Ninety-nine percent [1-
13
C] glucose was obtained from Eurisotop (Saint-
Aubin Cedex, France). All other chemicals were of analytical grade and purchased from Sigma 
Aldrich (Steinheim, Germany), Merck (Darmstadt, Germany), Roth (Karlsruhe, Germany) and Fluka 
(Buchs, Switzerland), respectively. 
 
 
4.2 Growth media 
 
4.2.1 Media for genetic engineering 
 
B. succiniciproducens was grown in liquid BHI medium (Table 4.1) for genetic engineering purposes, 
i.e. for electroporation and during the regeneration step of transformation. Selection of plasmid 
carriage was performed on BHI-MOPS agar plates (Table 4.2) by adding chloramphenicol stock 
solution (30 g L
-1
) to a final concentration of 5 mg L
-1
 prior to usage. Sucrose was added to 100 g L
-1
 
for second recombination selection before autoclaving.  
Table 4.1 Composition of BHI medium. 
Component  Quantity [g] 
BHI   37 
ad 1 L aqua dest 
autoclaved (121 °C, 20 min) 
 
Table 4.2 Composition of BHI-MOPS agar plates. 
Component  Quantity [g] 
BHI   37 
Agar  18 
 ad 750 mL aqua dest. 
autoclaved (121 °C, 20 min) 
 
MOPS  9.375 
Bis-Tris  5.75 
Mg(OH)2  0.625 
ad 250 mL aqua dest., stirred overnight 
NaHCO3  1.79 
sterile filtered, add 250 mL MOPS-Bis-Tris solution to 750 mL BHI agar medium 
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E. coli TOP10 cultivations for plasmid amplification were performed in LB broth (Luria Bertani) or on 
LB agar plates (Table 4.3). For selection purposes, chloramphenicol was added to the respective 
medium to a final concentration of 50 mg L
-1
. Agar plates were prepared by adding 18 g L
-1
 agar. 
 
Table 4.3 Compositions of LB medium. 
Component  Quantity [g] 
Tryptone  10 
Yeast extract  5 
NaCl  5 
ad 1 L aqua dest 
autoclaved (121 °C, 20 min) 
 
After heat shock, E. coli TOP10 cells were regenerated in SOC (super optimal broth (SOB) with 
catabolite repression) medium (Table 4.4).  
 
Table 4.4 Composition of SOC medium. 
Component  Quantity [g] 
Tryptone  20 
Yeast extract  5 
NaCl  0.5 
ad 970 mL aqua dest. 
autoclaved (121 °C, 20 min) 
MgCl2 (1M) sterile filtered 10 mL 
MgSO4 (1M) sterile filtered 10 mL 
Glucose (2M), autoclaved (121 °C, 20 min) 10 mL 
 
 
4.2.2 Media for growth and succinate production 
 
For all media, stock solutions were prepared separately (Table 4.5), subsequently sterile filtered and 
stored at room temperature. The vitamin solutions 1 and 2 were stored as aliquots at -20 °C. Prior to 
usage, the stock solutions were mixed at room temperature as needed. A complex medium A was 
applied for first pre-cultures of B. succiniciproducens. The second pre-culture and following main 
cultivations of B. succiniciproducens were conducted in respective media (Table 4.6 to Table 4.11).  
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Table 4.5 Composition of stock solutions for B. succiniciproducens cultivation. 
Component  Quantity [g] 
Glucose solution   
Glucose  500 
ad 1L aqua dest., sterile filtered 
Maltose solution   
Maltose  500 
ad 1L aqua dest., sterile filtered 
Glycerol solution   
Glycerol (99.5 %)  502.5 
ad 1L aqua dest., sterile filtered 
Yeast extract solution   
Yeast extract  100 
ad 1L aqua dest., sterile filtered 
Peptone solution   
Peptone  100 
ad 1L aqua dest., sterile filtered 
Salt solution   
NaCl  100 
MgCl2  20 
CaCl2  20 
ad 1L aqua dest., sterile filtered 
(NH4)2SO4 solution   
(NH4)2SO4  500 
ad 1L aqua dest., sterile filtered 
K2HPO4 solution   
K2HPO4  500 
ad 1L aqua dest., sterile filtered 
Amino acid solution   
L-valine  25 
L-glutamate  25 
ad 1L aqua dest., sterile filtered 
Vitamin solution 1   
Thiamin HCl (B1)  3 
Riboflavin (B2)  6 
Nicotinamide (B3)  3 
Pantothenic acid (B5)  10 
Pyridoxine HCl (B6)  1 
Biotin (B7)  0.5 
each vitamin was individually dissolved, biotin and riboflavin were titrated with 
2 M NaOH to complete dissolution, ad 1L aqua dest., sterile filtered 
Vitamin solution 2   
Cyanocobalamin (B12)  0.5 
ad 1L aqua dest., sterile filtered 
Na2CO3 solution   
Na2CO3  200 
ad 1L aqua dest., sterile filtered 
 
A total volume of 10 mL of each medium was freshly prepared from stock solutions (Table 4.5) for 
30 mL scale serum bottles. Serum bottles were autoclaved prior to usage containing 0.5 g MgCO3 
(final concentration in medium of 50 g L
-1
). Fermentations for MgCO3 free preparation of cell pellets 
for RNA isolation were carried out in bioreactors using minimal medium E according to Table 4.10 in 
corresponding volumes. Cultivation experiments of B. succiniciproducens variants carrying expression 
vectors were conducted in described media A – F (Table 4.6 to Table 4.11), containing 5 mg L-1 
chloramphenicol, respectively.  
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Table 4.6 Complex growth medium A for first pre-cultures.  
Stock solution Volume [mL] 
Yeast extract 50 
Peptone 50 
Salt solution 10 
(NH4)2SO4 2 
K2HPO4 6 
Glucose 100 
Aqua dest. ad 1 L 
 
Table 4.7 Complex glucose based growth medium B for succinate production. 
Stock solution Volume [mL] 
Yeast extract 100 
Na2CO3 20 
(NH4)2SO4 2 
K2HPO4 6 
Glucose 100 
Aqua dest. ad 1 L 
 
Table 4.8 Industrial growth medium C for succinate production. 
Stock solution Volume [mL] 
Yeast extract 100 
Na2CO3 20 
(NH4)2SO4 2 
K2HPO4 6 
Glycerol 100 
Maltose 40 
Aqua dest. ad 1 L 
 
Table 4.9 Complex growth medium D for MgCO3-free cultivations. 
Stock solution Volume [mL] 
Yeast extract 100 
Na2CO3 20 
(NH4)2SO4 2 
K2HPO4 24 
Glucose 100 
Aqua dest. ad 1 L 
 
Table 4.10 Defined growth medium E for succinate production. 
Stock solution Volume [mL] 
Amino acid solution 20 
Salt solution 10 
Vitamin solution 1 10 
Vitamin solution 2 1 
(NH4)2SO4 2 
K2HPO4 6 
Glucose 100 
Aqua dest. ad 1 L 
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Table 4.11 Defined growth medium F for succinate production. 
Stock solution Volume [mL] 
Amino acid solution 20 
Salt solution 10 
Vitamin solution 1 10 
Vitamin solution 2 1 
(NH4)2SO4 10 
K2HPO4 6 
Glucose 100 
Aqua dest. ad 1 L 
 
 
4.3 Genetic engineering 
 
4.3.1 Strains and plasmids 
 
The wild-type strain B. succiniciproducens DD1, the mutant B. succiniciproducens ΔldhA ΔpflD and 
the mutant B. succiniciproducens ΔldhA ΔpflA were obtained from BASF SE (Ludwigshafen, 
Germany) (Table 4.12). E. coli TOP 10 was acquired from Invitrogen (Karlsruhe, Germany) and used 
for plasmid amplification. 
 
Table 4.12 Strains of B. succiniciproducens used in the present work 
Strain Modification(s) Reference 
B.succiniciproducens DD1 Wild-type BASF SE 
B.succiniciproducens DD3 
DD1 + deletion of lactate dehydrogenase ldhA and formate C-
acetyltransferase pflD 
BASF SE 
B.succiniciproducens DD5 
DD1 + deletion of lactate dehydrogenase ldhA and formate C-
acetyltransferase activator pflA 
BASF SE 
E. coli TOP 10 
F- mcrA ∆(mrr-hsdRMS-mcrBC) φ80lacZ∆M15 ∆lacX74 recA1 
araD139 ∆(ara-leu)7697 galU galK rpsL (StrR) endA1 nupG 
Invitrogen 
 
A Pasteurellaceae specific episomal replicating expression vector (Frey 1992) was applied for 
B. succiniciproducens transformation. The vector had a size of 8.1 kb, contained an origin of 
replication for E. coli and B. succiniciproducens, a multiple cloning site for site specific insert 
integration and a chloramphenicol acetyltransferase gene for antibiotic resistance (Cm
R
) as selection 
marker. Genome-based transformation was realized using the pClik int sacB Cm integrative vector. It 
had a size of 4.3 kb, contained an origin of replication for E. coli, a multiple cloning site, the 
chloramphenicol resistance and the gene sacB encoding levansucrase of Bacillus subtilis. Cm
R
 and 
sacB served as selection marker for first and second homologous recombination events during genome 
integration.  
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Table 4.13 Plasmids used for targeted genetic modification of B. succiniciproducens. 
Plasmid Specification(s) Reference 
pJFF224-XN 
Episomal vector with ORI for E. coli, mob, CmR as selection 
marker and MCS 
BASF SE 
pClik sacB Cm 
Integrative transformation vector for B. succiniciproducens with 
MCS, ORI for E. coli, and CmR and sacB as selection markers 
BASF SE 
 
Transformation vectors were constructed by using respective DNA fragments, which were amplified 
via polymerase chain reaction employing site-specific primer pairs. End primers were artificially 
modulated by insertion of appropriate restriction sites for specific integration into the vector. Purified 
DNA fragments were restricted with two appropriate enzymes and ligated into the MCS of the vector. 
 
4.3.2 Isolation of chromosomal DNA from B. succiniciproducens 
 
Cells from a cryogenic stock were incubated overnight in BHI medium. The culture broth was 
centrifuged (16,000 x g, 4 °C and 5 min) and the supernatant was discarded. Then, 400 µL lysis buffer 
(DNeasy Plant Minikit; Qiagen, Hilden, Germany) and 4 µL RNase solution (100 mg mL
-1
) were 
added to the cell pellet. The suspension was vortexed and incubated for 15 min at room temperature. 
In the next step, 130 µL neutralization buffer was added to the suspension. The mixture was kept on 
ice for 5 min. Afterwards 600 µL Roti
®
-Phenol/Chloroform/Isoamylalcohol (Carl Roth GmbH, 
Karlsruhe, Germany) were added, followed by vigorous mixing and subsequently centrifugation 
(16,000 x g, 4 °C and 10 min). The upper phase was transferred to a sterile 1.5 mL reaction tube, 
mixed with 600 µL Chloroform/Isoamylalcohol (24:1) and again centrifuged (16,000 x g, 4 °C and 
10 min). Then, the upper phase was transferred to a sterile 1.5 mL reaction tube, followed by the 
addition of 50 µL sodium acetate (3 M, pH 5.5) and 1 mL pure ethanol. The precipitated DNA was 
then pelleted by centrifugation (16,000 x g, 4 °C and 10 min). After that the supernatant was 
discarded. Subsequently, 1 mL of icecold 70 % ethanol was added. The washed DNA pellet was 
harvested by centrifugation (16,000 x g, room temperature and 1 min). Right after removing the 
supernatant the pellet was dried at room temperature for 10 min. Finally, the pellet was dissolved in 
200 µL sterile aqua dest..  
During strain construction and screening steps, DNA was routinely isolated by following a fast 
preparation protocol. In this case, cells were disrupted using glass-beads (0.10 – 0.25 mm; Retsch, 
Haan, Germany) and a mixer mill (30 sec, 30 s
-1
; Mikro-Dismembrator S, Sartorius Stedim, Göttingen, 
Germany). Cell debris was removed by centrifugation (16,000 x g, room temperature and 1 min) and 
the supernatant, containing the DNA, was transferred into a sterile 1.5 mL reaction tube.  
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DNA quantity and quality were measured using the Nanodrop
®
-Spectrophotometer ND-1000 (Thermo 
Fisher Scientific Inc., Waltham, MA, USA). DNA samples exhibiting a 260/280 ratio of 1.8 to 2.0 
were considered to be pure DNA. For genome sequencing the DNA integrity was validated with an 
0.8 % agarose gel. Isolated DNA was stored at 4 °C. 
 
4.3.3 Polymerase chain reaction 
 
The polymerase chain reaction (PCR) was performed in a Mastercycler Eppgradient (Eppendorf, 
Hamburg, Germany). A Phusion
®
 polymerase (New England Biolabs, Frankfurt, Germany), exhibiting 
a proof-reading function, was applied for genetic engineering purposes and for sequencing supported 
verification of specific nucleotide exchanges. The validation of engineered strains was completed 
using PCR master (Roche Applied Science, Mannheim, Germany), which employed the Taq 
polymerase.  
 
Table 4.14 PCR profiles for Phusion® polymerase and PCR master (annealing temperature and elongation time were chosen 
primer specifically). 
  Phusion® polymerase Taq polymerase 
 Step Temperature [°C] Time [sec] Temperature [°C] Time [sec] 
1 x Denaturation 98 120 95 120 
30 x 
Denaturation 
Annealing 
Elongation 
98 
52 – 59 
72 
10 
30 
30 per kb 
95 
52 – 59 
72 
30 
30 
60 per kb 
1 x  Elongation 72 5 72 7 
 End 10  15  
 
Appropriate primers were designed with the Primer3 tool (http://biotools.umassmed.edu/bioapps/ 
primer3_www.cgi). Afterwards, relevant restriction sites were added to the designed primers. The 
calculation of primer annealing temperature was performed using the NEB Tm Calculator Tool 
(https://www.neb.com/tools-and-resources/interactive-tools/tm-calculator=). All primers were 
purchased from Life Technologies (Carlsbad, CA, USA). Purified genomic DNA, fast prepared 
genomic DNA and purified plasmid DNA were used as PCR templates according to following 
schemes (Table 4.15 and Table 4.16). 
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Table 4.15 Reaction setup for a PCR with Phusion® polymerase. 
Component Volume [µL] Final concentration 
Phusion
®
 HF buffer (5x) 10 1 x 
dNTPs 1 200 µM 
Forward primer 0.5 1 µM 
Reverse primer 0.5 1 µM 
Template DNA Variable ~ 200 ng 
Phusion
®
 polymerase 0.5 1 U 
Nuclease free water ad 50 µL  
 
Table 4.16 Reaction setup for a PCR using Taq polymeras. 
Component Volume [µL] Final concentration 
Forward primer 0.2 1 µM 
Reverse primer 0.2 1 µM 
Template DNA Variable ~ 200 ng 
Master 10 1 x 
Nuclease free water ad 20 µL  
 
PCR amplified products were purified with the illustra GFX™ PCR DNA & Gel Band Extraction Kit 
(GE Healthcare, Solingen, Germany). A list of all primers, applied in the present work, can be found 
in the appendix (Table 9.10). 
 
4.3.4 Gel electrophoresis 
 
Gel electrophoresis was performed to analyze PCR products and RNA integrity using agarose gels 
(0.8 % w/v and 1.5 % w/v in 1 x TAE buffer, respectively). Electrophoresis was realized at 100 –
120 V for 1 to 1.5 h in an Owl B1A easy cast mini or D2 wide gel system (Thermo Fisher Scientific, 
Waltham, MA, USA) with the Power Pack P25T (Biometra, Göttingen, Germany) in 1 x TAE buffer, 
freshly prepared from a 50 x TAE buffer stock solution (Table 4.17). RNA integrity gels were carried 
out with the Biometra Compact XS/S system, applying the Power Pack P25 (Biometra, Göttingen, 
Germany). 
 
Table 4.17 Composition of 50 x TAE buffer for gel electrophoresis.  
Component  Quantity 
Tris  242.28 g 
EDTA (0.5 M, pH 8)  100 mL 
Acetic acid  52 mL 
ad 1 L aqua dest. 
 
Prior to gel loading, samples were mixed with 10 x orangeG dye (Table 4.18) or 6 x loading dye 
(Fermentas, St. Leon-Rot, Germany). 
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Table 4.18 Composition of orangeG gel loading buffer. 
Component  Quantity 
Glycerol (60 %)  50 mL 
EDTA (0.5 M, pH 8)  100 mL 
OrangeG  75 mg 
 
Visualization of DNA fragments was performed by gel staining in an ethidium bromide bath 
(0.5 mg L
-1
 ethidium bromide). Appearing DNA-ethidium bromide complexes were illustrated under 
UV light with the Gel iX Imager (Intas Imaging Instruments GmbH, Göttingen, Germany). For size 
estimation of DNA and RNA fragments, a 1 kb ladder and a 100 bp ladder were used, respectively 
(GeneRuler™, Fermentas, St. Leon-Rot, Germany). 
 
4.3.5 Construction of transformation vectors 
 
B. succiniciproducens specific expression and integrative vectors were constructed by insertion of 
PCR amplified fragments into the MCS of empty vectors pJFF224-XN and pClik sacB Cm, 
respectively (Table 4.13). Two distinct restriction sites served as integration points, since vector and 
fragment were digested with appropriate restriction enzymes (FastDigest, Fermentas, St. Leon-Rot, 
Germany) (Table 4.19).  
 
Table 4.19 Restriction enzyme digestion setup for insert and vector. 
Component Volume [µL] Final concentration 
Restriction enzyme A 1  
Restriction enzyme B 1  
FastDigest buffer (10 x) 2 1 x 
DNA  Variable 
0.2 µg (insert);                  
up to 1 µg (vector) 
ad 20 µL nuclease free water 
Incubation for 30 min at 37 °C 
 
Afterwards, the digested vector was treated with shrimp alkaline phosphatase (SAP) to prevent self-
ligation (Table 4.20). Then, the dephosphorylated vector was directly applied in the following ligation 
reaction (Table 4.21). Both steps were conducted using the Rapid DNA Dephos & Ligation Kit 
(Roche Diagnostic, Mannheim, Germany). The ligation reaction mix was directly transformed into 
E. coli TOP10 cells by heat shock or stored at -20 °C. 
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Table 4.20 Reaction setup for vector dephosphorylation. 
Component Volume [µL] Final concentration 
Vector DNA Variable up to 1 µg 
rAPid Alkaline 
Phosphatase Buffer (10 x) 
2 1 x 
SAP 1 1 unit 
ad 20 µL nuclease free water 
Incubation for 10 min at 37 °C and deactivation for 2 min at 75 °C 
 
Table 4.21 Reaction setup for ligation of vector and insert. 
Component Volume [µL] Final concentration 
Vector DNA Variable 50 ng 
Insert DNA Variable 150 ng 
Dilution buffer  (10 x) 2 1 x 
ad 10 µL nuclease free water 
Ligation buffer (2 x) 10 1 x 
T4 DNA ligase 1 5 units 
Mix thoroughly 
Incubation for 20 min at room temperature 
 
 
4.3.6 Transformation 
 
E. coli  
Competent E. coli TOP10 cells were transformed by heat shock. Aliquoted cell suspension (50 µL) 
was thawed on ice and subsequently mixed with 5 µL ligation mixture. After 30 min incubation on ice, 
cells were shocked for 45 sec at 45 °C in a thermo block (Thermomixer comfort, Eppendorf, 
Hamburg, Germany). Afterwards, cells were cooled down immediately and kept on ice for 2 min. For 
regeneration, the transformed cells were incubated for 1 h at 37 °C and 600 rpm in SOC medium. 
Then, the cells were harvested (16,000 x g, room temperature and 1 min). The supernatant was 
discarded, except a residual volume of about 200 µL, which was used for resuspension of the cell 
pellet. Transformed E. coli Top10 cells were streaked out on LB
Cm
 agar plates and incubated for 24 h 
at 37 °C. 
 
B. succiniciproducens 
Cells from a cryogenic stock were incubated overnight in BHI medium (10 mL, 37 °C and 130 rpm). 
The main culture (100 mL, 37 °C and 130 rpm), initially started with an optical density (OD600) of 0.3, 
was grown until OD600 of 0.8 and cells were then harvested by centrifugation (10,000 x g, 4 °C and 
5 min). After washing with sterile, ice-cold glycerol (10 %), the cells were resuspended in 6 mL 
glycerol (10 %) per gram cell wet weight. The electroporation time was determined by using cell 
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suspension without plasmid DNA. If the electroporation time of the control was lower than 8 ms, the 
cell suspension was further diluted with glycerol (10 %). The transformation of B. succiniciproducens 
was conducted with the GenePulser XCell (Bio-Rad, Hercules, CA, USA) at 2 kV, 400 Ω and 25 µF 
after mixing 200 µL cell suspension with 2 and 5 µg of integrative plasmids or 200 and 500 ng of 
episomal plasmids in a 2 mm electroporation cuvette. After the electroporation pulse, cells were 
regenerated for 2 h or 1h for episomal plasmids in BHI medium at 37 °C and 600 rpm (Thermomixer 
comfort, Eppendorf, Hamburg, Germany). Afterwards, the cell suspension was plated on BHI-
MOPS
Cm
 agar plates and incubated for 2 – 3 days at 37 °C. Cells carrying the episomal plasmid and 
cells that successfully past the first recombination by integration of the integrative vector were 
selected for growth via the antibiotic resistance. The existence of desired inserts was then confirmed 
by PCR. In case of integrative plasmids, a second recombination was needed. Here, positive clones of 
the first recombination were incubated in 2 mL liquid BHI medium for 1 – 2 days at 37 °C and 
130 rpm. 200 µL of a 1:100 dilution was then streaked out on BHI-Sac agar plates and incubated at 
37 °C overnight, selecting for clones which have lost the sacB gene. Additionally, to increase the 
recombination probability, 50 µL of this cell suspension was used to inoculate 2 mL liquid BHI-Sac 
medium overnight at 37 °C and 130 rpm. This step was repeated 4 times to generate 5 generations of 
second recombination clones. Two clones from each recombination generation, validated by sucrose 
resistance, were used to validate the integration of the desired modification via PCR or sequencing. 
 
4.3.7 Plasmid DNA purification 
 
The GeneJET Plasmid Miniprep Kit (Thermo Fisher Scientific, Waltham, MA, USA) was used for 
purification of plasmid DNA from E. coli cells. This was performed from 3 mL overnight culture of a 
single E. coli colony in a total of 5 mL liquid LB
Cm
 medium at 37 °C and 130 rpm. The isolation was 
conducted according to the manufacturer’s protocol. Plasmid DNA concentration was measured 
spectrophotometrically (see 4.3.2) and the plasmid was subsequently checked for the desired inserts by 
digestion or PCR. 
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4.4 Cultivation 
 
4.4.1 Strain conservation 
 
Cells from a cryogenic stock were cultivated in complex medium (LB for E. coli and medium A for 
B. succiniciproducens). Exponentially growing cells were harvested, and 500 µL cell culture was 
mixed with 500 µL sterile glycerol (86 %). The suspension was subsequently stored at -80 °C in 2 mL 
cryo culture tubes. 
 
4.4.2 Batch cultivation in serum bottles 
 
First pre-cultures of B. succiniciproducens were grown in pre-sterilized serum bottles (30 mL, sealed 
with gas-tight butyl rubber stopper) filled with 0.5 g MgCO3 as buffering agent and 10 mL of complex 
medium A. The filled bottles were inoculated from cryo stocks, amended with CO2-rich atmosphere of 
0.8 bar overpressure after 10 automatic flushing steps and then incubated on a rotary shaker (37 °C, 
130 rpm; shaking diameter 50 mm; Certomat BS-1, Sartorius Stedim S.A., Göttingen, Germany). 
During exponential growth, cells were harvested by centrifugation (16,000 x g, 4 °C and 5 min) 
including a washing step with the afterwards applied medium (Table 4.6 to Table 4.11). The obtained 
cell suspension was then used for inoculation of the second pre-culture. The conditions of the 
incubation differed depending on experimental needs, as specified below. In all cases, exponentially 
growing cells were harvested and washed with fresh medium as described above and applied as 
inoculum for the main culture, which was carried out with three biological replicates. The initial cell 
concentration was adjusted to an OD600 of 0.3. For fluxome studies, naturally labeled glucose was 
replaced by 99 % [1-
13
C] glucose in second pre- and main cultures, respectively.  
 
4.4.3 Sequential batch fermentation in serum bottles for evolutionary adaptation 
 
For adaptive evolution the serum bottle batch experiments (see 4.4.2) were extended to sequential 
batch approaches. Hereby, exponentially growing cells from a first main culture in minimal glucose 
medium served as starting culture for the adaptation. During the adaptation experiment, proliferating 
cells were harvested and washed with fresh minimal medium and subsequently employed for 
inoculating serum bottles of the next batch generation applying the same medium. The initial cell 
concentration was always adjusted to OD600 of 0.3. The cultivation was conducted in a rotary shaker 
(see 4.4.2) and adaptation parameters were set according to experimental needs. Cellular adaptation 
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was monitored with OD600 and cells were sampled at an OD600 of about 5. This procedure was 
identically repeated for all iterations, each one conducted as triplicate from the respectively best grown 
culture.  
 
4.4.4 Sequential batch fermentation in small scale bioreactors for evolutionary adaptation 
 
Cultivation was performed in a SixFors fermenter system (Infors AG, Bottmingen, Switzerland) to 
monitor and control the pH (Mettler Toledo, Gießen, Germany). Cells from a serum bottle main 
culture (see 4.4.2) using minimal glucose medium were taken as starting culture for adaptation 
purposes and prepared by a washing step in fresh minimal medium. Initial cell concentration was 
adjusted to an OD600 of 0.3 and the starting pH was set to experimental needs by adding 0.5 M H3PO4. 
During cell proliferation the pH of the broth was maintained at a desired value by automatically 
controlled addition of 1 M Na2CO3. The added volume was calculated by measuring the pumping 
time. Cultivation was operated at a temperature of 37 °C, a stirrer speed of 500 rpm and a constant 
CO2-sparging at 0.1 NL h
-1
. Each iteration was conducted as a single experiment, during which the cell 
density and thus evolutionary progress was monitored by measuring OD600.  
 
4.4.5 Bioreactor cultivation 
 
Alternatively, B. succiniciproducens was cultivated in 1 L bioreactors (DASGIP AG, Jülich, 
Germany) with a working volume of 300 mL employing a 6-blade Rushton impeller. The DASGIP 
control 4 software (DASGIP AG, Jülich, Germany) was applied for online monitoring. Temperature of 
37 °C was controlled by the bioblock temperature control system TC4 (DASGIP AG, Jülich, 
Germany). A constant pH of 6.5 was maintained by on-line measurement with a pH electrode (Mettler 
Toledo, Gießen, Germany) in combination with the system PH4PO4 and 1 M Na2CO3 applying the 
miniature peristaltic pump of module MP8 (DASGIP AG, Jülich, Germany). The pumped volume was 
automatically monitored during batch fermentation. Anaerobic conditions, i.e. dissolved oxygen levels 
below 2 %, were adjusted by CO2-sparging with 0.1 NL h
-1
. The conditions were verified by a pO2 
electrode (Visiferm™ DO sensor, Hamilton, Bonaduz, Switzerland) using the DASGIP system 
PH4PO4. The cultivation was operated at 37 °C, 500 rpm and a controlled pH set-point of 6.5. The 
applied minimal medium E was inoculated with freshly grown cells from 100 mL serum bottles, 
containing 50 mL cultivation broth with 30 g L
-1
 MgCO3. The cells were harvested (8500 x g, 4 °C 
and 5 min), washed with prepared fresh culture minimal medium and subsequently used as inoculum. 
Batch fermentations were started at an optical density of 0.3.  
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4.5 Analytical procedures 
 
4.5.1 Cell concentration 
 
During cultivation, the cell concentration was measured as optical density by spectrometry (Libra S11, 
Biochrome, Cambridge, UK) at 600 nm (OD600) in 1.6 mL semi-micro cuvettes (Sarstedt, Nümbrecht, 
Germany). To remove residual MgCO3 and to obtain optical density values between 0.05 and 0.3, cells 
were appropriately diluted with 1 M HCl. Exact dilution factors were determined gravimetrically on 
an analytical balance (CP225D, Sartorius, Göttingen, Germany). 
 
4.5.2 Quantification of glucose 
 
Supernatants from culture broth were obtained by centrifugation (16,000 x g, 4 °C and 5 min). The 
analytical quantification of glucose concentration was carried out enzymatically using the STAT 2300 
Plus™ (YSI Life Sciences, Yellow Springs, OH, USA) after diluting samples with water as described 
above.   
 
4.5.3 Quantification of organic acids 
 
Culture supernatants were prepared as described above. Organic acids and ethanol were quantified 
using HPLC (LaChromElite, VWR Hitachi, West Chester, PE, USA) employing an Aminex HPX-87H 
column (300 x 7.8 mm; BioRad, Hercules, CA, USA) as stationary phase and 12 mM H2SO4 as mobile 
phase at 0.5 mL min
-1
 and 45 °C. The compounds were detected using refractive index (RI). 
 
4.5.4 Quantification of intracellular amino acids 
 
Intracellular amino acids were quantified from cell extracts (see 4.5.8) with α-aminobutyric acid as 
internal standard. The analysis was performed by HPLC (Agilent Series 1200; Agilent Technology, 
Waldbronn, Germany) as previously described (Krömer et al. 2005). Analytes were derivatized prior 
to injection, using o-phthaldialdehyde (OPA) and subsequently separated on a RP column (Gemini 5μ 
C18 110A, 150 x 4.6 mm; Phenomenex, Aschaffenburg, Germany) equipped with a precolumn 
(Gemini C18, MAX-RP, 4 x 3 mm; Phenomenex, Aschaffenburg, Germany) as stationary phase.  
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Table 4.22 Profile of mobile phase gradient applying eluent A (40 mM NaH2PO4, pH 7.8) and eluent B (45 % acetonitrile, 
45 % methanol, 10 % MilliQ) for separation and quantification of intracellular amino acids. 
Time [min] Eluent A [%] Eluent B [%] 
0.0 100.0 0.0 
40.5 59.5 40.5 
41.0 39.0 61.0 
43.0 39.0 61.0 
57.5 0.0 100.0 
59.5 0.0 100.0 
60.5 25.0 75.0 
61.5 50.0 50.0 
62.5 75.0 25.0 
63.5 100.0 0.0 
65.5 100.0 0.0 
 
Separation of amino acids was obtained by a gradient (Table 4.22) of applied mobile phase A (40 mM 
NaH2PO4, pH 7.8) and B (45 % acetonitrile, 45 % methanol, 10 % MilliQ) at 1 mL min
-1
 and 40 °C. 
OPA-derivated amino acids were detected using a fluorescence detector (340 nm excitation, 540 nm 
emission; Agilent, Waldbronn, Germany). 
 
4.5.5 Analysis of mass isotopomers by GC/MS 
 
The mass isotopomer fractions of proteinogenic amino acids from biomass and of succinate from 
culture broth supernatant were determined by GC-MS (Wittmann et al. 2002). About 1 mg biomass, 
harvested from exponentially growing cells, was washed with 1 M HCl until MgCO3 was completely 
removed. The cells were then hydrolyzed in 100 µL 6 M HCl for 24 h at 105 °C. Insoluble matter was 
cleared by filtration (Ultrafree-MC filter devices, 0.22 μm durapore membrane; Millipore, Billerica, 
MA, USA). Afterwards, the filtrate was dried under ambient nitrogen stream, resuspended in 50 µL 
dimethylformamid (0.1 % pyridine) and derivatized with 50 µL N-methyl-N-tert-butyl-dimethylsilyl-
trifluoracetamid (MBDSTFA; Macherey-Nagel, Düren, Germany) for 30 min at 80 °C. Possible salt 
precipitates were eliminated by centrifugation (1,177 x g, room temperature and 1 min). The labeling 
pattern of succinate was measured from dried culture supernatants (Becker et al. 2013), which were 
processed analog to the biomass procedure. The measurement of mass isotopomers was conducted 
with a GC/MS system, consisting of a HP 6890 gas chromatograph (Hewlett Packard, Paolo Alto, 
California, USA) employed with an HP-5MS GC column (5%-Phenyl-methylpolysiloxane; 30 m x 
0.25 mm x 0.25 µm; Agilent, Waldbronn, Germany) and a quadrupole MS 5973 (Agilent, Waldbronn, 
Germany) for detection. Helium was applied as carrier gas with a flow rate of 1.7 mL min
-1
. The inlet 
temperature was set to 250 °C, interface and quadrupole temperature were set to 280 °C. Electron 
ionization was performed at 70 eV. The injection volume was 1 µL and each sample was measured in 
duplicate. A potential isobaric interference of the analytes and matrix components was checked by first 
measurements in scan mode. Labeling patterns of amino acids were then determined by selective ion 
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monitoring (SIM) of preferred ion clusters after GC-separation using a temperature gradient 
(Table 4.23). 
 
Table 4.23 Temperature profile of GC oven for measurements of labeling patterns of amino acids and succinic acid. 
Time [min]  Temperature [°C] 
0.0  120 
2.0  120 
12.0  200 
24.5  325 
27.0  325 
 
Table 4.24 Mass fragments of analytes as MBDSTFA derivates used for flux calculation. 
Analyte M0 (m/z) Fragment Carbon atoms 
Alanine 260 M-57 C1 – C3 
 232 M-85 C2 – C3 
Glycine 246 M-57 C1 – C2 
 218 M-85 C2 
Aspartate 418 M-57 C1 – C4 
 390 M-85 C2 – C4 
Threonine 404 M-57 C1 – C4 
 376 M-85 C2 – C4 
Serine 390 M-57 C1 – C3 
 362 M-85 C2 – C3 
Phenylalanine 336 M-57 C1 – C9 
Tyrosine 466 M-57 C1 – C9 
    
Succinate 289 M-57 C1 – C4 
 
Amino acids and succinate were identified via retention time and fragmentation pattern from a 
standard of amino acids and succinate, respectively. The fragments [M-57] and [M-85] specific for 
MBDSTFA derivatization were taken for flux determination (Table 4.24). 
 
4.5.6 Genome sequencing of B. succiniciproducens strains 
 
Next generation sequencing was performed by the company BaseClear B.V. (Leiden, Netherlands). In 
a first step, 50 bp single reads were generated using the Illumina HiSEQ2500 platform and compiled 
to FASTQ sequence reads applying Illumina Casava pipeline (version 1.8.2), accompanied by two 
quality assessments (Illumina Chastity filtering and FASTQC quality control 0.10.0). Subsequent de 
novo assembly was performed with CLC Genomics Workbench (version 5.0; Aarhus, Denmark). 
Afterwards, the DD1 contigs (reference) were annotated using Genostar’s IOGMA based on the 
MicroB database (Montbonnet, France) integrating several online databases. All other genomes were 
aligned to the DD1 genome and subsequently, polymorphisms were analyzed using CLC Genomics 
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Workbench (version 5.1; Aarhus, Denmark). The calling of false positive was reduced by minimizing 
the variant frequency to 75 % and setting the coverage to five. 
  
4.5.7 Gene expression analysis 
 
Preparation of total RNA 
During bioreactor cultivation, cells were harvested and 14 mL cell suspension was mixed with 2 mL 
RNA Later
®
 (Ambion
®
 Life Technologies, Darmstadt, Germany) and subsequently aliquoted to 2 mL 
reaction tubes. After centrifugation (16,000 x g, room temperature and 20 sec) the supernatant was 
carefully discarded. The cell pellet was immediately frozen in liquid nitrogen and stored at -80 °C 
until further processing. The column based RNA preparation was performed with the RNeasy
®
 Plus 
Mini Kit (Qiagen, Hilden, Germany). The individual steps of the purification were performed 
according to the manufacturer’s protocol. Prior to RNA extraction, cell pellets were lyophilized 
overnight (Alpha 1-4 LD plus, Christ, Osterode, Germany). The dried cell pellets were then transferred 
into 1 mL cryo-tubes (Nalgene Nunc, Rochester, NY, USA) each containing a grinding ball (diameter: 
10 mm; Sartorius Stedim, Göttingen, Germany), and cooled in liquid nitrogen. The biomass was then 
homogenized using a laboratory ball mill (Mikro-Dismembrator S, Sartorius Stedim, Göttingen, 
Germany) at 3000 min
-1
 for 10 sec. The disrupted cells were resuspended in 600 µL lysis buffer (RLT 
Plus, containing 1 % v/v ß-mercaptoethanol), gently mixed by inversion and transferred into a new 
1.5 mL reaction tube, followed by 2 min incubation at 56 °C. The complete lysis solution was then 
transferred to a QiaShredder
TM
 column (Qiagen, Hilden, Germany) and centrifuged (10,000 x g, room 
temperature and 30 sec). The flow-through was directly transferred to a gDNA eliminator column and 
centrifuged (10,000 x g, room temperature and 30 sec), followed by the addition of 600 µL ethanol 
(70 %). After mixing carefully, the solution was transferred in two steps to an RNeasy mini column 
and centrifuged (10,000 x g, room temperature and 15 sec). The flow through was discarded and the 
column was washed once with RW1 buffer. A volume of 80 µL of a freshly prepared DNase solution 
(10 µL DNase I stock solution plus 70 µL RDD buffer; Qiagen, Hilden, Germany) was added to the 
column, which was placed into a new 1.5 mL reaction tube and subsequently incubated (600 sec
-1
, 
28 °C and 30 min). Afterwards, the column was washed with 350 µL RW1 buffer, placed into a new 
2 mL reaction tube, followed by three additional washing steps applying 500 µL buffer RPE 
(10,000 x g, room temperature and 2 min). RNA was eluted into a sterile 1.5 mL reaction tube by 
centrifugation (10,000 x g, room temperature and 2 min) within three steps using each 20 µL RNA 
free water. Purified RNA was stored at -80 °C. RNA quantification was performed using the 
Nanodrop
®
-Spectrophotometer ND-1000 (Thermo Fisher Scientific Inc., Waltham, MA, USA), 
followed by an 1.5 % agarose gel based quality control. Specific RNA quality was controlled using the 
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RNA 6000 Nano LabChip Kit with the 2100 Bioanalyzer (Agilent, Santa Clare, CA, USA). Quality 
criteria were set to a 23S/16S ratio higher than 1.5 and a RNA integrity number (RIN) above 8.  
 
DNA microarray analysis 
Comparative gene expression analysis was realized by application of a customized DNA microarray. 
For this purpose, all annotated genes derived from B. succiniciproducens genome sequencing were 
compiled and used for the array design in the online software Agilent eArray 
(https://earray.chem.agilent.com/). The employed format was an 8 x 15 k slide containing 8 arrays 
with a maximum of 15,000 probes. The oligonucleotide probe design was carried out applying 
following parameters: (i) preferred probe length of 60 bp, (ii) 3 probes per target gene, (iii) double 
coverage of all target genes, (iv) antisense probe orientation, and (v) melting temperature of 80 °C. 
The customized DNA microarray featured 14152 probes, whereas 536 Agilent probes served as 
control and 13616 probes represented three replicates of each target gene in twofold coverage. 
Fluorescence labeling was completed via direct chemical labeling of 1 µg purified RNA using the 
ULS Fluorescent Labeling Kit (Kreatech Diagnostics, Amsterdam, Netherlands) according to its 
protocol. Quality control of labeling degree was obtained with the Nanodrop
®
-Spectrophotometer ND-
1000 (Thermo Fisher Scientific Inc., Waltham, MA, USA) after removing residual labeling agent with 
KREApure columns (Kreatech Diagnostics, Amsterdam, Netherlands). 300 ng of the Cy3 or Cy5 
labeled RNA were fragmented in blocking agent and fragmentation buffer (Agilent, Santa Clare, CA, 
USA) for 30 minutes at 60 °C. The competitive hybridization was obtained by mixing equal amounts 
of differently labeled RNA, priorly diluted in 25 µL hybridization buffer, respectively. Then, 40 µL of 
a total of 50 µL mixture were used to load a gasket well on the gasket slide. After completing this step 
for all samples, the gasket slide was assembled with the microarray and hybridized (10 rpm, 65 °C and 
17 h). After incubation, the microarray was disassembled and washed for 1 min in gene expression 
buffer 1 (Agilent, Santa Clare, CA, USA), followed by 1 min incubation in pre-warmed gene 
expression buffer 2. Microarray analysis was performed with the Agilent C Scanner (Agilent, Santa 
Clare, CA, USA) at 532 nm and 635 nm. Scanning and extraction was conducted using the Agilent 
Scan Control and Feature Extraction software (Agilent, Santa Clare, CA, USA). Extracted raw data 
was further processed using R programming language and bioconductor (Yang and Paquet 2005). For 
gene specific data interpretation, genes from three biological replicates exhibiting a p value < 0.05 
combined with a |log2FC| > 0.8, describing a 1.7 fold change, were considered to be differentially 
expressed concerning operon regulation. Single gene expression relevance was set to a fold change of 
2.0. A global perspective of gene expression was gained using the gene set enrichment analysis 
(GSEA) tool (Subramanian et al. 2005) comprising all COG assigned genes according to 
M. succiniciproducens annotation (Hong et al. 2004). For this purpose 2291 designated gene 
sequences were taken from the DNA chip design, whereof 1900 genes could be assigned to proposed 
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gene clusters. For each GSEA analysis, 1000 permutations were conducted with the gene set as 
permutation type, while the genes were ranked according to the metric log2 values. Significantly 
changed gene sets were determined by p-values below 0.01 and a false discovery rate below 5 %.  
 
4.5.8 Metabolome analysis 
 
Sampling by fast filtration 
Intracellular amino acids were sampled by fast filtration, adapted from a validated protocol for other 
microorganisms (Bolten et al. 2007). Hereby, 2 mL exponentially growing cells from minimal glucose 
medium cultures were harvested by vacuum filtration (cellulose nitrate filter, 0.2 μm pore size, 
diameter 25 mm; Sartorius, Göttingen, Germany). Sampling included an additional washing step with 
5 % NaCl solution. The whole procedure was finished in less than 30 sec. Sampling was conducted at 
two cell concentrations, corresponding to OD600 of 3 and 5, respectively. Cultivations were performed 
with two biological replicates.  
 
Metabolite extraction 
The filter with attached cells was used for metabolite extraction. For this purpose, it was incubated for 
with 2 mL α-aminobutyric acid (200 µM) as internal standard for quantification in a sealable plastic 
cup (15 min in boiling water). Subsequently, the extraction mix was cooled down on ice. The 
suspension was transferred into a sterile 2 mL reaction tube and centrifuged (13,000 x g, 4 °C and 
5 min). Finally, the obtained extract was directly used for intracellular amino acid quantification or 
stored at -20 °C until further processing. 
 
4.5.9 Enzyme activity assays 
 
Preparation of crude cell extract 
Cells were harvested by centrifugation (10,000 x g, 4 °C and 5 min). To avoid residual MgCO3, cells 
pelleting above the insoluble MgCO3 from the medium, were removed with a spatula and washed with 
ice-cold 250 mM citric acid. A second washing step was then conducted, whereby the washing 
solution was chosen according to the need of the subsequent assay. Afterwards, cells were 
resuspended in the respective buffer. Cell disruption was carried out after adding two spatula tips of 
glass beads (0.10 – 0.25 mm; Retsch, Haan, Germany) to 500 µL of cell suspension in 2 mL reaction 
tubes with a laboratory ball mill (30 sec
-1
 for 30 sec; Mikro-Dismembrator S, Sartorius Stedim, 
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Göttingen, Germany). The cell debris was separated by centrifugation. The obtained supernatant was 
then used for enzyme assays and quantification of protein concentration. 
 
Determination of protein concentration 
Protein concentration of crude cell extracts was determined with the Pierce
TM
 BCA Protein Assay Kit 
(Thermo Fisher Scientific, Waltham, MA, USA). For calibration purposes, a bovine serum albumin 
stock solution was diluted according to the protocol. Cell extracts were diluted 1:10. Samples and 
standards were subsequently mixed with prepared working reagent. After incubation (37 °C and 
30 min) the absorption was measured by spectrometry at 562 nm. The respective protein concentration 
was calculated with the slope of a standard curve, obtained by plotting the measurement of each 
standard versus its concentration.  
 
Pyruvate kinase activity assay 
The washing buffer consisted of 100 mM TRIS HCl (pH 7.0). Pyruvate kinase activity assays were 
performed at 37 °C in a total volume of 200 µL in 96-well plates employing the micro titer plate 
reader SUNRISE (Tecan, Crailsheim, Germany). The reaction mix contained 15 mM MgCl2, 1 mM 
ADP, 0.25 mM NADH, phosphoenolpyruvate (PEP), 5.5 U mL
-1
 lactate dehydrogenase and 2.5 µL 
cell extract. For enzyme kinetic studies, PEP was added to a final concentration of 1, 2.5, 5, 10, 25, 50 
and 75 mM, respectively. Negative controls were carried out without PEP and without cell extract, 
respectively. The decline of NADH extinction was monitored at 340 nm (Magellan
TM
 data analysis 
software; Tecan, Crailsheim, Germany). All experiments were carried out with three biological 
replicates. The extinction coefficient for NADH at 340 nm is 6,220 M
-1
 cm
-1
. One unit of enzyme 
activity correlates to the amount of enzyme catalyzing the conversion of one micro mole of substrate 
per minute. 
 
4.5.10 Metabolic flux analysis 
 
Metabolic flux experiments were carried out with [1-
13
C] glucose as tracer substance and with two 
biological replicates. For minimizing effects of unlabeled biomass, the second pre-culture was already 
conducted on [1-
13
C] glucose. The metabolic network for B. succiniciproducens was taken from 
Becker et al. 2013. It contained all essential reactions for succinate formation based on glucose. 
Reversible reactions were defined as netto fluxes. Pyruvate and PEP, as well as oxaloacetate (OAA) 
and malate (Mal), respectively, were lumped into joint metabolite pools each, because the fluxes 
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between the single pools could not be resolved by the applied tracer substance [1-
13
C] glucose 
(Wittmann and Heinzle 2001a). Anabolic precursor demand was calculated from cellular composition 
of B. succiniciproducens biomass (Becker et al. 2013). The labeling data of the proteinogenic amino 
acids and of succinate from culture supernatant (Table 4.24), respectively, were combined with 
stoichiometric data (biomass yield, succinate yield, by-product yields and glucose uptake) from at 
least three biological replicates for calculation of metabolic fluxes. The simulation of metabolic fluxes 
was performed with an OpenFlux implementation (Quek et al. 2009) in MATLAB 7.6 (Mathworks 
Inc., Natick, MA, USA). OpenFlux directly corrected the raw mass spectrometry data for natural 
isotope abundance and fitted unknown flux parameters from the labeling data by isotopomer and 
metabolite balancing. The iterative fitting process finally generates a set of fluxes with minimized 
deviation between simulated and measured isotopomers, which was considered as best calculated 
intracellular flux distribution (Wittmann et al. 2002; Wittmann 2007). Statistical evaluation of the 
fluxes was conducted by a Monte-Carlo approach. Flux estimation from 50 independent calculations 
was used to determine 90 % confidence intervals for the flux parameters. 
 
4.5.11 Phenotypic microarray analysis 
 
Phenotypic characterization of B. succiniciproducens was conducted by the Omnilog
®
 PM system 
(Biolog, Hayward, CA, USA), using the carbon source plates PM1 and PM2 provided by the 
manufacturer. Cells were obtained by overnight incubation in liquid BHI medium. Then, 100 µL of the 
suspension was plated on BHI-MOPS agar plates and incubated for 24 h at 37 °C. Further processing 
was conducted according to the manufacturer’s protocol using the Redox Dye Mix D (Biolog, 
Hayward, CA, USA). 100 µL cell suspension was pipetted into each well. The prepared plates were 
wrapped in gas-tight bags (Biolog, Hayward, CA, USA), equipped with CO2Gen paper sachets 
(Oxoid, Thermo Fisher Scientific, Waltham, MA, USA) to create a carbon dioxide rich atmosphere 
and subsequently sealed with tape. Data acquisition was carried out for 48 h at 37 °C. Each type of 
plate was incubated as duplicate and the metabolic activity was analyzed by the area under curve 
(AUC) applying the opm package implemented in R (Vaas et al. 2012).  
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5 Results and Discussion 
 
The present work aimed at the development of superior strains of B. succiniciproducens for bio-
succinate production. Beyond previous rational, metabolic engineering strategies for reduced by-
product formation and enhanced product yield (Becker et al. 2013), this bacterium should be improved 
towards better process robustness, a key to its successful implementation into industrial production. As 
molecular mechanisms, that could provide enhanced tolerance to specific process configurations, are 
unknown, an evolutionary strategy was chosen to design superior phenotypes of interest. 
 
 
5.1 Production performance and basic physiological properties of 
B. succiniciproducens 
 
First experiments focused on the characterization of basic physiology of B. succiniciproducens. Its 
tolerance to extreme temperature, product concentration and pH-values should provide an insight into 
its natural robustness and possible strategic points for evolutionary adaptation. 
 
Figure 5.1 Growth (A) and production (B) performance of (●) B. succiniciproducens DD1 and its engineered derivative (▲) 
B. succiniciproducens DD3 in minimal glucose medium. Data and standard deviations derive from three biological replicates. 
 
The comparison of B. succiniciproducens DD1 and DD3, grown in minimal media, clearly illuminates 
the advantage of the rational strain development (Figure 5.1). The specific succinate yield of DD3 was 
increased by about 50 %, as compared to the wild-type (Table 5.1). Unfortunately, this improvement 
went along with detrimental growth effects. Deletion of lactate and formate pathways unbalanced the 
metabolic redox state, which is obviously linked to biomass formation, as observed from the decreased 
specific biomass yield and specific growth rate.  
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Table 5.1 Physiology of B. succiniciproducens DD1 and DD3. The data comprise specific growth rate (µ), biomass yield 
(YX/S), succinate yield (YSuc/S), formate yield (YFor/S), acetate yield (YAce/S), lactate yield (YLac/S), ethanol yield (YEtOH/S), 
pyruvate yield (YPyr/S) and maximal succinate productivity (PSuc). Data represent values from three biological replicates 
during exponential growth in complex and in minimal glucose medium with corresponding standard deviations. 
 Complex medium Minimal medium 
 DD1 DD3 DD1 DD3 
µ [h
-1] 0.64 ± 0 0.19 ± 0.01 0.29 ± 0.01 0.16 ± 0.01 
YX/S [g mol
-1] 62.4 ± 3.1 43.7 ± 3.3 35.6 ± 0.2 29.8 ± 2.5 
YSuc/S [mol mol
-1] 0.77 ± 0.02 1.18 ± 0.03 0.76 ± 0.03 1.13 ± 0.04 
YFor/S [mol mol
-1] 0.97 ± 0.02 < 0.01 0.58 ± 0.02 < 0.01 
YAce/S [mol mol
-1] 0.83 ± 0.05 0.34 ± 0.01 0.57 ± 0.01 0.21 ± 0.06 
YLac/S [mol mol
-1] < 0.01 < 0.01 0.03 ± 0 < 0.01 
YEtOH/S [mol mol
-1] 0.15 ± 0.01 < 0.01 0.03 ± 0 < 0.01 
YPyr/S [mol mol
-1] < 0.01 22.6 ± 0.02 < 0.01 0.16 ± 0.03 
PSuc [g L
-1 h-1] 1.31 ± 0.05 1.12 ± 0.07 1.42 ± 0.04 0.76 ± 0.01 
The yields were determined by linear fitting of the concentration of biomass and product with that of the substrate. 
 
Regarding the evolutionary adaptation approach, DD3, exhibiting a high specific yield for succinate 
seemed to be the most promising candidate. In addition, deletion of by-product pathways narrowed the 
degrees of freedom of the selection pressure down, i.e. cells can no longer adapt by redirection of flux 
into non-beneficial redox balancing.  
 
Impact of high temperature  
The cultivation temperature is a relevant process parameter. It strongly affects overall production costs 
by the linkage to microbial kinetics, i.e. productivity and by the efforts for cooling needs. In addition, 
temperatures beyond the growth optimum of contaminants can minimize the contamination risk.  
 
Figure 5.2 Influence of temperature on growth of the wild-type B. succiniciproducens DD1 in (●) complex medium A and 
(○) minimal medium F. The data represent mean values of three biological replicates with standard deviations. The growth is 
given as exponential growth rate at each temperature (µ). 
 
Results and Discussion 
46 
To this extent, the influence of temperature on B. succiniciproducens DD1 was evaluated in growth 
experiments in serum bottles and within a temperature range of 30 °C to 45 °C (Figure 5.2). Hereby, 
complex and minimal medium were applied. Temperatures below 37 °C decreased DD1 proliferation. 
At 30 °C, the specific growth rate was only 50 % of that at 37 °C. However, the strain was able to 
grow exponentially in complex and minimal medium, respectively, while producing succinate as main 
fermentation product. The maximal performance, regarding growth rate, succinate yield and 
productivity was observed between 37 and 39 °C reflecting the temperature of bovine rumen, the 
natural habitat of the bacterium. Under these conditions, DD1 produced almost 30 g L
-1
 succinate in 
24 h, while additionally forming lower amounts of acetate, formate and lactate. A cultivation 
temperature of 42 °C fully inhibited growth in minimal medium. Here, only an initial increase in cell 
concentration could be observed. Complex medium still enabled growth at 42 °C, however, at a 
drastically reduced growth rate. This implies specific metabolic pathways that probably relate to 
biosynthesis, which fail at 42 °C, but can be compensated by complex medium ingredients. This 
would also fit to the initial phase of growth in minimal medium. Here, intracellular pools of affected 
metabolites, derived from pre-cultures, could provide a reservoir, which then rapidly depletes. At 
45 °C, DD1 showed no growth in both media. The obtained results agreed with the growth behavior of 
other mesophilic bacteria, obviously linked to the natural habitat of B. succiniciproducens and its 
phylogenetic relatives (Scholten and Dägele 2008; Lee et al. 2002). The increased temperature 
tolerance by complex nutrients appeared promising with regard to the planned evolutionary 
adaptation, as the bacterium showed basic robustness with selective sensitive pathways. 
As shown, B. succiniciproducens DD1 revealed severe growth problems when cultivated in minimal 
medium at elevated temperatures (Figure 5.2). Considering this effect, the support of growth 
performance was first rationally analyzed by adding defined compounds (Table 5.2). The chosen 
amino acids have been previously identified as stimulatory or even essential for M. succiniciproducens 
MBEL55E (Song et al. 2008). Methionine seemed promising, since the first enzyme in methionine 
synthesis, homeserine O-transsuccinylase, is heat-sensitive in E. coli (Ron and Davis 1971; 
Mordukhova et al. 2008). In addition, compatible solutes were selected, due to the mediation of 
temperature tolerance in bacteria (Arakawa and Timasheff 1985; Lippert and Galinski 1992; Caldas et 
al. 1999; Bourot et al. 2000).  
None of the amino acid could restore growth at 42 °C (Table 5.2). Among the compatible solutes, only 
glycine betaine enabled growth of DD1 at 42 °C, whereas the other supplements had no effect. This is 
coherent with observations that glycine betaine prevents temperature-induced protein aggregation 
(Caldas et al. 1999) and induces increased thermal stability (Arakawa and Timasheff 1985; Lippert 
and Galinski 1992). 
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Table 5.2 Impact of specific medium ingredients on growth of B. succiniciproducens DD1 at 42°C in defined glucose-based 
medium. 
Compound Concentration [mM] Growth 
Alanine 5 - 
Asparagine 5 - 
Aspartic acid 5 - 
Cystein 5 - 
Methionine 5 - 
Proline 5 - 
Glycine betaine 1 + 
Ectoine 1 - 
Hydroxyectoine 1 - 
 
This finding suggested that temperature sensitivity of B. succiniciproducens DD1 was mainly caused 
by denatured proteins. Recapitulating, the addition of glycine betaine that is already applied in animal 
feedstuff and agro industry (Mäkelä 2004), appeared as one straightforward possibility to improve 
process performance of B. succiniciproducens. But, as this would add extra costs to the process, 
evolutionary adaptation was performed next to eventually create a new temperature phenotype. 
 
Impact of high succinate levels 
The product titer represents a key performance indicator of industrial competitiveness of bioprocesses 
and is highlighted in various reports as major prerequisite, i.e. desired values of about 100 g L
-1
 
(Werpy and Peterson 2004; Patel et al. 2006; Bastidon 2012). In this line, product tolerance displays a 
target for improvements. Indeed, succinate producers show sensitivity to high levels of succinate 
(Table 5.3) and the inhibition can be described by a linear relationship (Equation 1) (Lin et al. 2008). 
  
Table 5.3 Succinate tolerance of succinate producing bacteria. 
Strain Medium Succinate [g L-1] Reference 
Actinobacillus succinogenes  Complex (Glc, YE, Vit) 104.6  a (Lin et al. 2008) 
Actinobacillus succinogenes 130Z Complex (Glc, Cas, SP)  50  b (Li et al. 2010) 
Escherichia coli AFP111 Complex (Glc, YE, T) 80  b (Li et al. 2010) 
Mannheimia succiniciproducens 
MBEL55E LPK7 
Complex (Glc, YE) 5.1  a (Hoon et al. 2010) 
Basfia succiniciproducens DD3 Minimal (Glc, Vit) 19.1 a this work 
Medium components: Glc: glucose, YE: yeast extract, Cas: pancreatic digested casein, SP: soy peptone, T: tryptone, Vit: 
vitamins. 
a depicts calculated critical succinate concentration according to Lin et al. 2008 
b shows experimental data for tolerated final concentration of succinate for the growth according to Li et al. 2010  
 
 
 
Results and Discussion 
48 
 
Product tolerance was estimated for the producing strain B. succiniciproducens DD3 by conducting 
serum bottle experiments on minimal medium buffered with MgCO3. Succinate was added from a 
stock solution, after neutralization with 1 M NaOH, to a level of 2.5, 5, 7.5, 10, 15, and 20 g L
-1
, 
respectively, prior to inoculation. 
 
Figure 5.3 Influence of succinate on growth of B. succiniciproducens DD3 in minimal medium with (●) no, (■) 2.5 g L-1, 
(▲) 5 g L-1, (▼) 7.5  g L-1, (◄) 10 g L-1, and (►) 15 g L-1 succinate (A) and linear correlation between growth, pictured by 
normalized specific growth rate at each succinate level, and the succinate concentration (B). Maximal observed specific 
growth of 0.16 h-1 was set to 100 %. Data represent mean values from three biological replicates with corresponding standard 
deviations. 
 
As can be seen, cell growth was significantly inhibited by increasing succinate levels (Figure 5.3). 
With 20 g L
-1
 succinate, cells did not grow. Obviously, the resulting growth rate correlated linearly 
with the level of succinate (Figure 5.3), yielding a critical concentration (µ = 0) of nearly 20 g L
-1
, 
calculated according to the generalized Equation 1. Compared to other succinate producing 
microorganisms, B. succiniciproducens DD3 exhibited a moderate succinate tolerance (Table 5.3). 
Care has to be taken, because all other studies were carried out in complex media (Lin et al. 2008; 
Hoon et al. 2010; Li et al. 2010), while here, DD3 was cultivated in a minimal, defined medium. As 
discussed above, complex media can cover metabolic imbalances, since they provide ready to use 
substrates and enable basically interrupted or retarded pathways and thus facilitate more robustness. In 
comparison with M. succiniciproducens MBEL55E, the closest relative, B. succiniciproducens 
revealed a higher tolerance. 
 
 
 
(Equation 1) 
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Impact of low pH-value 
The industrial relevance of the pH-value results from specific downstream processing needs for 
organic acids. These are typically recovered from fermentation broth using calcium salts for 
precipitation (Kurzrock and Weuster-Botz 2010). After precipitation, the calcium salt of succinic acid 
has to be acidified for further preparations. This step requires large amounts of sulfuric acid, which 
can be reduced by a lower final fermentation pH. In special cases, calcium carbonate can be applied, 
which advantageously combines pH buffer function and carbon dioxide supply. This is beneficial for 
fermentative succinate production, but causes a slightly acidic pH of 5.8 in the medium under carbon 
dioxide saturated conditions. 
 
Figure 5.4 Growth of B. succinicproducens at (●) pH 6.0, (■) pH 5.5 and (▲) pH 5.3 in defined medium F during a pH-
controlled cultivation. 
 
To unravel the influence of an acidic pH on the growth behavior of B. succiniciproducens, the 
producing strain DD3 was grown at different pH-values in pH-controlled bioreactors applying 
minimal medium (Figure 5.4). While pH 6.0 allowed reasonable growth, pH 5.5 caused a pronounced 
lag-phase of about 15 h and slower growth. At a pH of 5.3, growth was almost fully inhibited. Further 
decrease to pH 5.0 completely eliminated growth of the cells. In addition to growth, the succinate 
production was severely inhibited by low pH. Whereas about 33 g L
-1
 succinate were achieved at pH 
6.0, only 9 g L
-1
 were produced at pH 5.5. No succinate production occurred at the lowest pH-value of 
5.3. 
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5.2 Evolutionary adaptation of B. succiniciproducens DD3 towards high 
temperature 
 
5.2.1 Evolutionary adaptation towards a new temperature phenotype 
 
The addition of single media supplements indicated the complexity of temperature sensitivity, since no 
single substance could overcome the growth inability at 42 °C. In this line, growth recovery at 
elevated temperatures was tackled by evolutionary adaptation. This approach generates novel 
phenotypes, which emerge under specific imposed conditions by natural selection of the fittest. As 
starting point, the double knockout mutant B. succiniciproducens DD3, lacking the ldhA and pflD 
genes to eliminate formation of lactate and formate appeared most promising. Despite its slower 
growth performance, DD3 has a 50 % increased succinate yield as compared to the wild-type (Becker 
et al. 2013). In this regard, DD3 possessed a high potential for valuable phenotype improvement. The 
lack of by-product forming pathways to lactate and formate reduced the adaptation probability of 
redirecting carbon flux into undesired redox balancing pathways. The following evolutionary 
adaptation was conducted in minimal medium to avoid accumulation of side-mutations in bio-
synthetic pathways that would not have been recognized in complex medium. In order to realize the 
evolutionary adaptation, B. succiniciproducens DD3 was cultivated applying a repeated batch method. 
The formed cell concentration served as criterion to evaluate the adapted population. The cultivation 
time of each of the batches was extended until a cell concentration was reached, equivalent to OD600 of 
5. The adaptation was started at 40 °C. Initial cell growth was remarkably retarded, which was 
validated by low specific growth rates (Figure 5.5).  
 
Figure 5.5 B. succiniciproducens DD3 adaptation towards 42 °C. The color legend visualizes the temperature during each 
batch of the evolutionary adaptation from 40 °C to 42 °C. The bar-chart represents the normalized specific growth rate, 
referring to the standard cultivation of DD3 in minimal medium (µ = 1) at 37 °C.  
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After 10 iterations however, the growth rate increased substantially. At this point, five clones were 
isolated from the heterogenic culture and briefly screened for their performance. As they showed 
identical growth properties, one of the clones, determined as DD3-T1, was chosen for further 
adaptation. A second adaptation round was started with the new B. succiniciproducens isolate DD3-
T1, by now gradually increasing the temperature to 42 °C. The sequential batch strategy was 
continued for 50 additional iterations. While increasing the temperature, a significant improvement 
was observed for cell growth (Figure 5.5). At 42 °C, the heterogenic culture was able to grow with a 
nearly constant performance over several batches. Here again, clones were isolated and one of them 
was designated DD3-T2. The wild-type strain could not grow under these conditions (Figure 5.2). The 
overall adaptation was not extended beyond 50 iterations since most beneficial mutations accompanied 
by significant phenotypic impacts occur early during adaptation, while the fitness trajectory strongly 
decelerates over time (Barrick et al. 2009). Taken together, two clones with improved temperature 
tolerance, i.e. DD3-T1 (40 °C) and DD3-T2 (42 °C) were created by the adaptive approach. 
 
5.2.2 Physiological characterization of evolutionary derived phenotypes 
 
It was now relevant to study the growth and production performance of the novel phenotypes. 
Comparative cultivation studies were conducted with both isolates B. succiniciproducens DD3-T1 and 
DD3-T2, and the parent strain DD3 as control (Figure 5.6). All strains were cultivated in serum bottles 
in minimal glucose medium. First, potential evolutionary trade-offs were investigated by testing all 
strains at 37 °C. The isolate DD3-T2 showed a significantly increased growth rate, whereas no 
difference was observed between DD3 and DD3-T1 (Table 5.4). At the end of the exponential growth 
phase all strains reached a similar cell concentration. The improved growth of DD3-T2 at 37 °C could 
result from the prolonged adaptation to the minimal medium, as a consequence of its continuous use 
during the adaptation process. For E. coli, similar effects have been described during adaptive 
approaches (Blaby et al. 2012; Jantama et al. 2008). Most important, the optimized performance did 
not occur at the expense of the succinate yield. The high yield of the DD3 strain could be fully 
maintained in both isolates (Figure 5.6). Slight changes were found regarding the formation of acetate 
and pyruvate, both originating from the phosphoenolpyruvate/pyruvate (PEP/Pyr) node. This branch 
point represents a metabolic switch in various microorganisms (Sauer and Eikmanns 2005). The fast 
growth and the high product yield of DD3-T2 resulted in an attractive succinate productivity of 
1.09 g L
-1
 h
-1
, whereas DD3 and DD3-T1 exhibited lower productivities of about 0.76 g L
-1
 h
-1
 each
 
(Table 5.4). Obviously, the adapted strains accumulated beneficial mutations. The defined medium 
hereby prevented the accumulation of detrimental auxotrophies as previously observed in E. coli LB-
medium adaptations (Blaby et al. 2012). 
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Figure 5.6 Physiological characterization of the adapted B. succiniciproducens strains (■) DD3-T1 and (▲) DD3-T2 
compared to the parent strain (●) DD3 at 37 °C in minimal medium F in serum bottles. The data shown comprise specific 
growth rate (A), the yield for succinate (B), the yield for pyruvate (C), and the yield for acetate (D) during exponential 
growth phase of three biological replicates, respectively. 
 
A more detailed insight into the metabolic changes, e.g. loss of function or gain of function was next 
screened applying phenotype microarrays.  
 
                
 
 
 
 
Figure 5.7 Phenotypic fingerprint of B. succiniciproducens DD3 as well as DD3-T1 and DD3-T2. The heat map pictures 
metabolic activity, whereas blue indicates no metabolic activity and green indicates high metabolic activity. The values 
represent the area under the measured curve of increasing redox dye coloration. Experiments were conducted with two 
biological replicates. 
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For this purpose, the adapted B. succiniciproducens strains were evaluated for metabolic defects or 
benefits by screening for their substrate potential (Figure 5.7). The obtained phenotypic patterns 
showed no significant differences and revealed that the evolutionary adaptation of 
B. succiniciproducens towards increased temperature was not linked to the use of specific substrates or 
their energetic metabolism. This implies a more subjacent adapting pattern, on the basis of regulatory 
pathways. However, it was important to prove that no loss of function was observed for industrially 
relevant substrates, such as glucose, maltose or sucrose. 
In a next set of experiments, the fitness gain in growth and production performance of DD3-T1 and 
DD3-T2 was compared to the parental DD3 at higher temperature. As evolved, DD3 was cultivated at 
40 and 42 °C, respectively. DD3 grew at 40 °C, although at a reduced specific growth rate of 0.10 h
-1
. 
The adapted variant DD3-T1 grew almost twice as fast (µ = 0.17 h
-1
; Figure 5.8). 
 
Figure 5.8 Growth of (●) B. succiniciproducens DD3 at 40 °C (A) compared to (■) DD3-T1 and at 42 °C (B) compared to 
(▲) DD3-T2. All cultivations were conducted as three biological replicates.  
 
Table 5.4 Growth and production characteristics of B. succiniciproducens DD3 and the temperature adapted strains DD3-T1 
and DD3-T2 during exponential phase of batch cultivations at different temperatures in glucose minimal medium. The data 
given are specific growth rate (µmax), biomass yield (YX/S), succinate yield (YSuc/S), formate yield (YFor/S), acetate yield 
(YAce/S), lactate yield (YLac/S), ethanol yield  (YEtOH/S), pyruvate yield (YPyr/S) and maximal succinate productivity (PSuc). The 
values represent mean values of three biological replicates with corresponding standard deviations. 
 DD3 DD3-T1 DD3-T2 
 37 °C 40 °C 42 °C 37 °C 40 °C 37 °C 42 °C 
µmax [h
-1] 0.16 ± 0.01 0.10 ± 0.02 - 0. 17 ± 0 0.15 ± 0 0.23 ± 0 0.23 ± 0 
YX/S [g mol
-1] 29.8 ± 2.5 28.5 ± 3.1 19.2 ± 2.2 29.2 ± 0.8 28.0 ± 0.4 29.2 ± 1.0 28.9 ± 0.5 
YSuc/S [mol mol
-1] 1.13 ± 0.04 1.11 ± 0.02 1.08 ± 0.12 1.14 ± 0.03 1.09 ± 0.06 1.12 ± 0.04 1.10 ± 0.05 
YFor/S [mol mol
-1] < 0.01 < 0.01 < 0.01 < 0.01 < 0.01 < 0.01 < 0.01 
YAce/S [mol mol
-1] 0.21 ± 0.06 0.28 ± 0.05 0.29 ± 0.02 0.11 ± 0.01 0.17 ± 0.01 0.28 ± 0.05 0.39 ± 0.03 
YLac/S [mol mol
-1] < 0.01 < 0.01 < 0.01 < 0.01 < 0.01 < 0.01 < 0.01 
YEtOH/S [mol mol
-1] < 0.01 < 0.01 < 0.01 < 0.01 < 0.01 0.02 ± 0.01 < 0.01 
YPyr/S [mol mol
-1] 0.16 ± 0.03 0.07 ± 0.00 0.11 ± 0.01 0.22 ± 0.01 0.13 ± 0.01 0.15 ± 0.03 0.09 ± 0.02 
PSuc [g L
-1 h-1] 0.76 ± 0.01 0.33 ± 0.12 0.16 ± 0.02 0.76 ± 0.01 0.55 ± 0 1.09 ± 0.03 1.02 ± 0.04 
Yields were determined by linear fitting of the concentration of biomass and product with that of the substrate. 
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At 42 °C, DD3 did not grow, whereas DD3-T2 still propagated. Overall, succinate production 
significantly declined with increasing cultivation temperature (Table 5.4). Interestingly, DD3-T2 
performed identical at 42 and 37 °C and even showed superior production performance to its parent 
strain. As a result of the evolutionary adaptation, the maximal temperature for succinate production 
could be increased to 42 °C in minimal medium, using DD3-T2. Since no loss of function was 
detected for this strain, it seemed a promising candidate for further evaluation toward its industrial 
performance. 
 
5.2.3 Metabolic pathway fluxes of B. succiniciproducens DD3-T2 
 
The evolutionary adaptation yielded the isolation of a new, well performing production mutant, which 
exceeds the performance of the parent strain regarding growth and succinate productivity. Towards a 
better understanding of the molecular mechanisms that mediated the obviously improved performance, 
the isolate was next analyzed by using 
13
C fluxomics and transcriptomics. Thereby, fluxomic analysis 
was recruited by using isotopic substrates to unravel the in vivo carbon flux distribution throughout the 
core metabolism of B. succiniciproducens (Becker et al. 2013). 
 
Figure 5.9 Growth balance during labeling experiments with B. succiniciproducens DD3-T2 was verified by metabolic (A) 
and isotopic (B) steady state. Metabolic steady state was determined from linear correlation between (●) biomass and (▲) 
succinate formation, respectively, and glucose consumption. Isotopic steady state was assessed by constant labeling patterns 
of proteinogenic amino acids and succinate. Hereby, exemplary shown amino acids and succinate stem from different parts of 
the metabolic network. M0 (non-labeled), M1 (single labeled) and M2 (double labeled) represent the relative fraction of 
corresponding isotopomers of (○) alanine, (□) glycine, (Δ) serine, ( ) phenylalanine, (◊) aspartate, and (x) succinate.  
 
B. succiniciproducens DD3-T2 producing significant amounts of succinate at 42 °C, strongly differed 
from its performance from DD3 and also from its direct predecessor DD3-T1 (Table 5.4). Labeling 
data of proteinogenic amino acids from the cultivations with [1-
13
C] glucose, together with 
stoichiometric data of biomass and product formation (Table 5.4) and of anabolic demands (Table 9.1) 
were used to compute the fluxes. The excellent fit of experimental and simulated labeling data 
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indicated a high consistency of the obtained fluxes (Table 9.2). The calculated flux distributions of 
both setups were directly compared to recently published data of DD3 (Becker et al. 2013). Metabolic 
steady state was enforced by constant growth and product formation over time (Figure 5.9). Isotopic 
steady state could be assessed from constant 
13
C labeling patterns of proteinogenic amino acids 
(Figure 5.9).  
 
 
Figure 5.10 In vivo carbon flux distribution of the central carbon metabolism of B. succiniciproducens DD3-T2 during 
growth on glucose minimal medium at 37 °C. The fluxes are given as percentage of the specific glucose uptake rate of 
qGlc = 8.2 mmol g
-1 h-1, that was set to 100 %. Net flux direction is indicated by small arrows. Rationally, prior to 
evolutionary adaptation deleted pathways are shown by a dashed line with corresponding gene name in a red box. 
Comparative metabolic flux response of the evolved mutant DD3-T2 to its parental strain DD3 is differentially visualized 
according to the color legend. Underlying fold changes of carbon flux were calculated based on data from DD3 taken from 
Becker et al. 2013 corrected for the specific glucose uptake rate (Table 9.4). The errors reflect 90 % confidence intervals. 
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As the temperature tolerant mutant DD3-T2 revealed an increased flux into the pentose phosphate 
pathway (PPP) (Figure 5.10), this might coincide with enhanced growth, because the PPP generates 
NADPH, required for various biosynthetic routes (Becker et al. 2013). For Pasteurellaceae growth, its 
supply even seemed to be the limiting factor  (McKinlay, Shachar-Hill, et al. 2007). An increased PPP 
flux could thus support better growth, as observed with the mutant. One could propose strategies to 
increase NADPH supply by rational genetic engineering as previously done for the soil bacterium 
C. glutamicum regarding industrial lysine production (Becker et al. 2007). The flux through the upper 
glycolysis was decreased by 10 %, but the flux through the lower glycolysis remained largely 
unaffected, as the PPP replenished carbon into their routes at the fructose 6-phosphate (F6P) and 
glyceraldehyde 3-phosphate (GAP) node, respectively. At the PEP/Pyr node, the flux to acetate 
formation increased. In more detail, the flux via pyruvate dehydrogenase (PDH) was increased by 
48 % to support the more than twofold increase in acetate flux by simultaneously reducing the flux 
towards pyruvate derived by-products (Table 9.4). In DD3, PDH is essential for acetyl-CoA formation 
due to the lack of the pflD gene, which predominantly accounts for acetyl-CoA synthesis in the wild-
type (Becker et al. 2013). Synthesis of acetate comprises the enzymes Pta and AckA and leads to the 
formation of ATP. In the close relative M. succiniciproducens MBELL55E LPK7, this pathway 
mainly contributes to acetate production. Deletion of these genes negatively affected cell growth, 
possibly due to ATP shortage (Lee et al. 2006). Thus, the observed flux shift towards acetate could 
provide more energy from carbon (Figure 9.2), beneficial for biomass formation, while maintaining 
succinate yield. Concerning the TCA cycle, the reductive and the oxidative branch, respectively, 
showed no significant change in carbon flux. 
It was now of interest to study the fluxes of the novel mutant DD3-T2 at 42 °C, as compared to DD3 at 
37 °C. Again, the mutant revealed an increased PPP flux (Figure 5.11). A major shift in carbon flux 
was observed around the highly flexible PEP/Pyr node. Flux was redirected to the formation of 
acetate, at the expense of pyruvate and other pyruvate derived products (Table 9.4). This could also be 
due to an enhanced need for ATP under stress conditions. The high temperature is particularly linked 
to a higher energy requirement to maintain cellular processes, such as protein homeostasis (synthesis 
and degradation), chaperone expression and cell-cycle control (DNA repair and cell constituent 
biosynthesis) (Clarke 2003). Taken together, obvious changes in carbon fluxes of DD3-T2 indicate a 
gain in function considering industrial implementation of this tolerant mutant. Furthermore, first 
suggestions could be made regarding possible targets for metabolic engineering. As shown, a higher 
glucose 6-phosphate (G6P) flux into the oxidative PPP for NADPH generation might contribute to 
faster and thus more efficient growth. In addition, intracellular provision of energy (ATP) could 
increase stress tolerance and thus improve strain robustness. 
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Figure 5.11 B. succiniciproducens DD3-T2 in vivo carbon flux distribution of the central carbon metabolism during growth 
in glucose minimal medium at 42 °C. Specific glucose uptake rate qGlc = 9.1 mmol g
-1 h-1 is set to 100 % and all fluxes are 
given as percentage thereof. Strain specific deleted pathways are shown as dashed line with corresponding gene names in red 
boxes, respectively. The flux changes are visualized as differential map, according to the color legend. Underlying fold 
changes of carbon flux were calculated based on data from DD3 taken from Becker et al. 2013, corrected for the specific 
glucose uptake rate (Table 9.4). The errors reflect 90 % confidence intervals. 
 
Regarding redox balancing, NAD(P)H supply was improved with B. succiniciproducens DD3-T2, as 
compared to the ancestor (Figure 9.1). However, a higher cultivation temperature revealed redox 
patterns similar to these observed for DD3 under standard conditions. This indicates a metabolic 
stabilization as consequence of evolutionary adaptation.   
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5.2.4 Gene expression profile of the temperature tolerant mutant B. succiniciproducens     
DD3-T2 
 
For gene expression profiling, a custom-made DNA microarray was designed and gene expression 
analysis was established for B. succiniciproducens, comprising 2291 annotated genes from the 
B. succiniciproducens genome sequence with a total of five probes per gene. For data analysis, the 
obtained expression profiles were ranked according to the metric log2 fold change and individually 
assigned to specific gene sets, so called clusters of orthologous groups (COG) (Tatusov et al. 2000). 
This gene set enrichment analysis (GSEA) (Subramanian et al. 2005) is frequently used to identify 
gene clusters that are ostensibly involved in the formation of phenotypes. The assignment of annotated 
genes to gene clusters was taken from literature (Hong et al. 2004) and subsequently implemented into 
the GSEA software tool. Experiments were conducted in pH-controlled bioreactors, preventing 
perturbing effects of MgCO3. Biomass samples were taken at a cell concentration equivalent to OD600 
of 2 – 3. The obtained expression data were analyzed by GSEA (Subramanian et al. 2005) to provide 
first information on favored or selectively preferred gene sets that contribute to the adaptation process. 
Analysis of the DD3-T2 transcriptome revealed three enriched gene clusters with significant statistics 
(Table 5.5), which positively correlate with the evolved phenotype. Surprisingly, the genes covered 
metabolic core functions to a larger extent. They imply that temperature adaptation is closely linked to 
intracellular exploitation of carbon and thus adapting the efficiency towards the required features.   
 
Table 5.5 Gene sets affected towards the evolutionary adaptation of B. succiniciproducens DD3-T2 compared to the gene 
expression patterns of the parent strain DD3. Data comprise the normalized enrichment score (NES), the nominal p-value 
(NOM p-val) and the false discovery rate (FDR) (Subramanian et al. 2005). Data derive from triplicate bioreactor cultivations 
in minimal glucose medium. 
Gene sets NES NOM p-val FDR 
Enriched in DD3-T2 vs. DD3 
  Carbohydrate metabolism and transport  
  Signal transduction  
  Energy production and conversion  
   
1.98 < 0.001 0.001 
1.81 0.005 0.004 
1.54 0.004 0.041 
 
In B. succiniciproducens DD3-T2, 63 genes were significantly up- or down-regulated, as compared to 
the parental strain DD3, whereby 36 genes were at least twofold induced. Within the group of affected 
genes, operons were identified that exhibited concerted transcriptional regulation (Table 9.5). They 
were related to carbon core and energy metabolism and pointed out the essential role of these 
functional groups in the improved phenotype. The strongest expression change was observed for a 
hexose phosphate phosphorelay system (MS2284-87) consisting of a conserved histidine kinase-like 
regulatory system and a hexose phosphate permease (Weston and Kadner 1988). One might speculate 
that the modified expression level of this regulatory and transport operon may contribute to an 
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optimized substrate uptake, leading to more efficient growth and production. In this line, other carbon 
transport related genes were induced, such as a monosaccharide transporting ATPase (Table 5.6) and a 
phosphotransferase operon (Table 9.5). In addition, gene expression was changed for genes of the 
pyruvate metabolism. The genes coding for pyruvate dehydrogenase (MS1333-35) revealed an 
averaged 4.2-fold increased expression. This could explain the observed flux increase from pyruvate 
towards acetyl-CoA (Figure 5.10). Acetyl-CoA, supplied by pyruvate dehydrogenase complex, is an 
essential building block for cellular growth and biomass production. Its enhanced supply could 
contribute to the improved growth rate of DD3-T2 (Table 5.4), and also trigger the formation of 
acetate, which was indeed produced at a higher yield, as compared to DD3. 
 
Table 5.6 Impact of evolutionary adaptation towards 42 °C on gene expression of B. succiniciproducens. Data comprise 
genes, up- and down-regulated in DD3-T2, as compared to the parental strain DD3 (corrected p-value < 0.05).  
Systematic 
namea 
Genea 
Fold 
change 
Descriptionb 
Operon 
numberc 
Functiond 
MS1335 aceF  4.6 
Pyruvate dehydrogenase complex, E2 
component 
2 
Energy production 
and conversion 
MS1334 lpd  4.4 
Pyruvate dehydrogenase complex, E3 
component 
2 
MS1336 ace  3.8 
Pyruvate dehydrogenase complex, E1 
component 
2 
MS1992 glpQ  2.4 Glycerophosphoryl diester phosphodiesterase  
MS2293 pckA  2.4 Phosphoenolpyruvate carboxykinase (ATP)  
MS1988 glpK  2.3 Glycerol kinase  
MS1984 aspA  3.8 Aspartate ammonia-lyase  Amino acid 
metabolism and 
transport 
MS0787 metF  2.2 5,10-methylenetetrahydrofolate reductase  
MS0941 metE  2.1 Methionine synthase II   
MS2284 uhpT  39.5 Hexose phosphate permease  
Carbohydrate 
metabolism and 
transport 
MS1236 amyA  4.1 Trehalose-6-phosphate hydrolase  
MS2287 uhpC  3.8 Hexose phosphate sensor protein  
MS1237 ptsG  3.8 
Phosphotransferase system, trehalose-specific, 
EIIBC components 
 
MS1991 uhpC  3.0 Glycerol-3-phosphate transporter  
MS1612 rbsB  2.9 Monosaccharide-transporting ATPase  
MS1615 fbp  2.7 Fructose-1,6-bisphosphatase  
MS1990 glpF  2.5 Glycerol uptake facilitator  
MS1607 dAK1  2.3 Dihydroxyacetone kinase, C-terminal 3 
MS1606 dAK1  2.3 Dihydroxyacetone kinase, N-terminal 3 
MS1608   2.1 
Phosphotransferase system, dihydroxyacetone 
kinase-dependent, phosphotranferase subunit 
3 
MS0618   2.1 
Phosphotransferase system, 
mannose/fructose/N-acetylgalactosamine-
specific component EIIAB 
1 
MS0373 ung  2.2 Uracil DNA glycosylase, BER initiating  Replication, 
recombination and 
repair 
MS0185 himA  2.0 DNA-binding protein HU  
MS2289   2.3 N-acetyltransferase 4 Cell wall, 
membrane, 
envelope biogenesis 
MS0740 ompW  2.1 Outer membrane protein W  
MS2285 uhpA  8.6 
UhpB-UhpA (hexose phosphate uptake) two-
component regulatory system, transcriptional 
regulator 
4 
Signal transduction 
MS2286 uhpB  5.6 
UhpB-UhpA (hexose phosphate uptake) two-
component regulatory system, sensory 
component  
4 
MS2288 narQ  2.5 Signal transduction histidine kinase 4 
MS0349 uspA  2.1 Universal stress protein UspA homolog 4 
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MS1823  - 2.0 Glycerol-3-phosphate acyltransferase  
Energy production 
and conversion 
MS0551 proX - 3.2 
ABC-type proline/glycine betaine transport 
systems, periplasmic components 
5 
Amino acid 
metabolism and 
transport 
MS0549 proV - 2.9 
ABC-type proline/glycine betaine transport 
system, ATPase component 
5 
MS0550 proW - 2.7 
ABC-type proline/glycine betaine transport 
system, permease component 
5 
MS0227 betT - 2.6 Glycine betaine transporter  
MS0353 alsT - 2.4 Na+/alanine or glycine symporter  
MS1797 avtA - 2.3 Aminotransferase AlaT  
MS1790 aroQ - 2.0 3-dehydroquinate dehydratase II  
MS1510 fruB - 5.6 
Phosphotransferase system, Phosphocarrier 
protein HPr 
 
Carbohydrate 
metabolism and 
transport 
MS1509 ptsA - 2.8 
Phosphotransferase system, PEP-protein kinase, 
EI component 
 
MS2073 glgP - 2.2 Glycogen phosphorylase 9 
MS1795 menF - 3.4 Menaquinone specific isochorismate synthase 6 
Coenzyme 
metabolism 
MS1794 mend - 3.2 
2-succinyl-5-enolpyruvyl-6-hydroxy-3-
cyclohexene-1-carboxylate synthase 
6 
MS1793 mhpC - 2.6 
2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-
carboxylate synthase 
6 
MS1826 lipA - 2.5 Lipoic acid synthetase  
MS1791 dgoA - 2.4 O-succinylbenzoate synthase 6 
MS1792 menB - 2.3 Dihydroxynaphthoic acid synthase 6 
MS1821 rluD - 2.0 Pseudouridylate synthases, 23S RNA-specific 8 Translation 
MS1820 nrfG - 2.7 Outer membrane assembly lipoprotein  Cell wall, 
membrane,   
envelope biogenesis 
MS1808 artI - 2.0 Membrane-bound lytic murein transglycosylase  
MS1801 nhaA - 2.7 Na+/H+ antiporter  
Inorganic ion 
transport and 
metabolism 
MS1818 nrfB - 2.6 
Formate-dependent nitrite reductase, penta-
heme cytochrome c 
7 
 
MS1816 nrfD - 2.6 
Formate-dependent nitrite reductase, membrane 
component 
7 
MS1819 nrfA - 2.5 
Formate-dependent nitrite reductase, 
periplasmic cytochrome c552 subunit 
7 
MS1817 nrfC - 2.4 
Formate-dependent nitrite reductase, 4Fe-4S 
subunit 
7 
MS1341 modB - 2.3 
ABC-type molybdate transport system, 
permease component 
 
a Gene entries and names are given in accordance with KEGG annotations for M. succiniciproducens MBELE55. 
b Information are adopted from Hong et al. 2004 and/or NCBI database using BLASTP swissprot (sequence coverage of 
50 % and amino acid sequence homologies above 30 %) in combination with annotations from KEGG. 
c Operons and their corresponding genes were assigned according to the Database of prOkaryotic OpeRons (Dam et al. 
2007; Mao et al. 2009) and the Prokaryotic Operon DataBase (Taboada et al. 2012) for M. succiniciproducens MBELE55 
predictions (see Table 9.5). 
d Functional grouping was taken from literature (Hong et al. 2004). 
 
The gene for the major anaplerotic carboxylation in B. succiniciproducens, PEP carboxykinase 
(PEPCK), was induced 2.4-fold. This probably re-directed the carbon flux towards the reductive TCA 
cycle and succinate (Figure 5.10). PEPCK was proven as a valuable engineering target towards tailor-
made succinate producing E. coli (Millard et al. 1996; Kim et al. 2004; Zhang et al. 2010) and 
represents the most important enzyme in anaerobic succinate production. The amplified expression of 
PEPCK might be correlated to the efficient formation of succinate throughout the whole evolutionary 
adaptation process and in the final isolate DD3-T2. Beyond carbon core metabolism, several stress-
related genes were induced at the level of RNA expression, comprising e.g. a DNA glycosylase (Table 
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5.6), mainly responsible for the base excision repair (Krokan et al. 1997) and the DNA stabilizing 
protein HU alpha (Kamashev and Rouviere-Yaniv 2000). 
Interestingly, menaquinone biosynthesis genes were among the 27 repressed genes, despite 
menaquinone’s presumed function in anaerobic fumarate reductase reaction towards succinate. 
Regarding the slightly increased carbon flux through the reductive TCA cycle (Figure 5.10), this 
down-regulation, however, seemed not limiting for the improved succinate formation with DD3-T2.  
 
5.2.5 Genome sequencing reveals distinct mutations evolved during temperature adaptation in 
B. succiniciproducens DD3-T2 
 
As shown, the evolutionary derived temperature tolerant mutant DD3-T2 exhibited altered metabolic 
fluxes. Furthermore, the adaptation process obviously affected gene expression. It was now relevant to 
identify the underlying mutations. For this purpose, both adapted strains, DD3-T1 and DD3-T2 were 
sequenced and compared to wild-type B. succiniciproducens DD1. Polymorphism significance was 
covered by a sequence coverage > 50 and a variant frequency set to 75 %. 
 
Table 5.7 Single nucleotide polymorphisms (SNP) and deletion – insertion – polymorphisms (DIP) are listed with their 
respective position specific nucleotide (Nt ex) and amino acid (AA ex) exchange in the temperature adapted strains 
B. succiniciproducens DD3-T1 and DD3-T2. The wild-type genome was annotated, according to the published 
M. succiniciproducens MBEL55E genome (Hong et al. 2004) and served as reference for detection of mutations in the 
adapted phenotypes. 
Strain 
Systematic 
name 
Nt ex AA ex Pm Gene Function 
DD3-T1 MS0136 1435C>T Pro479Ser SNP nhaP Monovalent cation:H+ antiporter 
 MS2084 919G>T Gly307Cys SNP lysA Meso 2,6-diaminopimelate decarboxylase 
 MS2286 586C>A Gln196Cys SNP baeS/uhpB  Glucose-6-phosphate specific two-
component signal transduction system  MS2286 599C>T Pro200Leu SNP baeS/uhpB  
DD3-T2 MS0136 1435C>T Pro479Ser SNP nhaP Monovalent cation:H+ antiporter 
 MS0213 692C>A Thr231Lys SNP rpoC β’ prime subunit of RNA polymerase 
 MS0911 46A>C Thr16Pro SNP rfe 
UDP-GlcNAc:undecaprenyl-phosphate 
GlcNAc-1-phosphate transferase 
 MS2084 919G>T Gly307Cys SNP lysA Meso 2,6-diaminopimelate decarboxylase 
 MS2286 586C>A Gln196Cys SNP baeS/uhpB  Glucose-6-phosphate specific two-
component signal transduction system  MS2286 599C>T Pro200Leu SNP baeS/uhpB  
 MS1237 -70C>A - SNP PptsG 
Promoter of trehalose (maltose)-specific 
transporter subunit IIBC of PTS 
 MS1336 -207insA - DIP PaceE 
Promoter of pyruvate dehydrogenase 
subunit E1 
Pm: type of occurring polymorphism 
 
The genome sequence of the temperature adapted strains B. succiniciproducens DD3-T1 and DD3-T2 
revealed four and eight mutations, respectively (Table 5.7). The mutated genes, identified in DD3-T1, 
were attributed to energy and carbon metabolism and amino acid metabolism and transport. All these 
modifications were still present in DD3-T2 and, thus, were obviously kept during the further 
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adaptation process (Figure 5.12). This maintenance indicates their apparent metabolic value. The 
mutations, additionally present in DD3-T2, belonged to the transcription machinery, carbon 
metabolism and cell wall composition. Most relevant, the number of mutations mediating the superior 
phenotype was rather low. This promised metabolic engineering targets for rational improvement of 
increased temperature tolerance in B. succiniciproducens. 
 
 
Figure 5.12 Overview on mutations evolved during temperature adaptation to 40 °C (DD3-T1) and 42 °C (DD3-T2) in 
B. succiniciproducens DD3. Systematic name and COG identifier (in brackets) are taken from M. succiniciproducens 
MBEL55E annotation (Hong et al. 2004). For further information on the single modifications, see Table 5.7. 
 
Taken together, B. succiniciproducens DD3 was successfully adapted to a higher temperature level. 
The finally adapted strain DD3-T2 was proven at high temperature, initially inhibiting growth 
performance of the ancestor DD3 and the wild-type strain. Careful growth experiments and system 
biology approaches revealed a complex picture of tolerance underlying mechanisms. The increased 
tolerance might result from re-orientation of carbon fluxes, regulated at the level of transcriptomics 
and genomics. Regarding a rational engineering approach towards improvement of 
B. succiniciproducens, it appeared most relevant to analyze the impact of mutations, acquired during 
the adaptation process. In particular, mutations that contribute to straight-forward metabolic reactions 
seemed promising with regard to an industrial performance.  
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5.3 Increasing succinate tolerance in B. succiniciproducens 
 
5.3.1 Sequential batch adaptation of B. succiniciproducens DD3 towards high succinate stress 
 
It has been proposed that an efficient production process for succinate has to achieve a product titer 
above 100 g L
-1 
(Patel et al. 2006). Clearly, such performance relies on the robustness and tolerance of 
the producing microorganism to elevated levels of the product. Unfortunately, individual genetic 
targets that mediate such a tolerance are primarily not known. In particular organic acid tolerance, 
such as succinate, cannot be tailored by rational strain design, since the respective phenotype requires 
polygenic modifications to exhibit this higher stress tolerances (Patnaik 2008). In order to improve 
tolerance to succinate, B. succiniciproducens DD3, lacking ldhA and pflD to eliminate formation of 
the by-products lactate and formate, was chosen for the evolutionary process by exposing it to high 
succinate concentration in a minimal medium based sequential batch approach. At the starting point of 
the evolutionary adaptation, the external succinate concentration was set to 5 g L
-1
, and was gradually 
increased further on. The batch interval was adjusted to cell growth, i.e. cells were harvested from a 
batch culture only when they had reached a cell density corresponding to an OD600 of 5 to ensure an 
appropriate adapted cell population prior to inoculating the next batch at an even higher succinate 
level. In case of a slow cell proliferation, the cultivation was simply extended to allow for the 
formation of sufficient biomass for the next following batch. During the first two adaptive rounds DD3 
struggled with the external amount of 5 g L
-1 
succinate (Figure 5.13). It took about 24 h to reach 
notable cell growth. The third batch, still at 5 g L
-1 
succinate, showed a distinct improvement of 
growth. Suddenly, the cells revealed similar growth performance as observed for DD3 under standard 
conditions, i.e. without added succinate. The specific growth rate almost reached 0.1 h
-1
. The specific 
succinate productivity advanced to nearly 1 g L
-1
 h
-1
 (Figure 5.13). Based on this sudden improvement, 
single clones were isolated from the population of this round three. One of the clones, selected for 
further analysis, was designated DD3-Suc1. Subsequently, the succinate concentration in the medium 
was stepwise increased throughout the following iterations. Each round of the further adaptation was 
accompanied by a significant improvement of growth, compared to the parental strain (Figure 5.13). In 
response to each further increase in externally added succinate, the cells were able to compensate for 
the extracellular stress. Two more superior strains were isolated. The designated strain DD3-Suc2 was 
isolated after 15 iterations, due to the remarkably increased specific growth rate and succinate 
productivity (Figure 5.13). It was interesting to note that the adapted cells performed well at almost 
20 g L
-1
 of initially added succinate. This level was previously found to fully inhibit the parental strain 
(Figure 5.3). 
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Figure 5.13 Evolutionary adaptation of B. succiniciproducens DD3 to high levels of succinate, visualized according to the 
color legend. The bar chart shows the normalized specific growth rate, referring to standard cultivations of un-adapted DD3 
at respective succinate levels in minimal glucose medium (µ = 1). The top level indicates the specific succinate productivity 
during each batch. The data were estimated from the time specific succinate production of each round, after correcting for the 
initially added succinate (see color legend). 
 
At the 25
th
 iteration, succinate was supplemented at 25 g L
-1
. Obviously, this imposed pronounced 
stress, clearly visible by a sudden decrease of growth and productivity, affected the performance 
(Figure 5.13). However, during the subsequent rounds the cells could recover and exhibited efficient 
growth and improved succinate productivity. From cultures that tolerate 25 g L
-1
 succinate, the clone 
DD3-Suc3 was isolated for further studies. At the higher succinate levels, succinate productivity never 
reached the values, observed for the parent strain DD3 without imposed succinate stress, but still 
remained at reasonable levels. 
 
5.3.2 Physiological characterization of B. succiniciproducens DD3-Suc1, DD3-Suc2 and DD3-
Suc3 adapted towards higher succinate levels 
 
In order to gain information on the newly isolated succinate tolerant phenotypes, comparative 
cultivations were carried out with the parent strain B. succiniciproducens DD3 and with the mutants 
DD3-Suc1, DD3-Suc2 and DD3-Suc3. The focus was first set on evaluation of fermentation 
performance. Cultivation experiments were conducted in serum bottles at 37 °C. All adapted strains 
showed faster growth, as compared to DD3, and enhanced succinate production (Figure 5.14). 
Succinate productivity could be increased by about 30 % with DD3-Suc1 and DD3-Suc2, considering 
DD3 standard performance (Table 5.4). 
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Figure 5.14 Growth physiology of the three succinate tolerant strains B. succiniciproducens (▲) DD3-Suc1, (■) DD3-Suc2 
and (♦) DD3-Suc3 compared to their parental strain (●) DD3 (A) and maximal specific succinate productivity during 48 h 
cultivation period (B). The data points represent mean values from three biological replicates with their corresponding 
standard deviations. All cultivations were performed in minimal glucose medium E at 37 °C.  
 
In addition to these observed improvements, the mutants revealed a pronounced change in their by-
product spectrum (Table 5.8). All succinate tolerant mutants showed enhanced formation of pyruvate 
(Table 5.8). This organic acid is more tolerable according to inhibition studies with A. succinogenes, 
another succinate producing bacterium (Lin et al. 2008). The increased formation of pyruvate 
obviously went to the expense of succinate and acetate (Table 5.8). 
 
Table 5.8 Growth and production characteristics of succinate adapted strains B. succiniciproducens DD3-Suc1, DD3-Suc2 
and DD3-Suc3, compared to their parent strain DD3 at 37 °C in minimal glucose medium E. The data given are specific 
growth rate (µmax), biomass yield (YX/S), succinate yield (YSuc/S), formate yield (YFor/S), acetate yield (YAce/S), lactate yield 
(YLac/S), ethanol yield  (YEtOH/S), pyruvate yield (YPyr/S) and maximal succinate productivity (PSuc). Data represent mean 
values of three biological replicates with their corresponding standard deviations. 
 DD3 DD3-Suc1 DD3-Suc2 DD3-Suc3 
µmax [h
-1] 0.16 ± 0.01 0. 22 ± 0.01 0.22 ± 0.01 0.22 ± 0.01 
YX/S [g mol
-1] 29.8 ± 2.5 30.5 ± 1.0 30.1 ± 2.4 30.7 ± 4.0 
YSuc/S [mol mol
-1] 1.13 ± 0.04 1.09 ± 0.05 0.96 ± 0.04 0.90 ± 0.03 
YFor/S [mol mol
-1] < 0.01 < 0.01 < 0.01 < 0.01 
YAce/S [mol mol
-1] 0.21 ± 0.06 0.14 ± 0.01 0.15 ± 0.03 0.28 ± 0.03 
YLac/S [mol mol
-1] < 0.01 < 0.01 < 0.01 < 0.01 
YEtOH/S [mol mol
-1] < 0.01 < 0.01 < 0.01 < 0.01 
YPyr/S [mol mol
-1] 0.16 ± 0.03 0.33 ± 0.01 0.27 ± 0.01 0.23 ± 0.02 
PSuc [g L
-1 h-1] 0.76 ± 0.01 1.00 ± 0.04 1. 00 ± 0.04 0.83 ± 0.04 
The yields were determined by linear fitting of the concentration of biomass and 
product with that of the substrate. 
 
A next round of experiments now evaluated the joined tolerance to increased succinate levels. For this 
purpose, B. succiniciproducens DD3, DD3-Suc1, DD3-Suc2 and DD3-Suc3 were cultivated under 
external addition of succinate to the growth medium, i.e. succinate was added prior to inoculation at 
concentrations of 5, 7.5, 10, 15 and 25 g L
-1
 (Figure 5.15).  
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Figure 5.15 Succinate tolerance studies of B. succiniciproducens (■) DD3-Suc1, (▲) DD3-Suc2 and (♦) DD3-Suc3 
compared to the parental strain (●) DD3 for specific growth (A) and final succinate titer, corrected for initially added 
succinate (B). Growth (µ) and succinate production of DD3 at standard conditions, i.e. 37 °C and no imposed succinate 
stress, were set to 100 %. Cultivations were conducted in minimal glucose medium with the addition of five succinate 
concentrations. Data represent three biological replicates with corresponding standard deviations. 
 
Taken together, the isolated clones from the evolutionary adaptation revealed a remarkably increased 
tolerance towards external succinate (Figure 5.15). The parent strain DD3 was strongly inhibited in 
growth and responded to higher succinate levels with a drastic decrease in succinate formation. In 
contrast, all mutants were much more robust. The final isolate, DD3-Suc3 was almost unaffected in 
growth and succinate production at levels of 10 and 15 g L
-1
 added succinate, respectively. This was 
an exceptional performance when compared to that of DD3, the starting point of the evolutionary 
adaptation. The potential to adapt to higher succinate levels can be regarded as an important feature of 
B. succiniciproducens towards industrial succinate production. 
 
5.3.3 Metabolic pathway fluxes in the succinate-tolerant B. succiniciproducens strains DD3-
Suc2 and DD3-Suc3 
 
The cellular tolerance to organic acids is complex and its regulation is barely understood (Warnecke 
and Gill 2005). Throughout the evolution, extremophile bacteria adapted to harsh environmental 
conditions, including organic acids and coupled pH stress, by developing various techniques (Booth 
1985). The promising B. succiniciproducens mutants were now analyzed by systems biology 
approaches to shed some light upon the underlying molecular mechanisms in succinate tolerance and 
adaptation. To this end, metabolic flux analysis (fluxomics), metabolomics and transcriptomics, 
respectively, was conducted for the obtained isolates. Additionally, the mutants were sequenced to 
unravel correlations between phenotype and genotype.  
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Metabolic pathway fluxes for B. succiniciproducens DD3-Suc2 and DD3-Suc3 were determined by 
tracer cultivations, using [1-
13
C] glucose as carbon source. On the basis of the obtained stoichiometric 
data (Table 5.8), 
13
C labeling patterns of proteinogenic amino acids and succinate (Table 9.2) and 
anabolic demands (Table 9.1), the intracellular flux distribution was estimated using the Open Flux 
Tool (Quek et al. 2009). Metabolic and isotopic steady-state, an important prerequisite for the flux 
approach, was obtained for both adapted strains (Figure 5.16). An excellent fit of the labeling data was 
achieved during flux estimation (Table 9.2) underlining the consistency of the obtained fluxes. The 
statistical evaluation of the flux partitioning showed a high precision, so that flux differences to the 
parent strains could be attributed to strain-specific differences. 
 
Figure 5.16 Metabolic (A) and isotopic (B) steady state during labeling experiments with B. succiniciproducens DD3-Suc2. 
The metabolic steady state was verified from linear correlation between (●) biomass and (▲) succinate formation, 
respectively, and glucose consumption. Constant labeling patterns of proteinogenic amino acids confirmed isotopic steady 
state. Hereby, exemplary shown amino acids and succinate stem from different parts of the metabolic network. M0 (non-
labeled), M1 (single labeled) and M2 (double labeled) represent the relative fraction of corresponding isotopomers of (○) 
alanine, (□) glycine, (Δ) serine, ( ) phenylalanine, (◊) aspartate, and (x) succinate. 
 
Both succinate-adapted mutants showed an increased flux into the oxidative PPP, as compared to their 
ancestor DD3 (Figure 5.17 and Figure 5.18). This might relate the superior growth performance of the 
evolved phenotypes that could benefit from enhanced supply of NADPH via the PPP. The enhanced 
flux into the PPP was also observed in the temperature-tolerant strain DD3-T2, which also showed 
improved growth (see 5.2.2). NADPH presumably supports the biomass formation and is a limiting 
factor for Pasteurellaceae growth (McKinlay et al. 2007). Interestingly, the two independent 
adaptation approaches, towards high temperature and elevated succinate levels, respectively, induced 
both the same increased flux into the PPP. 
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Figure 5.17 In vivo carbon flux distribution of B. succiniciproducens DD3-Suc2 during growth in minimal glucose medium. 
Fluxes are shown as percentage of the specific glucose uptake rate qGlc = 7.8 mmol g
-1 h-1 that was set to 100 %. Small arrows 
indicate net flux direction. Dashed lines show rationally deleted pathways prior to evolutionary engineering with their 
respective genes (red boxes). Flux fold change (Table 9.4) was estimated from specific glucose uptake rate corrected data 
from DD3 (Becker et al. 2013) and DD3-Suc2 and differentially visualized according to the color legend. The errors reflect 
90 % confidence intervals. 
           
Taken together, this flux re-distribution at the G6P-node could reflect an indirect response to provide 
extra redox power to cover an enhanced need as observed for other bacteria (Wittmann and Heinzle 
2001b; Wittmann and Heinzle 2002). One might suggest, on basis of this molecular switch, rational 
engineering of the PPP flux in order to improve growth performance of B. succiniciproducens. 
However, enhanced growth would have to be carefully balanced with product formation, due to their 
direct link to each other (Becker et al. 2013). 
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Figure 5.18 In vivo carbon flux distribution of B. succiniciproducens DD3-Suc3 during growth in minimal glucose medium. 
Specific glucose uptake rate qGlc = 7.6 mmol g
-1 h-1 is set to 100 % and all further fluxes are given as percentage. Net flux 
direction is indicated by small arrows. Rationally deleted pathways, i.e. ldhA and pflD, are shown by dashed lines. 
Comparison of specific glucose uptake rate corrected carbon fluxes of DD3 (Becker et al. 2013) and DD3-Suc3 is 
differentially visualized according to the color legend. The errors reflect 90 % confidence intervals. 
 
The fluxes at the PEP/Pyr node showed a more complex picture. DD3-Suc2 redirected carbon flux 
from PDH and reductive TCA cycle towards pyruvate secretion (Figure 5.17), possibly favoring 
pyruvate’s less toxic impact as compared to other organic acids (Lin et al. 2008). In contrast, DD3-
Suc3 showed decreased pyruvate flux, but rather channeled the carbon into acetate production (Figure 
5.18). This was supported by enhanced flux through the PDH. Here, the oxidative TCA cycle flux 
remained nearly unchanged, so that the formed acetyl-CoA was fully used for acetate synthesis. The 
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acetate production pathway generates ATP, which obviously supports the higher requirements under 
stress, as it was also observed during temperature adaptation (Figure 5.10). Taken together, 
B. succiniciproducens seems to exploit different mechanism to achieve a higher robustness. The shifts 
to less toxic by-products (i.e. pyruvate) and to energy-providing metabolic routes (i.e. acetate) seemed 
to be involved in this adaptation, so that the rearrangement of the by-product spectrum probably bears 
a substantial metabolic flexibility of B. succiniciproducens. The flux towards succinate production was 
decreased by 9 % in DD3-Suc2 and by 13 % in DD3-Suc3, respectively. Despite the necessity of this 
pathway for redox balancing, its reduction seemed to be linked to the adaptation process to higher 
external succinate concentrations. The flux through PEPCK, the driving force for anaerobic succinate 
formation in other microorganisms (Lee et al. 2006; McKinlay et al. 2010), is coherently reduced with 
increased tolerance against succinate (Figure 5.19). The reduced succinate formation as response to the 
stress becomes also obvious from the decreased succinate yields in the mutants (Table 5.8). 
Apparently, reduced succinate production itself supported the adaptation. 
 
Figure 5.19 Correlation of succinate tolerance and relative carbon flux through phosphoenolpyruvate carboxykinase in 
B. succiniciproducens DD3, DD3-Suc2 and DD3-Suc3. The flux from PEP/Pyr towards the reductive part of the TCA was 
attributed to the reaction of the PEP carboxykinase, known as major anaplerotic enzyme in succinate producing 
microorganisms (Lee et al. 2006; McKinlay et al. 2010). The tolerance was determined from linear fit between specific 
growth rates at different succinate levels. The values given relate to the critical concentration (µ = 0).  
 
The decreased flux through the reductive TCA cycle branch finally resulted in lower regeneration of 
NAD
+
, as this route accounts for 80 to 90 % of total NADH consumption in B. succiniciproducens 
(Becker et al. 2013). Obviously, this led to increased redox imbalances, as observed by supply and 
consumption of NADH in both mutants, as compared to DD3 (Figure 9.1).  
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5.3.4 Intracellular amino acid pools in succinate-tolerant B. succiniciproducens DD3-Suc3 
 
Clearly, elevated succinate concentrations causes osmotic stress, so that the phenotypic response may 
involve the activation of mechanisms for osmotic protection, observed for other succinate producing 
microorganisms (Andersson et al. 2009; Fang et al. 2011). As example, proline has been identified as 
compatible solute in other bacteria (Brill et al. 2011). To this end, the intracellular pools of free amino 
acids were compared between the most tolerant strain B. succiniciproducens DD3-Suc3 and the wild-
type strain DD1 (Figure 5.20).  
 
Figure 5.20 Intracellular amino acid (A) and glutamine (B) pools of B. succiniciproducens DD1 and DD3-Suc3. Data 
represent mean values with corresponding standard deviations from two biological replicates, each with two technical 
replicates, obtained during exponential growth phase on minimal glucose medium by applying an appropriate fast filtration. 
 
As major difference, the succinate adapted strain DD3-Suc3 revealed an extreme up-regulation of 
intracellular glutamine (Figure 5.20). Indeed, glutamine has been found as compatible solute during 
moderate osmoadaptation (Frings et al. 1993; Goude et al. 2004). It was interesting to note that this 
compatible solute like amino acid was present without externally imposed stress. That might reflect a 
constitutive protection activated during the adaptation. Proline instead was observed in similar 
amounts in DD3-Suc3 as compared to DD1. Cysteine was increased 5-fold. It is reported to facilitate 
tolerance against oxidative stress (Turnbull and Surette 2010). This can be accredited to its function as 
precursor molecule for glutathione, an antioxidant. Glutathione-supplemented M. succiniciproducens 
MBEL55E fermentations revealed increased growth and productivity (Hoon et al. 2010). Cysteine is 
also known to be an essential compound for M. succiniciproducens MBEL55E growth (Song et al. 
2008). The reduced intracellular asparagine pool might be explained by the reduced flux through the 
reductive TCA cycle in the succinate-tolerant mutant DD3-Suc3. Leucine was increased about 
twofold. This seemed not to be linked to enhanced tolerance, but due to the lack of ldhA and pflD in 
the mutant. In consequence of these deletions, B. succiniciproducens DD3 accumulates pyruvate-
based metabolites, such as leucine and leucine specific precursors (Becker et al. 2013). 
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5.3.5 Gene expression profile in succinate-adapted B. succiniciproducens DD3-Suc2 and DD3-
Suc3 
 
In order to obtain more information on changes of the regulatory network, linked to the adaptation, 
gene expression studies were conducted with the adapted strains. For DD3-Suc2, adapted to 10 g L
-1
 
succinate (Figure 5.13), significant changes were found for two gene groups (Table 5.9), i.e. the 
nucleotide metabolism and the translation. Both are crucial processes of living cells. Moreover, a 
direct link to the evolved tolerance is difficult to extract. Apart from that, the evolved strain DD3-Suc3 
showed an altered expression pattern concerning genes that belong to the group of cell wall and 
membrane synthesis genes. This appeared quite straightforward, due to known microbial mechanisms 
which alter the membrane composition against acid stress (Warnecke and Gill 2005). 
 
Table 5.9 Gene sets affected through the evolutionary adaptation of B. succiniciproducens DD3-Suc2 and DD3-Suc3 
towards high succinate levels, as compared to the gene expression patterns of the parental DD3. Data show the normalized 
enrichment score (NES), the nominal p-value (NOM p-val) and the false discovery rate (FDR) (Subramanian et al. 2005). 
Data derive from three biological replicates in minimal glucose medium. 
Gene sets NES NOM p-val FDR 
Enriched in DD3-Suc2 vs. DD3 
  Translation  
  Nucleotide metabolism and transport  
   
1.71 < 0.001 0.033 
1.67 < 0.001 0.020 
Enriched in DD3-Suc3 vs. DD3 
  Cell wall, membrane, envelope biogenesis  
   
1.63 < 0.001 0.046 
 
 
A more detailed inspection of the expression data revealed 75 genes that were significantly changed in 
their expression in DD3-Suc2, as compared to the ancestor DD3. Among these, 30 genes were induced 
(Table 5.10), including five operons related to carbohydrate and energy conversion, stress tolerance 
and amino acid metabolism (Table 9.6). Additionally, genes encoding for components of proton 
dislocation i.e. NADH dehydrogenase and the cytochrome:quinol oxidase were induced 5- and 3-fold, 
respectively. This could support a decrease of intracellular proton concentration, known as a putative 
mechanism against organic acid stress (Warnecke and Gill 2005) to maintain constant internal pH 
(Booth 1999). In addition, the PDH complex was twofold induced. The corresponding carbon flux, 
however, remained unchanged (Figure 5.17). This could indicate the up-regulation of the PDH 
complex genes to maintain flux homeostasis or perturbing factors limiting flux through their reaction. 
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Table 5.10 Gene expression changes after evolutionary adaptation of B. succiniciproducens towards 10 g L-1 succinate. Data 
comprise genes up- and down-regulated in DD3-Suc2, as compared to the parental strain DD3 (corrected p-value < 0.05).  
Systematic 
namea 
Genea 
Fold 
change 
Descriptionb 
Operon 
numberc 
Functiond 
MS0181 ndh  5.1 NADH dehydrogenase  
Energy production 
and conversion 
MS0716 appB  3.3 Cytochrome oxidase subunit 2  
MS0715 cydA  3.1 Cytochrome oxidase subunit 1  
MS1335 aceF 
 
2.3 
Pyruvate dehydrogenase complex, E2 
component 
4 
MS1336 aceE 
 
2.3 
Pyruvate dehydrogenase complex, E1 
component 
4 
MS1334 lpd 
 
2.2 
Pyruvate dehydrogenase complex, E3 
component 
4 
MS1251 cysN  5.3 Sulfate adenylyltransferase subunit 1 2 
Amino acid 
metabolism and 
transport 
MS0941 metE  4.6 Methionine synthase II   
MS0787 metF  4.6 5,10-methylenetetrahydrofolate reductase  
MS1252 cysH  4.6 Sulfate adenylyltransferase subunit 2 2 
MS1250 cysJ  4.5 Sulfite reductase alpha subunit (flavoprotein) 2 
MS1249 cysI  4.0 Sulfite reductase beta subunit (hemoprotein) 2 
MS1253 cysH  3.6 Phosphoadenosine phosphosulfate reductase  
MS1277 artI 
 
3.1 
ABC-type amino acid transport (substrate-
binding protein) 
3 
MS1684 artI 
 
2.7 
ABC-type amino acid transport (potential 
glutamine binding protein) 
 
MS1261 cysA  2.6 Sulfate transport system, ATP-binding protein  
MS1276 artM  2.3 ABC-type cystine transport system, permease 3 
MS1275 glnQ 
 
2.3 
ABC-type cystine transport system, ATP-
binding protein 
3 
MS0045 ilvC  2.2 Ketol acid reductoisomerase  
MS0372   2.5 Autonomous glycyl radical enzyme  Nucleotide 
metabolism and 
transport 
MS0575 uraA  2.0 Purine permease  
MS0992 nrdA  2.0 Ribonucleotide reductase, alpha subunit  
MS1254 cysG  2.3 Uroporphyrinogen-III methyltransferase  
Coenzyme 
metabolism 
MS1683 gshA 
 
2.1 
Bifunctional glutamate-cysteine 
ligase/glutathione synthetase 
 
MS1015 cirA  2.1 Vitamin B12 transporter  
MS1856   2.0 6-pyruvoyl-tetrahydropterin synthase 5 
MS1857 nrdG 
 
2.2 
7-carboxy-7-deazaguanine synthase; queuosine 
biosynthesis (radical SAM superfamily) 
5 
Molecular 
chaperons and 
related functions MS0458 groS  2.0 Co-chaperonin GroES  1 
MS0389 sodA  3.8 Superoxide dismutase (Mn)  Inorganic ion 
transport and 
metabolism 
MS1205 cirA 
 
2.4 Iron complex outermembrane recepter protein  
MS0040 oadG - 3.5 Oxaloacetate decarboxylase, gamma subunit 6 
Energy production 
and conversion 
MS1653 frdB - 3.4 Fumarate reductase, Fe-S protein subunit 12 
MS1654 frdC - 3.3 Fumarate reductase subunit C 12 
MS0038 oadB - 3.3 Oxaloacetate decarboxylase, beta subunit 6 
MS1655 frdD - 3.3 Fumarate reductase subunit D 12 
MS1652 sdhA - 3.2 Fumarate reductase, flavoprotein subunit 12 
MS2293 pckA - 3.0 Phosphoenolpyruvate carboxykinase (ATP)  
MS0039 oadA - 2.9 Oxaloacetate decarboxylase, alpha subunit 6 
MS1105 leuA - 2.7 Tartrate dehydrogenase/decarboxylase  
MS0760 fumC - 2.1 Fumarate hydratase  
MS0732  - 2.1 Formate dehydrogenase subunit alpha  
MS0550 proW - 3.6 
ABC-type proline/glycine betaine transport 
system, permease component 
7 
Amino acid 
metabolism and 
transport 
MS0551 proX - 3.5 
ABC-type proline/glycine betaine transport 
systems, periplasmic components, substrate 
binding protein 
7 
MS0549 proV - 3.4 
ABC-type proline/glycine betaine transport 
system, ATPase component 
7 
MS0731 gltD - 2.9 
Putative NADPH-dependent glutamate 
synthase beta chain and related oxidoreductases 
9 
MS0815 pepD - 2.5 Aminotripeptidase  
MS0288/89  - 2.1 
Putative transporter protein (Asp-Al_Ex 
superfamily) 
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MS0633 nrdD - 2.0 
Anaerobic ribonucleoside-triphosphate 
reductase 
 
Nucleotide 
metabolism and 
transport 
MS2216 dcuB - 3.6 
Anaerobic C4-dicarboxylate transporter (DcuA 
DcuB superfamily) 
 
Carbohydrate 
metabolism and 
transport 
MS1612 rbsB - 2.9 
ABC-type sugar transport system, periplasmic 
component 
 
MS2066 lamb - 2.5 Maltose-inducible porin 14 
MS2377  - 2.5 
Phosphotransferase system, 
mannose/fructose/N-acetylgalactosamine-
specific, component IID 
15 
MS2378  - 2.4 
Phosphotransferase system, 
mannose/fructose/N-acetylgalactosamine-
specific, component IIC 
15 
MS2379  - 2.3 
Phosphotransferase system, 
mannose/fructose/N-acetylgalactosamine-
specific, component EIIAB 
15 
MS1121 glgC - 2.3 Glucose-1-phosphate adenylyltransferase 10 
MS1877 dcuB - 2.3 
Anaerobic C4-dicarboxylate transporter (DcuA 
DcuB superfamily) 
 
MS2355 mipB - 2.3 Transaldolase  
MS0616  - 2.1 
Phosphotransferase system, 
mannose/fructose/N-acetylgalactosamine-
specific, component IID 
8 
MS0618  - 2.1 
Phosphotransferase system, 
mannose/fructose/N-acetylgalactosamine-
specific, component IIB 
8 
MS0617  - 2.1 
Phosphotransferase system, 
mannose/fructose/N-acetylgalactosamine-
specific, component IIC 
8 
MS2068 malE - 2.0 
ABC-type maltose transport system, maltose-
binding periplasmic protein 
 
MS0639 rbsB - 2.0 
ABC-type sugar transport system, periplasmic 
component 
 
MS1124 malQ - 2.0 4-alpha-glucanotransferase 10 
MS1006 bioD - 3.4 Dethiobiotin synthetase  Coenzyme 
metabolism MS0842 cof - 3.2 Pyridoxyl phosphate phosphatase  
MS0352  - 2.9 Ribosome-associated protein Y  Translation 
MS1504 ompR - 2.0 
Aerobic respiration control protein ArcA 
homolog 
 Transcription 
MS1159  - 2.6 
Ferrous iron transport protein A (FeoA 
superfamily) 
 
Inorganic ion 
transport and 
metabolism 
MS1583 tbpA - 2.6 
ABC-type Fe3+ transport system, periplasmic 
component  
 
MS1817 hybA - 2.2 
Formate-dependent nitrite reductase, 4Fe-4S 
subunit 
13 
MS1158 feoB - 2.2 Fe2+ transport system protein B 11 
MS1818 nrfB - 2.1 
Formate-dependent nitrite reductase, penta-
heme cytochrome c 
13 
MS1816 nrfD - 2.1 
Formate-dependent nitrite reductase, membrane 
component 
13 
MS1819 nrfA - 2.0 
Formate-dependent nitrite reductase, 
periplasmic cytochrome c552 subunit 
13 
MS0349 uspA - 6.1 Universal stress protein UspA homolog  Signal transduction 
a Gene entries and names are given in accordance with KEGG annotations for M. succiniciproducens MBELE55. 
b Information are adopted from Hong et al. 2004 and/or NCBI database using BLASTP swissprot (sequence coverage of 
50 % and amino acid sequence homologies above 30 %) in combination with annotations from KEGG. 
c Operons and their corresponding genes were assigned according to the Database of prOkaryotic OpeRons (Dam et al. 
2007; Mao et al. 2009) and the Prokaryotic Operon DataBase (Taboada et al. 2012) for M. succiniciproducens MBELE55 
predictions (see Table 9.5). 
d Functional grouping was taken from literature (Hong et al. 2004). 
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Regarding general stress response, several genes showed changes in their expression level. 
Ribonucleotide reductase (RNR), conserved among most microorganisms and essential for DNA 
synthesis, was over-expressed in combination with an acid-induced glycyl radical enzyme, which 
supports RNR function under anaerobic conditions (Buckel and Golding 2006). Moreover, genes 
encoding enzymes of the qeueosine pathway were found to be up-regulated (Table 5.10). Qeueosine 
increases the accuracy of translation processes (Urbonavicius et al. 2001). In addition, superoxide 
dismutase and a Gro chaperone were induced, as also observed for acid-stressed L. lactic (Sanders et 
al. 1995). The glutamate/cysteine ligase, involved in glutathione biosynthesis, was increased 2.1-fold, 
as compared to DD3. Expression of superoxide dismutase and synthesis of glutathione are part of the 
general stress response (Mager et al. 2000). The strongest transcriptional activation was found for 
genes contributing to the biosynthesis of cysteine. In addition, a cysteine related ABC amino acid 
transport system was induced. This could activate glutathione biosynthesis based on the fact that 
cysteine represents a building block for glutathione. Thus, it may support stress tolerance regarding 
optimized glutathione accessibility. Glutathione indeed improved succinate production with 
M. succiniciproducens MBELL55E (Hoon et al. 2010), certainly based on the fact that cysteine is 
known to be an essential compound during M. succiniciproducens MBEL55E and A. succinogenes 
cultivation, due to incomplete biosynthetic pathways (Song et al. 2008; McKinlay et al. 2010).  
Among the 45 repressed genes in DD3-Suc2, as compared to DD3, were ten operons (Table 9.7), 
mainly related to transport and carbohydrate conversion. Two candidates (MS1877, MS2216), 
encoding for anaerobic C4-dicarboxylic acid transporters, were significantly reduced in expression. 
These genes, belonging to the DcuA DcuB superfamily, potentially prevent efflux of produced 
succinate to adjust to the extracellular stress and thus limit its production. The resulting intracellular 
accumulation of succinate may be the reason for the observed induction of genes related to proton-
pumping to minimize internal pH perturbations. In contrast to E. coli, where the dcu genes share an 
operon with aspartase and fumarase, respectively (Six et al. 1994), and are thus physiologically 
controlled, such a genomic structure could not be found in B. succiniciproducens, proving non-
proximal transcription of the transporters. A putative permease of the Asp-Al_Ex superfamily showed 
repression on the transcription level. Recently, a novel succinate transporter was predicted for 
C. glutamicum, exhibiting the same domains as the transporter here and it was characterized to be part 
of the succinate excretion system (Huhn et al. 2011). Regarding carbohydrate metabolism, PEPCK, 
the major anaplerotic enzyme towards succinate, was 3-fold repressed in the succinate tolerant mutant 
DD3-Suc2. The reaction from fumarate towards succinate was obviously repressed on the level of the 
complete fumarate reductase complex (Table 9.6). Altogether, the whole reductive TCA cycle branch 
and potential succinate efflux mechanisms were repressed in a concerted manner (Figure 5.21).  
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Figure 5.21 In vivo flux and gene expression response of B. succiniciproducens DD3-Suc2 linked to biosynthetic pathway of 
succinate as compared to the parental strain DD3. Flux ratios (Table 9.4) are shown in squared brackets. Transcriptional 
changes (Table 5.10) are shown in curly brackets. Systematic and gene names are allocated to their reactions and indicate up- 
(green) and down-regulation (red). 
 
Obviously, cells actively down-regulate formation and export of succinate to counteract external 
succinate stress (Figure 5.21). Moreover, genes encoding for sugar transporters and components of 
glycogen metabolism were decreased in expression. In addition, the gene encoding for the response 
regulator ArcA was repressed in DD3-Suc2. The regulator ArcA is specifically responsible for 
regulating the intracellular redox system (Malpica et al. 2006). It controls the glucose specific PTS 
system in E.coli (Jeong et al. 2004) and is also responsible for several genes and operons involved in  
anaerobic metabolism, e.g. the cydAB genes coding for a cytochrome:quinol oxidase (Gunsalus and 
Park 1994). Additionally, this regulator plays an important role in the related succinate producer 
M. succiniciproducens, where it seems to control various genes, e.g. PDH and fumarate reductase 
(Yun et al. 2012). Interestingly, genes related to glycine betaine/proline transport were repressed in 
DD3-Suc2, despite their well-known function as osmoprotectants (Arakawa and Timasheff 1985; 
Bourot et al. 2000). 
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Table 5.11 Impact of succinate adaptation towards 25 g-1 L-1 on B. succiniciproducens gene expression profile. Data 
comprise genes up- and down-regulated in DD3-Suc3, as compared to the parental strain DD3 (corrected p-value < 0.05).  
Systematic 
namea 
Genea 
Fold 
change 
Descriptionb 
Operon 
numberc 
Functiond 
MS1188   3.2 Phosphoglycerate dehydrogenase  
Energy production 
and conversion 
MS0883   2.7 NADH-dependent butanol dehydrogenase A  
MS0760 fumC  2.0 Fumarate hydratase  
MS1674 ftsL  2.4 Cell division protein FtsL 4 
Cell division and 
chromosome 
partitioning 
MS1676   2.4 Cell division protein MraZ  
MS1673 ftsI 
 
2.3 
Cell division protein FtsI (peptidoglycan 
synthesis) 
4 
MS1703 thrA 
 
4.6 
Bifunctional aspartokinase I/homoserine 
dehydrogenase I 
5 
Amino acid 
metabolism and 
transport 
MS1984 aspA  4.4 Aspartate ammonia-lyase  
MS1702 thrB  2.9 Homoserine kinase 5 
MS1701 thrC  2.9 Threonine synthetase 5 
MS1177 dapD 
 
2.8 
2,3,4,5-tetrahydropyridine-2,6-carboxylate N-
succinyltransferase 
 
MS0924 metX  2.8 Homoserine O-acetyltransferase  
MS0045 ilvC  2.3 Ketol acid reductoisomerase  
MS0992 nrdA 
 
3.0 Ribonucleotide reductase, alpha subunit  
Nucleotide 
metabolism and 
transport 
MS1197 pykA  2.6 Pyruvate kinase  
Carbohydrate 
metabolism and 
transport 
MS0967 glmM  2.4 Phosphoglucosamine mutase 1 
MS1965 glpF  2.3 Aquporin Z (MIP family)  
MS1615 fbp  2.1 Fructose 1,6-bisphosphatase  
MS1111 chb  2.0 N-acetyl beta hexosaminidase (GH family)  
MS0669 metK  5.0 S-adenosylmethionine synthetase  Coenzyme 
metabolism MS0503 hemB  2.2 Delta-aminolevulinic acid dehydratase  
MS1446   3.1 Ribosome maturation protein RimP 3 
Translation 
MS1444 infB  3.1 Translation initiation factor IF-2 3 
MS1442 rbfA  2.7 Ribosome binding factor A 2 
MS2312 cca  2.5 tRNA nucleotidyltransferase 7 
MS1441 truB  2.4 tRNA pseudouridine synthase B 2 
MS1175 truA  2.0 tRNA pseudouridine synthase A  
MS1445 nusA 
 
3.7 
Transcription termination/antitermination 
protein 
 
Transcription MS2131 araC  3.2 HTH-type transcriptional activator   
MS1675 mraW 
 
2.6 
Ribosomal RNA small subunit 
methyltransferase H 
4 
MS1331  
 
2.1 DNA mismatch repair protein  
Replication, 
recombination and 
repair 
MS1565 mltE  3.4 Soluble lytic murein transglycosylase  
Cell wall, 
membrane,    
envelope biogenesis 
MS0387   3.2 Phosphoethanolamine transferase  
MS1697   2.8 Opacity family porin protein  
MS1189 kdsA  2.6 2-dehydro-3-deoxyphosphooctonate aldolase  
MS0242 dgkA  2.3 Diacylglycerol kinase  
MS1670 mraY 
 
2.2 
Phospho-N-acetylmuramoyl-pentapeptide-
transferase 
4 
MS0267 nlpE  2.1 Outer membrane protein assembly factor  
MS1672 murE 
 
2.1 
UDP-N-acetylmuramoylalanyl-D-glutamate--
2,6-diaminopimelate ligase 
4 
MS1671 murF 
 
2.1 
UDP-N-acetylmuramoyl-tripeptide--D-alanyl-
D-alanine ligase 
4 
MS1922 lpxD 
 
2.1 
UDP-3-O-[3-hydroxymyristoyl] glucosamine 
N-acyltransferase 
5 
MS1161   2.0 Opacity family porin protein  
MS1829 dacC  2.0 D-alanyl-D-alanine carboxypeptidase  
MS0993 degQ  2.9 Periplasmic serine proteases  
Molecular 
chaperons and 
related functions 
MS1923 hlpA 
 
2.5 
Outer membrane protein, periplasmic 
chaperone 
5 
MS1134 htpX  2.4 Protease HtpX  
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MS1141 sseA  2.7 Sulfurtransferase  
Inorganic ion 
transport and 
metabolism 
MS1417 pheA 
 
2.2 
Glutathione-regulated potassium-efflux system, 
quinone oxidoreductase 
 
MS1959 arsC  2.1 Arsenate reductase  
MS1205 cirA  2.0 Iron complex outermembrane recepter protein  
MS1131 tolC  2.0 Cation efflux system   
MS2229 rseA  2.1 Sigma-E factor negative regulatory protein  Signal transduction 
MS1823  - 2.7 Glycerol-3-phosphate acyltransferase  
Energy production 
and conversion 
MS1654 frdC - 2.7 Fumarate reductase subunit C  10 
MS1028  - 2.6 
Formate dehydrogenase, cytochrome b556 
subunit 
 
MS1655 frdD - 2.5 Fumarate reductase subunit D 10 
MS1653 frdB - 2.4 Fumarate reductase, Fe-S protein subunit 10 
MS1105 leuB - 2.2 Tartrate dehydrogenase/decarboxylase   
MS1029 hybA - 2.2 Formate dehydrogenase iron-sulfur subunit  
MS0551 proX - 12.7 
ABC-type proline/glycine betaine transport 
system, substrate binding protein 
8 
Amino acid 
metabolism and 
transport 
MS0550 proW - 10.3 
ABC-type proline/glycine betaine transport 
systems, periplasmic components, permease 
component  
8 
MS0549 proV - 8.8 
ABC-type proline/glycine betaine transport 
system, ATPase component 
8 
MS0353 alsT - 4.3 Na+/alanine or glycine symporter  
MS1687 artM - 3.1 
ABC-type amino acid transport system, 
permease 
11 
MS0832 sstT - 2.8 Na+/serine-threonine symporter  
MS1686 artM - 2.6 
ABC-type amino acid transport system, 
permease 
11 
MS0815 pepD - 2.4 Aminotripeptidase  
MS1321 nhaC - 2.3 Arginine/ornithine antiporter  
MS1790 aroQ - 2.3 3-dehydroquinate dehydratase II  
MS1685  glnQ - 2.2 
ABC-type amino acid transport system, ATPase 
component 
11 
MS0030 gltS - 2.2 Na+/glutamate symporter  
MS1770 cysK - 2.1 Cysteine synthase  
MS1318 ilvH - 2.1 Acetolactate synthase, small subunit  
MS1253 cysH - 2.0 Phosphoadenosine phosphosulfate reductase  
MS2066  - 6.8 Maltose-inducible porin 17 
Carbohydrate 
metabolism and 
transport 
MS2068 malE - 4.0 
ABC-type maltose transport systems, Maltose-
binding periplasmic protein 
18 
MS2069 malF - 3.6 ABC-type maltose transport systems, permease 18 
MS2070 malG - 3.5 ABC-type maltose transport systems, permease 18 
MS2074 malQ - 3.2 4-alpha-glucanotransferase 19 
MS2073 glgP - 3.0 Glycogen phosphorylase 19 
MS2071 malS - 2.9 Periplasmic alpha-amylase precursor  
MS2067 malK - 2.8 
ABC-type maltose transport systems, ATP-
binding protein 
17 
MS2065  - 2.1 Maltose regulon periplasmic protein  
MS1795 menF - 3.7 Menaquinone specific isochorismate synthase 13 
Coenzyme 
metabolism 
MS1254 cysG - 3.3 Uroporphyrinogen-III methyltransferase  
MS1794 menD - 3.1 
2-succinyl-5-enolpyruvyl-6-hydroxy-3-
cyclohexene-1-carboxylate synthase 
13 
MS1824 folB - 2.3 Dihydroneopterin aldolase 16 
MS1793 mhpC - 2.3 
2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-
carboxylate synthase  
13 
MS1821 rluD - 2.4 Pseudouridylate synthases, 23S RNA-specific 15 
Translation 
MS1476 rpsA - 2.2 small subunit ribosomal protein S1  
MS2116 lysR - 2.7 HTH-type transcriptional activator  Transcription 
MS0227 betT - 7.9 Choline-glycine betaine transporter  
Cell wall, 
membrane,   
envelope biogenesis 
MS1333 spr - 3.4 
Cell wall-associated hydrolases (invasion-
associated proteins) 
 
MS1808 artI - 3.0 Membrane-bound lytic murein transgycosylase   
MS1220 ompA - 2.6 Outer membrane protein P5  
MS1820 nrfG - 2.1 Outer membrane protein assembly factor  
MS0911 rfe - 2.0 
UDP-GlcNAc:undecaprenyl-phosphate  
GlcNAc-1-phosphate transferase 
9 
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MS1255 sbp - 5.2 
ABC-type sulfate transport system, periplasmic 
component 
 
Inorganic ion 
transport and 
metabolism 
MS1816 nrfD - 4.6 
Formate-dependent nitrite reductase, membrane 
component 
14 
MS1817 hybA - 4.6 
Formate-dependent nitrite reductase, 4Fe-4S 
subunit 
14 
MS1819 nrfA - 4.5 
Formate-dependent nitrite reductase, 
periplasmic cytochrome c552 subunit 
14 
MS1818 nrfB - 4.4 
Formate-dependent nitrite reductase, penta-
heme cytochrome c 
14 
MS1801 nhaA - 4.0 Na+/H+ antiporter  
MS1805 cha - 2.1 Carbonic anhydrase  
MS1259 cysU - 2.0 ABC-type sulfate transport system, permease   
a Gene entries and names are given in accordance with KEGG annotations for M. succiniciproducens MBELE55. 
b Information are adopted from Hong et al. 2004 and/or NCBI database using BLASTP swissprot (sequence coverage of 
50 % and amino acid sequence homologies above 30 %) in combination with annotations from KEGG. 
c Operons and their corresponding genes were assigned according to the Database of prOkaryotic OpeRons (Dam et al. 
2007; Mao et al. 2009) and the Prokaryotic Operon DataBase (Taboada et al. 2012) for M. succiniciproducens MBELE55 
predictions (see Table 9.5). 
d Functional grouping was taken from literature (Hong et al. 2004). 
 
Next, the gene expression profile of DD3-Suc3 was analyzed to identify transcriptomic changes that 
were kept throughout the further evolutionary adaptation of DD3-Suc2 and highlight additional 
changes linked to its superior tolerance. Taken together, 52 genes were induced in DD3-Suc3. Among 
them were genes related to peptidoglycan and lipid biosynthesis and cell division. Indeed, the 
adjustment of membrane properties by variation of the lipid composition is widely known to mediate 
organic acid tolerance in bacteria (Booth 1999; Warnecke and Gill 2005). Regarding the transcription 
and translation machinery, the gene nusA increased about 4-fold in expression. Twelve operons were 
repressed in DD3-Suc3 as compared to the control DD3. They mostly related to transport of 
carbohydrates and amino acids (Table 5.11). These expression changes were specific for DD3-Suc3. 
Obviously, a few genes were similarly expressed in both mutants. In this line, the glycine 
betaine/proline transporter system was strongly repressed in DD3-Suc3, even though both substances 
are very well known as osmoprotectants (Arakawa and Timasheff 1985; Bourot et al. 2000). Further 
conjointly repressed genes comprised the fumarate reductase and the nitrite reductase (Table 5.10 and 
Table 5.11). Taken together, gene expression analysis of succinate adapted B. succiniciproducens 
strains draw a rather complex picture of the adapted metabolism.  
 
5.3.6 Identification of genomic mutations acquired in B. succiniciproducens DD1-Suc1, DD3-
Suc2 and DD3-Suc3 during evolutionary adaptation 
 
All strains were sequenced to unravel genomic modifications acquired during adaptation towards high 
succinate. Significance of occurring mutations was ensured by a sequence coverage > 50 and a variant 
frequency of 75 %. The sequence analysis of the first isolate revealed two mutations that resulted from 
evolutionary adaptation towards moderate succinate levels. Both mutations are also present in the 
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subsequent isolate DD3-Suc2. Interestingly the most tolerant strain DD3-Suc3 did not contain all 
mutations present in its ancestors. This fact implies that it had evolved independently from the others 
and at some point during evolution became fitter and outcompeted the other mutants from the 
population. One can conclude that the mutation in the pta gene (MS0998) was the first one 
accumulating in advance of the mutation in the pykA gene (MS1197). 
 
Table 5.12 Single nucleotide polymorphisms (SNP) and deletion – insertion – polymorphisms (DIP) are listed with their 
respective position specific nucleotide (Nt ex) and amino acid (AA ex) exchange in the succinate adapted strains 
B. succiniciproducens DD3-Suc1, DD3-Suc2 and DD3-Suc3. The wild-type genome was annotated according to the 
published M. succiniciproducens MBEL55E genome (Hong et al. 2004) and served as reference for detection of mutations in 
the adapted phenotypes. 
Strain An Nt ex AA ex Pm Gene Function 
DD3-Suc1 MS0998 1996G>A Val666Ile SNP pta Phosphate acetyltransferase 
 MS1197 1391G>A Cys417Tyr SNP pykA Pyruvate kinase 
DD3-Suc2 MS0998 1996G>A Val666Ile SNP pta Phosphate acetyltransferase 
 MS1197 1391G>A Cys417Tyr SNP pykA Pyruvate kinase 
 MS1875 62A>G Glu21Gly SNP acpP Acyl-carrier protein 
DD3-Suc3 MS0904 1134A>T - SNP N.A. N.A. 
 MS0998 1996G>A Val666Ile SNP pta Phosphate acetyltransferase 
 MS1445 432delA Lys144fs DIP nusA 
Transcription 
termination/antitermination factor 
 MS1494 846A>T - SNP rfaG Lipopolysaccharide glucosyltransferase 
Pm: type of occurring polymorphism, N.A.: not assigned. 
 
The deriving evolutionary tree that can be de deduced from the obtained sequencing data, visualized 
the evolutionary process. The mutation affected genes contribute to energy production and conversion, 
carbohydrate metabolism and transport, lipid metabolism, transcription, and cell wall, membrane, and 
envelope biogenesis, respectively (Figure 5.22). 
 
 
Figure 5.22 Genealogy tree for succinate adaptation of B. succiniciproducens DD3 towards 5, 10, and 25 g L-1 added 
succinate, yielding DD3-Suc1, DD3-Suc2 and DD3-Suc, respectively. Systematic name and COG identifier (in brackets) are 
taken from M. succiniciproducens MBEL55E annotation (Hong et al. 2004). For further information on the single 
modifications see Table 5.12. 
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Taken together, B. succiniciproducens could be successfully adapted to increased succinate levels. The 
adapted strains could be proven at high succinate levels, not feasible for the initially applied DD3. The 
characterization of the molecular mechanisms behind the acquired tolerance, by careful growth 
experiments and system biology approaches, revealed a complex picture. The increased tolerance 
obviously resulted from concerted reduction of succinate formation, together with beneficial changes 
in cellular constitutes such as osmoprotectants, and more robustness. With regard to rational 
improvement of B. succiniciproducens, it appeared most relevant to dissect the types of tolerance 
mechanisms, acquired during the adaptation process. Particularly, mutations that resulted in reduced 
product formation seemed detrimental regarding industrial performance. Other genetic targets 
however, promised the possibility to rationally achieve superior tolerant phenotypes.  
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5.4 Evolutionary adaptation of B. succiniciproducens towards lower pH-values 
 
5.4.1 Adaptation of B. succiniciproducens towards pH 5.3 
 
A desired low pH that would economize biotechnological succinate production represents a harsh 
condition for non-acidophilic microorganisms. From the industrial perspective, a low pH reduces the 
demand for costly acidification during downstream processing and for buffer agents, otherwise needed 
to maintain the pH at neutral. Overall, production costs for succinate decrease with decreasing 
cultivation pH (Jansen et al. 2012). B. succiniciproducens has its fermentative optimum within a pH 
range of 7.5 to 6.0 (Figure 5.4) (Scholten et al. 2011). As shown, B. succiniciproducens DD3 exhibited 
a reasonable fermentation performance at pH 6 (Figure 5.4) and produced about 40 g L
-1
 succinate 
within 55 hours, while completely consuming the supplied glucose. A further decrease of the pH to 
about 5.5, however, tremendously reduced the performance of DD3. Succinate was only produced up 
to a titer of 11 g L
-1
. An initial cultivation of the double mutant DD3 at pH 5.3 did not yield any 
growth and succinate production so that pH 5.5 could be regarded as critical pH for growth and 
production performance of B. succiniciproducens. According to these findings, pH adaptation started 
at an initial pH-value of 5.5. In order to maintain and control the pH-value at desired levels, the 
adaptation was conducted in small scale bioreactors equipped with automatic control of the pH and 
operated as sequential batches.  
 
Figure 5.23 Bioreactor based sequential batch adaptation of B. succiniciproducens DD3 under non-physiological pH values. 
The vertical line indicates the switch from the primary critical pH 5.5 to pH 5.3. Once cells have reached sufficient cell 
concentration, a fraction was harvested and inoculated into the next batch. 
 
The first adaptation rounds showed slow but consistent growth. After about five days and during the 
third iterative batch, cell density increased faster, indicating an adaptation of the population to the 
acidic environment. The cells were allowed to further adapt to pH 5.5 before the cultivation pH was 
decreased to 5.3. Interestingly, the cell growth was not significantly hampered, despite certain lag-
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phases at the beginning of each batch. Through further adaptation, the lag-phases shortened and cells 
grew quickly at pH 5.3. Finally, the heterogenic population was used to isolate the pH-tolerant 
phenotype DD3-pH1. 
 
5.4.2 Physiology of the pH-tolerant strain B. succiniciproducens DD3-pH1 
 
Closer inspection of the growth performance of the isolated strain DD3-pH1 was carried out to 
describe its superior performance. Bioreactor cultivations were conducted at various pH-values at 
37 °C in minimal glucose medium and growth as well as production performance were monitored in 
comparison to the parent strain DD3 (Table 5.13).  
 
Table 5.13 Fermentation performance of pH-tolerant phenotype B. succiniciproducens DD3-pH1 at different pH-values in 
bioreactor cultivation, as compared to its ancestor DD3. Growth rate (µ) is given for the exponential growth phase. Succinate 
yield (YSuc/S) and maximal succinate productivity (PSuc) are calculated for the complete 48 h period of cultivation. Product 
titers for succinate (ΔcSuccinate), formate (ΔcFormate), acetate (ΔcAcetate), lactate (ΔcLactate), ethanol (ΔcEthanol) and pyruvate 
ΔcPyruvate) represent final concentrations after 48 h.  
 DD3 DD3-pH1 
 pH 6 pH 5.5 pH 5.3 pH 6 pH 5.5 pH 5.2 pH 5.0 
µ [h
-1] 0.18 0.10 0.02 0.22 0.17 0.09 < 0.01 
YSuc/S [mol mol
-1] 0.93 0.86 - 0.99 1.01 0.95 < 0.1 
ΔcSuccinate [g L
-1] 39.1 10.6 1.0 40.8 21.5 11.5 < 0.1 
ΔcFormate [g L
-1] < 0.1 < 0.1 < 0.1 < 0.1 < 0.1 < 0.1 < 0.1 
ΔcAcetate [g L
-1] 2.6 2.1 0.4 1.1 3.8 1.5 < 0.1 
ΔcPyruvate [g L
-1] 0.3 < 0.1 < 0.1 1.2 0.5 < 0.1 < 0.1 
ΔcEthanol [g L
-1] < 0.1 < 0.1 < 0.1 0.1 < 0.1 < 0.1 < 0.1 
ΔcLactate [g L
-1] < 0.1 0.2 < 0.1 0.1 0.1 0.1 < 0.1 
PSuc [g L
-1 h-1] 0.8 0.2 < 0.1 1.3 0.5 0.3 < 0.1 
    
 
At pH 6.0, the evolved strain DD3-pH1 exceeded the performance of DD3 in maximal productivity by 
about 60 % and in growth rate by about 20 % (Table 5.13). A pH-value of 5.5 reduced growth and 
succinate production. However, the evolved mutant performed by far better than DD3. This fact 
indicated the successful adaptation of B. succiniciproducens to lower pH-values. At pH 5.2, which 
partially abolished DD3 proliferation, the adapted phenotype was still able to grow exponentially and 
produced 11 g L
-1
 succinate. Further decrease to a pH of 5.0, however, was not tolerated by DD3-pH1. 
The graphical presentation of the resulting growth rates at different pH values clearly reveals the 
superiority of the evolved strain (Figure 5.24). For all pH-values tested, DD3-pH1 data points were 
located closer to the area of fast growth and low pH, preferred as industrial settings. 
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Figure 5.24 The specific growth rate is shown for (■) B. succiniciproducens DD3 and (●) DD3-pH1 at different pH-values. 
Data derive from pH-controlled bioreactor cultivations in minimal glucose medium. The color gradient represents industrially 
desired (green) and unfavored (orange) characteristics.  
 
5.4.3 Adaptation derived genetic modifications in DD3-pH1 
 
As verified by genome sequencing, B. succiniciproducens DD3-pH1 accumulated only two mutations. 
The affected genes belonged to the functional groups of carbohydrate metabolism and cell wall, 
membrane, envelope biogenesis. A closer view revealed that the first mutation was located in the 
pyruvate kinase gene, which had also evolved in the succinate adapted strains. In addition, a gene 
belonging to the cell wall synthesis apparatus harbored a frame-shift mutation, putatively leading to an 
incomplete protein.  
 
Table 5.14 Single nucleotide polymorphisms (SNP) and deletion – insertion – polymorphisms (DIP) with their respective 
position specific nucleotide (Nt ex) and amino acid (AA ex) exchange in the pH adapted strains B. succiniciproducens DD3-
pH1.  
Strain An Nt ex AA ex Pm Gene Function 
DD3-pH1 MS1197 640G>T Gly167Cys SNP pykA Pyruvate kinase 
 MS1492 80_81insC Tyr27fs DIP wcaJ EpsL like protein 
Pm: type of occurring polymorphism. 
 
Overall, the successful pH adaptation of B. succiniciproducens yielded the promising new phenotype 
DD3-pH1. Its superior performance at low pH-values, as compared to its ancestor DD3 (Figure 5.24) 
showed high potential with regard to industrial applicability. In addition, the small number of 
evolutionary acquired mutations is a good starting point for rationally engineering towards this 
phenotype.  
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5.5 Metabolic engineering of B. succiniciproducens exploiting targets identified 
from evolutionary adaptation 
 
As shown, B. succiniciproducens mutants established a narrow set of genetic mutations, which 
obviously contributed to their improved phenotypes. It now was highly interesting to test candidate 
genes individually in order to see to which extent they allow a rational improvement of the producing 
strains. According to obtained sequence data and the knowledge of the physiology and biochemistry of 
B. succiniciproducens, different second-generation mutants were created on basis of producing strains. 
Vector construction and subsequent transformation of E. coli and B. succiniciproducens as well as 
control of integration were applied according to 4.3. 
 
5.5.1 Modification of the pyruvate node at the level of pyruvate kinase 
 
The pyruvate kinase gene pykA was mutated independently during the evolutionary adaptation to high 
succinate levels and to low pH, respectively. This indicated a central role of the metabolic reaction of 
the encoded enzyme, i.e. the interconversion of PEP to pyruvate. Indeed, a re-direction of carbon 
fluxes was observed at the pyruvate node in the adapted strains (Figure 5.10, Figure 5.17 and Figure 
5.18). The node is relevant for distributing cellular carbon flux between different pathways, i.e. TCA 
cycle, anaplerosis, gluconeogenesis, anabolism and overflow metabolism and to flexibly adapt the 
supply of energy and building block to cellular needs (Sauer and Eikmanns 2005). Particularly under 
anaerobic conditions, the pyruvate node is important for redox-balancing. Different approaches have 
been attempted to engineer the node by rational strain development (Becker et al. 2013). However, 
considering the complexity of the interlinked metabolic networks around the node, knockout-studies in 
E. coli showed important effects on glycolysis, PPP and by-product formation (Siddiquee et al. 2004). 
The genomic sequencing of the adapted strains revealed a nucleotide exchange in the pykA gene of 
DD3-Suc2, replacing cysteine at position 417 by tyrosine. The pH-adapted DD3-pH1 revealed a pykA 
mutation leading to substitution of Gly
167
 to Cys. In order to obtain second generation mutants, the 
first step of the engineering strategy, deletion of the gene, was attempted, but did not result in positive 
clones. Then, direct homologue recombination of mutated and native gene was pursued as second 
strategy, but permanently revealed the parental genotype.  
As genetic engineering strategies could not be completed successfully, the study of the effect of the 
acquired mutations on enzyme kinetics seemed interesting. Regarding the enzyme structure, both 
modifications were located in proximity to the allosteric and the active site, respectively, when 
mapped against G. stearothermophilus (PDB ID: 2E28 (Suzuki et al. 2008)). This potentially indicated 
that both, enzyme control and activity were affected. To further study this, experiments were 
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conducted to investigate the kinetic properties of pyruvate kinase for the wild-type and the mutated 
variants. The comparative assays were carried out with cell extract from DD3, DD3-Suc2 and DD3-
pH1 and with varied concentrations of PEP as substrate.  
 
A substrate inhibition model described the data well (Equation 2), where [S] is the substrate 
concentration, KI represents the dissociation constant for the binding of the inhibitor to the free 
enzyme, KM represents the Michaelis constant and υ and υmax are reaction rate and maximal reaction 
rate, respectively. Such a behavior seemed consistent with the metabolism of B. succiniciproducens, 
since the primary pathway for PEP runs via the PEPCK. Thus PEP-dependent inhibition of pyruvate 
kinase seems to be involved in the control of succinate production.  
 
Figure 5.25 Enzyme kinetics of pyruvate kinase. The data points for (●) B. succiniciproducens DD3, (■) DD3-Suc2 and (▲) 
DD3-pH1 represent mean values of three replicates and their corresponding standard deviation. In all cases, higher levels of 
PEP inhibited the enzyme. 
 
Regarding the obtained characteristics, all three enzyme variants strongly differed from each other in 
their kinetics (Figure 5.25 and Table 5.16). The wild-type enzyme revealed a theoretical maximum 
reaction rate of about 3000 mU mg
-1
, combined with a high substrate affinity. The variant from DD3-
Suc2, putatively affected at the allosteric site, exhibited a decrease of the maximal activity by about 
60 %. In addition, the KM-value increased about 8-fold, resulting in significantly less substrate affinity. 
The pyruvate kinase of DD3-pH1 exhibited a similar KM-value, as compared to the wild-type enzyme, 
but its maximal enzyme activity was decreased by 70 %, with a substantially higher KI-value. Taken 
together, the mutated enzymes appeared strongly reduced in their in vivo activity, which suggested a 
potential re-direction of flux towards the reductive TCA cycle. Generally, the attenuation and deletion 
of pyruvate kinase in bacteria resulted in a re-direction of flux at the pyruvate node by stimulating 
(Equation 2) 
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anaplerotic reactions at the interconversion of PEP and OAA (Emmerling et al. 2002; Becker et al. 
2008; Meza et al. 2012). In all cases, the substantially decreased enzyme activity of the mutated 
variants is assumed to match with the desired changes, so that a positive effect on succinate production 
can be expected.  
 
Table 5.15 Enzyme kinetics of pyruvate kinase of B. succiniciproducens DD3, DD3-Suc2 and DD3-pH1. The values 
represent modeled data, assuming substrate inhibition kinetics. The underlying assays were conducted as three biological 
replicates. 
Strain vmax [mU mg
-1] KM [mM] KI [mM] 
DD3 3041 2.4 46.8 
DD3-Suc2 1158 22.7 62.1 
DD3-pH1 931 1 147.5 
 
 
5.5.2 Transcription machinery engineering of B. succiniciproducens through overexpression of 
a mutated rpoC 
 
Genomic analysis of adapted B. succiniciproducens DD3-T2 revealed a modification in the beta'-
subunit of the DNA-directed RNA polymerase, which may contribute to RNA synthesis and DNA 
interaction (Nedea et al. 1999). Hereby, a nucleotide exchange resulted in the change of Thr
231
 to Lys. 
This modification locus might affect the global transcription machinery, which has a high potential in 
strain improvement (Alper and Stephanopoulos 2007). Structural analysis of the identified mutation 
within the bacterial multisubunit RNA polymerase revealed no obvious contribution to conserved 
domains (Lane and Darst 2010).  
 
Table 5.16 Growth and production characteristics of B. succiniciproducens DD3 pJFF224-XN and DD3 pSUC-1 showing 
the impact of overexpressing the mutated polymerase subunit encoded by rpoCT231K at 37 °C. The data comprise specific 
growth rate (µ), biomass yield (YX/S), succinate yield (YSuc/S), formate yield (YFor/S), acetate yield (YAce/S), lactate yield 
(YLac/S), ethanol yield  (YEtOH/S), pyruvate yield (YPyr/S) and maximal succinate productivity (PSuc). Data represent values from 
three biological replicates with their corresponding standard deviations in minimal glucose medium, supplemented with 
5 mg L-1 chlorampehnicol as selection marker. 
 DD3 pJFF224-XN DD3 pSUC-1 
µ [h
-1] 0.06 ± 0.01 0. 11 ± 0.01 
YX/S [g mol
-1] 17.9 ± 1.5 26.3 ± 1.4 
YSuc/S [mol mol
-1] 1.19 ± 0.03 1.18 ± 0.07 
YFor/S [mol mol
-1] < 0.01 < 0.01 
YAce/S [mol mol
-1] 0.34 ± 0.03 0.15 ± 0.01 
YLac/S [mol mol
-1] < 0.01 < 0.01 
YEtOH/S [mol mol
-1] < 0.01 < 0.01 
YPyr/S [mol mol
-1] 0.06 ± 0.01 0.18 ± 0.02 
PSuc [g L
-1 h-1] 0.33 ± 0.02 0.56 ± 0.04 
Yields were determined during exponential phase by linear fitting of the 
concentration of biomass and product with that of the substrate. 
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In order to investigate the effect of this mutated polymerase, the gene was co-expressed in DD3 via a 
plasmid, yielding DD3 pSUC-1. The constructed plasmid contained the mutated gene under control of 
the native promoter. The point mutation was validated by sequencing and plasmid carriage was 
guaranteed by addition of 5 mg L
-1
 chloramphenicol to the medium.  
Taken together, the engineered mutant revealed a remarkably improved production performance. In 
particular, the overexpression yielded a better growth performance with a twofold increased maximal 
growth rate and an increased succinate production, as compared to the control DD3 pJFF224-XN, 
carrying the empty vector (Table 5.16). The specific yield for succinate remained at the high level of 
the parent strain. It was now interesting to test the effect of overexpressing the mutated polymerase 
subunit for its contribution to temperature tolerance, considering its acquisition during the 
evolutionary adaptation towards higher temperature. The cultivation of DD3 pSUC-1 at 42 °C 
revealed improved growth and succinate production, as compared to DD3 pJFF224-XN. It even 
exceeded the performance of the basic strain DD3 by 30 %, regarding cell concentration and succinate 
titer, respectively (Figure 5.26). However, cell growth stopped at a maximal concentration equivalent 
to OD600 of about 3, indicating further temperature sensitive parts of the metabolism.  
 
Figure 5.26 Growth physiology of the rationally engineered (▲) B. succiniciproducens DD3 pSUC-1 compared to the 
control strains (●) DD3 and (■) DD3 pJFF224-XN at 42 °C in minimal glucose medium, supplemented with 5 mg L-1 
chloramphenicol, for retaining the plasmid. Data comprise growth (A) and succinate titer (B) from three biological replicates 
with corresponding standard deviations. 
 
Obviously, the rpoC mutation affected the cellular propagation in a beneficial manner. Its plasmid 
based introduction into B. succiniciproducens DD3 improved growth and production performance at 
both temperatures, i.e. 37 and 42 °C, respectively, as compared to DD3 pJFF224-XN. First, these 
observations proved the temperature tolerant phenotype to be very complex, due to the multitude of 
genes that might be affected by an altered transcription machinery (Alper and Stephanopoulos 2007). 
Nevertheless, the identified rpoC modification could improve the competitiveness of succinate 
production with B. succiniciproducens. 
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5.5.3 Engineering of cell envelope metabolism through a mutation in a sugar transferase 
 
During high temperature adaptation, B. succiniciproducens DD3 acquired a mutation in the rfe gene, 
encoding for the UDP-GlcNAc:undecaprenyl-phosphate GlcNAc-1-phosphate transferase. Rfe is an 
integral membrane protein with 11 predicted transmembrane helices. Known functions of this gene are 
associated to outer membrane glycolipid compounds in Gram-negative cells (Lehrer et al. 2007). 
Sequence analysis located the amino acid exchange Thr
16
 to Pro in the first transmembrane helix, 
belonging to the presumed functional N-terminal region (Amer and Valvano 2000). However, 
transmembrane helix prediction (http://www.cbs.dtu.dk/services/TMHMM/) revealed no changes in 
the structure. In a next step, both, the complete disruption of the rfe gene and the site-specific 
integration of the point mutation, were tested for phenotypic effects within B. succiniciproducens by 
constructing the strains DD3 Δrfe and DD3 rfeT16P, respectively. 
 
Table 5.17 Physiology of rationally engineered strains B. succiniciproducens DD3 Δrfe and DD3 rfeT16P compared to DD3. 
Data comprise specific growth rate (µ), biomass yield (YX/S), succinate yield (YSuc/S), formate yield (YFor/S), acetate yield 
(YAce/S), lactate yield (YLac/S), ethanol yield  (YEtOH/S), pyruvate yield (YPyr/S) and maximal succinate productivity (PSuc). Data 
represent values from three biological replicates in minimal glucose medium with corresponding standard deviations. 
 DD3 DD3 Δrfe DD3 rfeT16P 
µ [h
-1] 0.16 ± 0.01 0.06 ± 0.01 0. 20 ± 0.01 
YX/S [g mol
-1] 29.8 ± 2.5 12 ± 1.1 33.8 ± 2.5 
YSuc/S [mol mol
-1] 1.13 ± 0.04 1.1 ± 0.04 1.05 ± 0.07 
YFor/S [mol mol
-1] < 0.01 < 0.01 < 0.01 
YAce/S [mol mol
-1] 0.21 ± 0.06 0.23 ± 0.06 0.44 ± 0.03 
YLac/S [mol mol
-1] < 0.01 < 0.01 < 0.01 
YEtOH/S [mol mol
-1] < 0.01 < 0.01 < 0.01 
YPyr/S [mol mol
-1] 0.16 ± 0.03 < 0.01 0.03 ± 0 
PSuc [g L
-1 h-1] 0.76 ± 0.01 0.31 ± 0.07 0.62 ± 0.02 
Yields were determined by linear fitting of the concentration of biomass and product with that of 
the substrate. 
 
First, deletion of the rfe gene in B. succiniciproducens DD3 clearly impaired growth and specific 
biomass formation (Table 5.17), besides it caused a flocculent biomass appearance. Additionally, only 
15 g L
-1
 succinate were produced, as compared to 36 g L
-1
 with DD3 after 48 h. Introduction of the 
evolved gene variant now improved the specific growth rate by 20 %, as compared to the basic strain. 
However, succinate productivity slightly decreased (Table 5.17). In a next step, DD3 rfe
T16P
 was tested 
for its temperature tolerance at 42 °C (Figure 5.27). Interestingly, the strain steadily grew throughout a 
48 h period to a final cell concentration corresponding to an OD600 of 4. Hereby, succinate was 
produced with a titer of about 9 g L
-1
. Thus, the second generation mutant exceeded the performance 
of DD3 in both, growth and succinate production, respectively. This indicates the contribution of rfe in 
temperature adaptation by possibly affecting cell envelope composition as previously discussed for 
other bacteria (Yuk and Marshall 2003; Koga 2012). 
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Figure 5.27 Physiologic characterization of second generation mutant (▲) B. succiniciproducens DD3 rfeT16P compared to 
its ancestor (●) DD3 at 42 °C in minimal glucose medium. Data comprise growth (A) and succinate titer (B) of a 48 h 
cultivation period. Data derive from three biological replicates with corresponding standard deviations. 
 
Overall, the introduction of the evolutionary acquired point mutation in rfe was proved highly 
advantageous for B. succiniciproducens performance. At both temperatures, 37 and 42 °C, 
respectively, DD3 rfe
T16P
 showed improved growth performance. At high temperature, succinate titer 
increased by about 65 % as compared to DD3, suggesting further consideration for industrial 
application. 
 
5.5.4 Improving cellular sedimentation by engineering cell envelope metabolism 
 
Low pH adaptation revealed a mutation in B. succiniciproducens DD3-pH1 in the gene wcaJ by 
nucleotide insertion in Tyr
27
. This led to a frame shift mutation, introducing a stop codon at this very 
position, thus generating a truncated wcaJ-variant. Homology analysis revealed a conserved domain in 
wcaJ, dedicated to a bacterial sugar transferase function, that is supposed to be a part of the B. subtilis-
like exopolysaccharide synthesis machinery (van Kranenburg et al. 1997; Nagorska et al. 2010). 
During cultivation of DD3-pH1, significantly faster cell sedimentation was observed with this strain, 
indicating changes in cellular composition. To verify the functional relationship between this 
improved and industrially attractive sedimentation performance and the frame shift mutation, 
DD3 wcaJ
T27fs
 was constructed, carrying the genome based modification. 
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Figure 5.28 Sedimentation behavior of B. succiniciproducens DD3 and DD3 wcaJT27fs in complex medium. The picture 
shows sedimentation of DD3 (left) and DD3 wcaJT27fs (right) after 24 h (A). Data comprise sedimentation kinetics of (●) 
DD3 and (▲) DD3 wcaJT27fs in BHI medium according to defined centrifugal forces (B). Data points represent mean values 
of three replicates with standard deviations. 
 
The industrial relevance of sedimentation behavior was then tested in terms of centrifugal cell 
separation. Therefore, a defined cell density was initially adjusted of cells grown in MgCO3-free 
complex medium. For each centrifugation step, one milliliter of the cell suspension was pipetted into a 
1.5 mL reaction tube. Subsequently, three samples were centrifuged for 30 seconds at defined 
centrifugal forces. Afterwards, cell concentration of the supernatant was measured photometrically and 
compared to the initial concentration. In doing so, 50 % supernatant clearance was achieved with 
DD3 wcaJ
T27fs
 at about 3,500 x g, whereas DD3 cell suspension was cleared to 50 % at approximately 
8,000 x g (Figure 5.28). Considering energy costs in industrial downstream processing, a major factor 
in process competitiveness, this modification will decrease overall separation costs and therefore 
represents a promising target for process improvement.  
 
5.5.5 Metabolic engineering of lysine biosynthesis through expression of modified 
diaminopimelate decarboxylase 
 
The lysA encoded diaminopimelate decarboxylase is the last enzyme in lysine biosynthesis (Gokulan 
et al. 2003). The enzyme is conserved among all microorganisms and typically occurs as a dimer 
(Momany et al. 2002; Gokulan et al. 2003). The genome sequencing of B. succiniciproducens DD3-T2 
revealed a nucleotide exchange in lysA. As consequence, the conserved amino acid Gly
307
 was 
replaced by Cys (Figure 5.29).  
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H. influenza 
A. succinogenes 
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DD3-T2 
Consensus  
Figure 5.29 The alignment is shown for LysA proteins from different bacteria with the respective consensus sequence. The 
position of the evolutionary acquired amino acid exchange in B. succiniciproducens DD3-T2 is shown in blue, in respect to 
the aligned sequences. 
 
Initially, the potential impact of lysine biosynthesis on temperature tolerance was analyzed by 
studying the growth effect of the wild-type by adding lysine to minimal medium. Compared to DD1, 
grown without external lysine, DD1 supplemented with 3 mM lysine grew to a cell concentration 
corresponding to OD600 of 6 and produced significantly more succinate, as compared to the control 
(Figure 5.30). Obviously, the lysine pathway is heat-sensitive and thus linked to growth of 
B. succiniciproducens at elevated temperatures.  
 
Figure 5.30 Growth and production performance of B. succiniciproducens DD1 in minimal glucose medium at 42 °C. Given 
data comprise the growth of (●) DD1 and (▲) DD1, supplemented with 3 mM lysine (A) and their respective succinate titer 
after 24 h cultivation period (B). Asterisk indicates lysine supplemented wild-type. Data derive from three biological 
replicates with corresponding standard deviations.  
 
Regarding the consequence of the mutation on the enzyme, position specific analysis with the E. coli 
homologue revealed an introversive orientation of the modification locus, suggesting an enzyme 
stabilizing function while excluding dimer specific stabilization (PDB ID: 1KNW (Levdikov et al. 
2003)) (Figure 5.31). This is supported by the beneficial growth effect of glycine betaine at high 
temperature (Table 5.2). In this line, the natural diaminopimelate decarboxylase seemed temperature 
instable.  
Results and Discussion 
93 
  
 
Figure 5.31 Overview of E. coli diaminopimelate decarboxylase (PDB ID: 1KNW (Levdikov et al. 2003)). Arrow indicates 
inward orientation of nucleotide exchange affected amino acid position (yellow) after homology study of 
B. succiniciproducens lysA sequence relative to E. coli sequence (left). This is supported by the calculated surface (Conolly 
method; probe radius 1.399) that reveals no outward orientation of the exchanged amino acid (right). Yellow domains are 
associated to other sulfur containing amino acids.  
 
Introduction of the obtained modification into the priorly engineered production strain 
B. succiniciproducens DD5 yielded the second generation mutant DD5 lysA
G307C
, which was verified 
by sequencing of the site-specific PCR product. Cultivation of DD5 lysA
G307C
, in minimal glucose 
medium at 42 °C, showed stable growth and production performance. The succinate titer increased by 
nearly 400 % to about 27 g L
-1
 with a significantly improved maximal succinate productivity of 
0.8 g L
-1
 h
-1
, as compared to DD3 (Table 5.18). However, glucose was not completely consumed, in 
contrast to the temperature tolerant mutant DD3-T2. This indicated further temperature sensitive 
metabolic burdens. At 37 °C, the engineered strain DD5 lysA
G307C
 performed better than DD3 
regarding growth and succinate productivity, which increased by about 60 % and 30 %, respectively. 
 
Table 5.18 Growth and production characteristics of B. succiniciproducens DD5 lysAG307C compared to DD3. Data comprise 
specific growth rate (µ), biomass yield (YX/S), succinate yield (YSuc/S), formate yield (YFor/S), acetate yield (YAce/S), lactate 
yield (YLac/S), ethanol yield (YEtOH/S), pyruvate yield (YPyr/S) and maximal succinate productivity (PSuc). Data represent values 
from three biological replicates in minimal glucose medium with their corresponding standard deviations. 
 DD3 DD5 lysAG307C 
 37 °C 42 °C 37 °C 42 °C 
µ [h
-1] 0.16 ± 0.01 - 0.26 ± 0 0. 25 ± 0 
YX/S [g mol
-1] 29.8 ± 2.5 19.2 ± 2.2 34.1 ± 1.9 30.3 ± 1.9 
YSuc/S [mol mol
-1] 1.13 ± 0.04 1.08 ± 0.12 1.08 ± 0.01 1.10 ± 0.04 
YFor/S [mol mol
-1] < 0.01 < 0.01 < 0.01 < 0.01 
YAce/S [mol mol
-1] 0.21 ± 0.06 0.29 ± 0.02 0.33 ± 0.02 0.41 ± 0.04 
YLac/S [mol mol
-1] < 0.01 < 0.01 < 0.01 < 0.01 
YEtOH/S [mol mol
-1] < 0.01 < 0.01 < 0.01 < 0.01 
YPyr/S [mol mol
-1] 0.16 ± 0.03 0.11 ± 0.01 0.08 ± 0.01 0.03 ± 0.01 
PSuc [g L
-1 h-1] 0.76 ± 0.01 0.16 ± 0.02 0.97 ± 0.01 0.8 ± 0.05 
Yields were determined during exponential phase by linear fitting of the concentration of biomass and product with that 
of the substrate. 
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Taken together, introduction of a modified diaminopimelate decarboxylase, carrying an evolutionary 
acquired point mutation, showed significantly advanced performance of B. succiniciproducens at 
standard and at high temperature, obviously improving industrial potential. 
 
5.5.6 Metabolic engineering of by-product spectrum through expression of a modified 
phosphate acetyltransferase 
 
During high succinate adaptation, B. succiniciproducens acquired a mutation in the pta gene, encoding 
for the phosphate acetyltransferase. Significance of this gene is related to the acetate biosynthetic 
pathway, which is directly coupled to energy production via ATP formation in M. succiniciproducens 
MBEL55E (Lee et al. 2006). Disruption of this pathway by deletion of the ackA gene led to decreased 
growth performance (Lee et al. 2006) and indicated cellular need for this reaction. To verify the 
phenotypic effect of the acquired mutation, strain DD1 Δldh ptaV666I was constructed. Introduction of 
the point mutation was validated by sequencing of the site-specific PCR product.  
 
Table 5.19 Physiology of B. succiniciproducens DD1 and DD1 Δldh ptaV666I. The data comprise specific growth rate (µ), 
biomass yield (YX/S), succinate yield (YSuc/S), formate yield (YFor/S), acetate yield (YAce/S), lactate yield (YLac/S), ethanol yield 
(YEtOH/S), pyruvate yield (YPyr/S) and maximal succinate productivity (PSuc). Data represent values from three biological 
replicates with standard deviation in minimal glucose medium. 
 DD1 DD1 Δldh ptaV666I 
µ [h
-1] 0.29 ± 0.01 0.43 ± 0.01 
YX/S [g mol
-1] 35.6 ± 0.2 34.5 ± 1.5 
YSuc/S [mol mol
-1] 0.76 ± 0.03 0.72 ± 0.07 
YFor/S [mol mol
-1] 0.58 ± 0.02 0.15 ± 0.02 
YAce/S [mol mol
-1] 0.57 ± 0.01 0.31 ± 0.02 
YLac/S [mol mol
-1] 0.03 ± 0 < 0.01 
YEtOH/S [mol mol
-1] 0.03 ± 0 < 0.01 
YPyr/S [mol mol
-1] < 0.01 0.04 ± 0.01 
PSuc [g L
-1 h-1] 1.42 ± 0.04 0.78 ± 0.06 
Yields were determined during exponential phase by linear fitting of the 
concentration of biomass and product with that of the substrate. 
 
Obviously, cell growth was positively affected in DD1 Δldh ptaV666I, as compared to the wild-type 
DD1. Interestingly, despite similar yields for biomass and succinate, the by-product spectrum changed 
in DD1 Δldh ptaV666I. Formate and acetate were formed with about 75 and 50 % decreased yields, 
respectively, while pyruvate accumulated extracellular. This observation is supported by similar 
results for acetate and pyruvate yield in high succinate evolved strains DD3-Suc1, DD3-Suc2 and 
DD3-Suc3 (Table 5.8). This indicates a change in carbon distribution in B. succiniciproducens 
metabolism, since pyruvate was not observed as by-product in the wild-type and other wild-type 
succinate producing microorganisms (Lee et al. 2002; McKinlay et al. 2005; Becker et al. 2013). 
Moreover, this emphasizes the inevitability of future engineering rounds regarding further by-
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products, especially pyruvate-based substances, as observed with the rationally engineered double 
mutant DD3 (Becker et al. 2013) and due to the high flexibility of the pyruvate node, observed with all 
adapted strains. Taken together, the mutation in the pta gene seemed to affect the carbon distribution 
regarding by-product formation in B. succiniciproducens, which is a highly relevant fact concerning 
industrial succinate production. Even though pyruvate filled in for formate and acetate, its higher 
tolerability, compared to formate and acetate (Lin et al. 2008), gives a promise for future performance 
and titer improvements.  
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5.6 Succinate production of evolved strains in industrial glycerol medium 
 
In order to assess the production performance on raw materials, such as glycerol, the adapted strains 
B. succiniciproducens DD3-T2 and DD3-Suc2 were cultivated in a maltose/glycerol based complex 
medium and compared to their ancestor DD3.  
 
Table 5.20 Production characteristics of B. succiniciproducens DD3 and the evolved phenotypes DD3-T2 and DD3-Suc2 in 
complex glycerol medium. Data comprise specific cell growth (µ), consumption of glycerol and maltose, formation of 
succinate, acetate, pyruvate, lactate and formate, maximal succinate productivity (PSuc) and specific succinate yield (YSuc/S). 
Data represent mean values of three biological replicates with corresponding standard deviations. 
 DD3 DD3-T2 DD3-Suc2 
µmax 0.22 ± 0.01 0. 29 ± 0.01 0.32 ± 0.01 
ΔcGlycerol [g L
-1] 15.0 ± 0.6 47.1 ± 0.8 27.0 ± 0.6 
ΔcMaltose [g L
-1] 16.0 ± 0 20 ± 0 17.2 ± 0.1 
ΔcSuccinatel [g L
-1] 27.2 ± 1.1 74.3 ± 3.0 44.1 ± 2.1 
ΔcAcetate [g L
-1] 1.7 ± 0.2 1.6 ± 1.4 1.8 ± 0.2 
ΔcPyruvate [g L
-1] 0.4 ± 0.1 0.2 ± 0 0.6 ± 0.1 
ΔcLactate [g L
-1] < 0.1 1.0 ± 0.2 0.1 ± 0 
ΔcFormate [g L
-1] < 0.1 < 0.1 < 0.1 
PSuc [g L
-1 h-1] 1.07 ± 0.13 2.94 ± 0.26 1.82 ± 0.09 
YSuc/S [Cmol Cmol
-1] 0.92 ± 0.06 1.13 ± 0.04 0.99 ± 0.05 
Cmol yield was determined during exponential phase by linear fitting of the C molar 
concentration of product with that of the substrates. 
 
The two adapted strains showed improved growth rates (Table 5.20). During 24 h, DD3-T2 nearly 
completely consumed the provided glycerol, accompanied by complete maltose consumption and 
produced about 75 g L
-1
 succinate, three times more than DD3.  
 
 
B. succiniciproducens DD3-T2 
 
M. succiniciproducens 
 
A. succiniciproducens 
 
A. succinogenes 
 
E. coli 
 
Figure 5.32 Maximal succinate productivity of B. succiniciproducens DD3-T2 (Table 5.20) as compared to other succinate 
producers. Reviewed data (Beauprez et al. 2010) comprise M. succiniciproducens (Lee et al. 2002), A. succiniciproducens 
(Glassner and Datta 1992), A. succinogenes (Guettler 1998) and E. coli (Andersson et al. 2007). Cultivations were conducted 
as anaerobic or dual-phase batches with complex medium. 
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The succinate productivity was increased about 2.5-fold, as compared to the ancestor strain DD3 
(Table 5.20). Compared to other industrial succinate producers, the performance of DD3-T2 exceeds 
that of conventional batch fermentations (Figure 5.32). Furthermore, the observed productivity 
matches the industrial prerequisite of about 2.5 g L
-1
 h
-1
 (Werpy and Peterson 2004). Thus, 
evolutionary adaptation and the derived mutant B. succiniciproducens DD3-T2 enabled superior bio-
succinate production and displayed a mile-stone towards industrial production of this high-value 
chemical.  
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6 Conclusion and Outlook 
 
The present work dealt with the systematic evolutionary adaptation of succinate producing 
B. succiniciproducens towards an improved industrial process for this top-value chemical. Initially, the 
approach comprised the establishment of a sequential batch culture, developed for serum bottles and 
small scale bioreactors, to specifically adapt the microorganism to industrial parameters, i.e. high 
temperature, high succinate levels and low pH. The analysis of successfully evolved phenotypes 
recruited comparative cultivation experiments and in-depth omics profiling to shed light on metabolic 
responses, underpinning the evolutionary adaptation. Hereby, only few acquired mutations seemed to 
be involved in the significant expansion of B. succiniciproducens tolerance, i.e. the derived mutants 
DD3-T2, DD3-Suc3 and DD3-pH1 could grow at 42 °C, 25 g L
-1
 succinate and a pH-value of 5.2, 
respectively, far beyond the values tolerated by the wild-type. Targets could be identified, suitable for 
eventual optimization strategies regarding tolerance and performance improvements. Finally, studying 
the effect of introducing identified targets into producing strains revealed faster growth, higher 
productivity, increased tolerance and simplified biomass separation. Hence, this work contributes to 
the realization of a bio-economical succinate process, enabling future opportunities towards 
competitive and sustainable succinate production. 
In context with such industry scale succinate production, process requirements emerge, previously 
reviewed in different reports (Werpy and Peterson 2004; Patel et al. 2006; Bastidon 2012). Hereby, the 
industry has to contemplate on technological progress to accomplish several key challenges, i.e. (i) to 
achieve high productivities, ideally exceeding the benchmark of 2.5 g L
-1
 h
-1
, (ii) to reduce unfavored 
by-products, (iii) to increase titers above 100 g L
-1
, (iv) to develop low-cost media in combination with 
robust and unpretentious production strains, (v) to optimize directly affiliated recovery processes, and 
(vi) to overall reduce production costs to 0.55 $ kg
-1
 (Patel et al. 2006). In addition, broadening and 
improving the substrate conversion to the desired product displays one of the most attractive and 
crucial fields of work. There is a continuing quest for new, renewable and sustainable feedstocks, 
regarding procurement costs, applicability and efficiency. Non-food substrates, such as hemicellulose 
or glycerol are widely abundant in industry, mainly as waste products, and were recently studied in 
combination with succinate producing microorganisms for performance validation (Lee et al. 2003; 
Kim et al. 2004; Blankschien et al. 2010; Borges and Pereira Jr 2011; Liu et al. 2012). Taking this into 
account, future metabolic engineering approaches may also comprise further questions that emerged 
from systems biology studies in this work, i.e. validation of increased flux towards the pentose 
phosphate pathway as well as through the pyruvate dehydrogenase complex, functional verification of 
succinate secretion pathways or energy/redox balancing. Additional approaches may comprise an 
increase in succinate production efficiency by applying strategies, recently reported for lysine and 
diaminopentane production with C. glutamicum (Becker et al. 2011; Kind and Wittmann 2011). A 
carefully reflected combination of functional targets discovered in this work could be a promising task 
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for future work. Therefore, establishing a straight-forward genetic tool box, facilitating fast, simple 
and valid genetic engineering, would substantially improve rational engineering approaches with 
B. succiniciproducens.  
The excellent production properties of B. succiniciproducens, the recent establishment of systems 
biological methods for in depth metabolic analysis and the successful demonstration of directed 
evolutionary adaptation, coupled with targeted strain improvements, make this organism an 
outstanding candidate for a future succinate bioprocess. Regarding the large variety of succinate 
application in the downstream market, rational engineering of B. succiniciproducens towards other 
promising non-natural reaction products that are chemically described, such as 1,4-butanediol or 
succinate esters (Cukalovic and Stevens 2008), seems rather promising. It might also be relevant to 
consider succinate precursors as valuable products, such as malate, fumarate, and pyruvate and in this 
line, directly derived amino acids. Taken together, B. succiniciproducens could thrive as a high-value 
cell factory. The understanding of its metabolic behavior, enabled by systems biology, combined with 
rational strategies of metabolic engineering will extend the production spectrum. This integrated 
approach may lead to a further mainstay in the new bioeconomy. 
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7 Abbreviations and Symbols 
 
Abbreviations 
aceEF  genes, encoding pyruvate dehydrogenase in B. succiniciproducens 
ATP  adenosine triphosphate 
AUC  area under curve 
BHI  brain heart infusion 
bp  base pair(s) 
BSA  bovine serum albumin 
C4   metabolite containing four carbon atoms 
Cm  chloramphenicol 
Cm
R
  chloramphenicol resistence 
COG  clusters of orthologous groups 
Cys  cysteine 
DD1  B. succiniciproducens wild-type 
DD3  B. succiniciproducens Δldh ΔpflD 
DD3-pH1 low pH evolved phenotype, isolated after 22 iterations 
DD3-Suc1 high succinate evolved phenotype, isolated after 3 iterations 
DD3-Suc2  high succinate evolved phenotype, isolated after 15 iterations 
DD3-Suc3 high succinate evolved phenotype, isolated after 50 iterations 
DD3-T1 high temperature evolved phenotype, isolated after 10 iterations 
DD3-T2 high temperature evolved phenotype, isolated after 60 iterations 
DD5  B. succiniciproducens Δldh ΔpflA 
DIP  deletion – insertion – polymorphism 
DNA  deoxyribonucleic acid 
F6P  fructose 6-phosphate 
FC  fold change 
FDR  false discovery rate 
fumC  gene, encoding fumarase in B. succiniciproducens 
G6P  glucose 6-phosphate 
GAP  glyceraldehyde 3-phosphate 
GC  gas chromatography 
GC-MS gas chromatography-mass spectrometry 
Glc  glucose 
Gly  glycine 
GSEA  gene set enrichment analysis 
HPLC  high-performance liquid chromatography 
Ile  isoleucine 
int  integrative 
KEGG  Kyoto Encyclopedia of Genes and Genomes 
Kb  kilo base pairs 
LB  Luria Bertani 
ldhA  gene, encoding lactate dehydrogenase in B. succiniciproducens 
Lys  lysine 
lysA  gene, encoding diaminopimelate decarboxylase in B. succiniciproducens 
MBDSTFA N-methyl-N-tert-butyldimethylsilyl-trifluoroacetamide 
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MCS  multiple cloning site 
MFA  metabolic flux analysis 
MOPS  3-(N-morpholino)propanesulfonic acid 
NAD(P) nicotinamide adenine dinucleotide (phosphate), oxidized 
NAD(P)H nicotinamide adenine dinucleotide (phosphate), reduced 
NES  normalized enrichment score 
NOM p-val normalized p-value 
OAA  oxaloacetate 
OD600  optical density (λ = 600 nm) 
OPA  ortho-phthaldialdehyde 
ORI  origin of replication 
PaceE  promoter of pyruvate dehydrogenase subunit E1 in B. succiniciproducens 
PptsG  promoter of trehalose (maltose)-specific transporter subunit IIBC of PTS in 
B. succiniciproducens 
PA  polyamine 
PBS  polybutylene succinate 
PCR  polymerase chain reaction 
PDB ID protein database identifier 
PDH  pyruvate dehydrogenase  
PES  polyethylene succinate 
PEP  phosphoenolpyruvate 
PEP/Pyr lumped pool of phosphoenolpyruvate and pyruvate 
PEPCK  PEP-carboxykinase 
pflA  gene, encoding formate C-acetyltransferase activator in B. succiniciproducens 
pflD  gene, encoding formate C-acetyltransferase in B. succiniciproducens 
PPP  pentose phosphate pathway 
Pro  proline 
pta  gene, encoding phosphate aetyltransferase in B. succiniciproducens 
pykA  gene, encoding pyruvate kinase in B. succiniciproducens 
Pyr  pyruvate 
RIN  RNA integrity number 
RNA  ribonucleic acid 
rfe  gene, encoding UDP-GlcNAc:undecaprenyl-phosphate GlcNAc-1-phosphate 
transferase in B. succiniciproducens 
rpm  rounds per minute 
rpoC  gene, encoding beta'-subunit of the DNA-directed RNA polymerase in 
B. succiniciproducens 
sacB  gene, encoding levansucrase in B. subtilis 
SAP  shrimp alkaline phosphatase 
SIM  selective ion monitoring 
SNP  single nucleotide polymorphism 
SOB  super optimal broth 
SOC  super optimal broth with catabolite repression 
TAE  buffer consisting of Tris, EDTA and acetic acid 
TCA  tricarboxylic acid 
Thr  threonine 
TRIS  tris(hydroxymethyl)aminomethane) 
Tyr  tyrosine 
Val  valine 
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wcaJ  gene, encoding predicted colanic acid biosynthsis UDP-glucose lipid carrier 
transferase in B. succiniciproducens 
wt  wild type 
 
Symbols 
µ  specific growth rate    [h
-1
] 
qGlc  specific glucose uptake rate   [mmol g
-1
 h
-1
] 
t  time      [h] or [d] 
T  temperature     [°C] 
U  unit      [μmol min-1]  
PSuc  maximal succinate productivity   [g L
-1
 h
-1
] 
YAce/S   specific acetate yield    [mol mol
-1
] 
YEtOH/S   specific ethanol yield    [mol mol
-1
] 
YFor/S   specific formate yield    [mol mol
-1
] 
YLac/S   specific lactate yield    [mol mol
-1
] 
YPyr/S   specific pyruvate yield    [mol mol
-1
] 
YSuc/S   specific succinate yield    [mol mol
-1
] 
YX/S   specific biomass yield    [g mol
-1
] 
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9 Appendix 
 
9.1 Data related to 13C metabolic flux analysis 
 
The precursor demand for biomass synthesis was taken from the literature (Becker et al. 2013). The 
excellent fit between simulated and experimentally obtained mass isotopomer fractions is shown for 
the evolutionary derived mutant B. succiniciproducens DD3-T2, DD3-Suc2 and DD3-Suc3. In 
addition, carbon fluxes towards biomass formation and redox balance are shown for all adapted strain, 
as compared to the parent strain DD3 (data taken from (Becker et al. 2013)). The fold change for 
carbon flux re-distribution is listed, as compared to DD3 (data taken from (Becker et al. 2013)). 
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Table 9.1 Precursor demand for biomass synthesis in B. succiniciproducens. Biomass composition was based on previous 
studies (Neidhardt et al. 1990; Kim et al. 2007). 
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Table 9.2 Relative mass isotopomer fractions of amino acids from hydrolyzed cell protein and of secreted succinate from 
B. succiniciproducens cultivation with 99 % [1-13C] glucose. Data denote experimental GC-MS data (exp) and values 
predicted by the solution of the mathematical model corresponding to optimized fluxes (calc). M+0 represents the amount of 
non-labeled mass isotopomers fractions, M+1 the amount of single labeled mass isotopomers fractions and corresponding 
terms refer to higher labeling. 
Analyte 
fragment 
Mass isotopomer Mass isotopomer distribution 
DD3-T2 DD3-T2 42 °C DD3-Suc2 DD3-Suc3 
exp calc exp calc exp calc exp Calc 
Alanine M+0 0.434 0.431 0.415 0.414 0.418 0.414 0.413 0.408 
M-57 M+1 0.419 0.419 0.434 0.432 0.434 0.436 0.438 0.441 
 M+2 0.112 0.114 0.114 0.116 0.111 0.113 0.112 0.114 
Alanine M+0 0.453 0.454 0.434 0.436 0.436 0.434 0.432 0.428 
M-85 M+1 0.435 0.436 0.451 0.451 0.452 0.453 0.456 0.458 
 M+2 0.112 0.110 0.114 0.112 0.112 0.113 0.113 0.114 
Glycine M+0 0.741 0.737 0.733 0.731 0.755 0.755 0.738 0.738 
M-57 M+1 0.185 0.189 0.192 0.194 0.173 0.174 0.188 0.188 
 M+2 0.074 0.074 0.075 0.074 0.071 0.071 0.074 0.073 
Glycine M+0 0.811 0.813 0.803 0.805 0.820 0.821 0.804 0.804 
M-85 M+1 0.189 0.187 0.197 0.195 0.180 0.179 0.196 0.196 
Aspartate M+0 0.363 0.362 0.350 0.350 0.351 0.349 0.344 0.343 
M-57 M+1 0.402 0.402 0.412 0.411 0.415 0.414 0.420 0.418 
 M+2 0.160 0.160 0.161 0.162 0.158 0.160 0.160 0.162 
Aspartate M+0 0.372 0.373 0.359 0.360 0.357 0.358 0.351 0.353 
M-85 M+1 0.410 0.410 0.421 0.420 0.423 0.422 0.427 0.425 
 M+2 0.159 0.158 0.160 0.159 0.159 0.159 0.160 0.160 
Threonine M+0 0.363 0.363 0.349 0.350 0.349 0.349 0.343 0.344 
M-57 M+1 0.404 0.403 0.414 0.412 0.417 0.415 0.421 0.419 
 M+2 0.159 0.160 0.161 0.162 0.159 0.160 0.161 0.161 
Threonine M+0 0.374 0.374 0.360 0.361 0.357 0.359 0.352 0.354 
M-85 M+1 0.410 0.410 0.421 0.421 0.424 0.422 0.428 0.426 
 M+2 0.157 0.157 0.159 0.158 0.159 0.159 0.160 0.160 
Serine M+0 0.379 0.375 0.363 0.360 0.361 0.360 0.354 0.355 
M-57 M+1 0.407 0.405 0.418 0.416 0.423 0.422 0.426 0.425 
 M+2 0.156 0.160 0.159 0.162 0.156 0.158 0.159 0.159 
Serine M+0 0.406 0.404 0.390 0.389 0.386 0.387 0.380 0.382 
M-85 M+1 0.433 0.436 0.445 0.448 0.451 0.449 0.454 0.453 
 M+2 0.162 0.160 0.165 0.163 0.163 0.164 0.166 0.165 
Phenylalanine M+0 0.190 0.188 0.165 0.165 0.175 0.173 0.155 0.154 
M-57 M+1 0.373 0.375 0.362 0.363 0.374 0.376 0.359 0.360 
 M+2 0.283 0.279 0.299 0.296 0.293 0.294 0.307 0.307 
Tyrosine M+0 0.167 0.162 0.145 0.142 0.152 0.149 0.135 0.133 
M-57 M+1 0.342 0.342 0.329 0.330 0.339 0.341 0.324 0.326 
 M+2 0.287 0.285 0.299 0.298 0.296 0.297 0.306 0.307 
          
Succinate M+0 0.430 0.420 0.416 0.405 0.406 0.404 0.399 0.398 
M-57 M+1 0.410 0.415 0.423 0.428 0.431 0.432 0.435 0.436 
 M+2 0.116 0.119 0.116 0.120 0.117 0.118 0.118 0.119 
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Table 9.3 Biomass specific in vivo carbon fluxes of B. succiniciproducens DD3-T2 at 37 and 42 °C, respectively, and DD3-
Suc2 and DD3-Suc3 at 37 °C during growth on minimal glucose medium. Data also comprise specific biomass yield (YX/S), 
calculated by linear fitting of the concentration of biomass and product with that of the substrate. 
Reaction DD3-T2 DD3-T2 (42 °C) DD3-Suc2 DD3-Suc3 
YX/S [g mol
-1] 29.2 ± 1.0 28.9 ± 0.5 30.1 ± 2.4 29.1 ± 1.5 
GLC6P = GLC6P_B 0.6 ± 0 0.6 ± 0 0.6 ± 0 0.6 ± 0 
F6P = F6P_B 0.2 ± 0 0.2 ± 0 0.2 ± 0 0.2 ± 0 
P5P = P5P_B 2.5 ± 0 2.5 ± 0 2.6 ± 0.1 2.7 ± 0.1 
E4P = E4P_B 0.7 ± 0 0.7 ± 0 0.7 ± 0 0.7 ± 0 
GAP = GAP_B 0.4 ± 0 0.4 ± 0 0.4 ± 0 0.4 ± 0 
3PG = 3PG_B 3.9 ± 0 3.8 ± 0 3.9 ± 0 4.0 ± 0.1 
PYR_PEP = PYR_PEP_B 9.3 ± 0.1 9.3 ± 0.1 9.6 ± 0.1 9.9 ± 0.1 
ACCOA = ACCOA_B 8.9 ± 0.1 8.8 ± 0.1 9.3 ± 0.2 10.4 ± 0.2 
OAA_MAL = OAA_MAL_B 5.6 ± 0 5.6 ± 0 5.8 ± 0 5.9 ± 0.1 
AKG = AKG_B 3.3 ± 0 3.2 ± 0 3.4 ± 0 3.5 ± 0.1 
 
 
Table 9.4 Response of in vivo flux distribution of the evolutionary adapted stains B. succiniciproducens DD3-T2, at 37 and 
42 °C, respectively, and DD3-Suc2 and DD3-Suc3 at 37 °C as compared to their ancestor DD3 (Becker et al. 2013) on 
minimal glucose medium. Flux fold change is calculated from specific glucose uptake rate corrected in vivo carbon fluxes.  
Reaction DD3-T2 DD3-T2 (42 °C) DD3-Suc2 DD3-Suc3 
Specific glucose uptake rate [mmol g-1 h-1] 8.2 ± 0.5 9.1 ± 0.6 7.8 ± 0.8 7.6 ± 0.8 
GLC_EX + ATP = GLC 1 1.1 1 0.9 
GLC + ATP = GLC6P 1 1.1 1 0.9 
GLC6P = F6P 0.9 1.1 0.9 0.9 
F6P + ATP = F16BP 1 1.1 0.9 0.9 
F16BP = DHAP + GAP 1 1.1 0.9 0.9 
DHAP = GAP 1 1.1 0.9 0.9 
GAP = 3PG + ATP + NADH 1 1.1 0.9 0.9 
3PG = PYR_PEP 1 1.1 0.9 0.9 
GLC6P = P5P + CO2 + NADPH + NADPH 2.3 1.4 2.1 1.6 
P5P + P5P = S7P + GAP 2.8 1.4 2.5 1.8 
GAP + S7P = E4P + F6P 2.8 1.4 2.5 1.8 
P5P + E4P = GAP + F6P 3.9 1.6 3.4 2.3 
PYR_PEP + CO2 = OAA_MAL + ATP 1.1 1.1 0.9 0.8 
PYR_PEP = ACCOA + CO2 + NADH 1.5 2 0.9 1.5 
DHAP = MethGlyox = LAC 0.3 0.4 0 0.7 
OAA_MAL = 0.5 FUM + 0.5 FUM 1.1 1.1 0.9 0.8 
FUM + NADH = SUC 1.1 1.1 0.9 0.8 
ACCOA + OAA_MAL  = CIT 0.6 0.7 0.6 0.6 
CIT = AKG + CO2 + NADPH 0.6 0.7 0.6 0.6 
Acetateex 2.1 3.2 1 2.0 
Ethanolex 1.8 0.8 0 2.3 
Pyruvateex 0.7 0.5 1.4 1.1 
Pyruvate derived by-productsex 0.1 0.1 0.9 0.4 
Lactateex 0.3 0.4 0 0.7 
Succinateex 1 1.1 0.9 0.8 
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Figure 9.1 Redox balance of investigated B. succiniciproducens phenotypes DD3-T2, DD3-Suc2 and DD3-Suc3, as 
compared to their parent strains DD3 (Becker et al. 2013). NADH (dark grey) and NADPH (light grey) supply were 
calculated from metabolic flux distribution. Corresponding demands were estimated from production characteristics 
including biomass formation and specific yields for secreted products (Table 5.4 and Table 5.8). NADH supplying reactions 
were assumed for glyceraldehyde-3-phosphate dehydrogenase, pyruvate dehydrogenase, 2-oxo-glutarate dehydrogenase. 
Considered reactions for NADPH supply were glucose-6-phosphate dehydrogenase, 6-phosphogluconate dehydrogenase, and 
isocitrate dehydrogenase. NADH consuming reactions were assumed for alcohol dehydrogenase, malate dehydrogenase, and 
fumarate reductase. Under the assumption of an existing NADH dehydrogenase, transferring electrons from NADH to 
menaquinone, menaquinone consumption was regarded as NADH consumption (Kim et al. 2009). The NADPH demand for 
anabolism was obtained from cellular composition (Table 9.1). Data represent mean values with 90 % confidence intervals. 
 
 
Figure 9.2 Energy balance for B. succiniciproducens phenotypes DD3-T2, DD3-Suc2 and DD3-Suc3, as compared to their 
parent strains DD3 (Becker et al. 2013). ATP demand (dark grey) and supply (light grey) were calculated from biomass 
formation, metabolic flux distribution and production characteristics. ATP supply was assumed for phosphoglycerate kinase, 
phosphoenolpyruvate carboxykinase, acetate kinase, and succinyl-CoA synthetase. The ATP demand was calculated from 
hexokinase and phosphofructokinase. The anabolic demand was obtained from cellular composition (Table 9.1). Data 
represent mean values with 90 % confidence intervals. 
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9.2 Gene expression analysis of evolved B. succiniciproducens phenotypes 
 
The obtained gene expression profiles of B. succiniciproducens DD3-T2, DD3-Suc2 and DD3-Suc3 
were used for database-aided operon search. Operons and their corresponding genes were listed 
according to the Database of prOkaryotic OpeRons (Dam et al. 2007; Mao et al. 2009) and the 
Prokaryotic Operon DataBase (Taboada et al. 2012) for M. succiniciproducens MBELE55 predictions. 
  
Table 9.5 Operon linked gene expression of B. succiniciproducens DD3-T2. Data comprise operons, up- and down-regulated 
in response to temperature adaptation, as compared to the ancestor DD3. 
Number 
Systematic 
namea 
Gene namea Mean FCb Specificationc Functiond 
1 MS616-18   2.0 Phosphotransferase system G 
2 MS1334-36 lpd, aceF, aceE  4.2 Pyruvate dehydrogenase complex C 
3 MS1606-08 dAK1, dAK2  2.2 Dihydroxyacetone kinase G 
4 MS2284-89 
uhpT, uhpA, 
uhpB, uhpC, baeS 
 10.4 
Hexose phosphate phosphorelay 
system 
G, T, M 
5 MS0549-51 proV, proW, proX - 3.0 Glycine betain/proline transport E 
6 MS1791-95 
dgoA, menB, 
mhpC, mend, 
menF 
- 2.8 Menaquinone biosynthesis H, R 
7 MS1816-19 
nrfD, nrfC, nrfB, 
nrfA 
- 2.5 Formate dependent nitrite reductase P, C 
8 MS1821-22 rluD - 2.0 
Pseudouridine synthase and conserved 
protein 
J, S 
9 MS2073-74 glgP, malQ - 2.0 Glycogen metabolism G 
a Gene entries and names are given by KEGG annotations for M. succiniciproducens MBELE55. 
b Mean fold change represents the mean value of gene expression of all operon involved genes. 
c The operon specifications were assigned using the databases of KEGG and BLAST. 
d Functional grouping was taken from literature (Hong et al. 2004). 
 
 
Table 9.6 Impact of succinate adaptation on B. succiniciproducens gene expression. Data comprise operons, up- and down-
regulated in DD3-Suc2, as compared to the ancestor DD3. 
Number 
Systematic 
namea 
Gene namea Mean FCb Specificationc Functiond 
1 MS0458-59 groE, groEL  2.0 Molecular chaperones O 
2 MS1249-52 
cysI, cysJ, cysN, 
cysH 
 4.6 Cysteine biosynthesis E 
3 MS1275-77 glnQ, artM, artI  2.6 
Cysteine related ABC transporter 
system 
E 
4 MS1334-35 lpd, aceF, ace  2.3 Pyruvate dehydrogenase complex C 
5 MS1855-57 nrdG  2.1 Queosine biosynthesis R, H, O 
6 MS0038-40 
oadB, oadA, 
oadG 
- 3.2 Oxaloacetate decarboxylase C 
7 MS0549-51 proV, proW - 3.5 Glycine betain/proline transport E 
8 MS0616-18  - 2.1 Phosphotransferase system  G 
9 MS0731-32 gltD - 2.5 
Putative glutamate synthase and 
formate dehydrogenase subunit alpha 
E, R 
10 MS1120-24 
glgA, glgC, glgX, 
glgB, malQ 
- 2.0 Glycogen metabolism G 
11 MS1156-58 feoB, feoB - 2.2 Ferrous iron transport P 
12 MS1652-55 
sdhA, frdB, frdC, 
frdD 
- 3.3 Fumarate reductase C 
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13 MS1816-19 
nrfD, nrfC, nrfB, 
nrfA 
- 2.2 Formate dependent nitrite reductase P, C 
14 MS2066-67 lamB, malK - 2.2 Maltose, maltodextrins uptake G 
15 MS2377-79  - 2.4 Phosphotransferase system G 
a Gene entries and names are given by KEGG annotations for M. succiniciproducens MBELE55. 
b Mean fold change represents the mean value of gene expression of all operon involved genes. 
c The operon specifications were assigned using the databases of KEGG and BLAST. 
d Functional grouping was taken from literature (Hong et al. 2004). 
       
 
 
Table 9.7 Operon linked gene expression of B. succiniciproducens DD3-Suc3. Data comprise operons, up- and down-
regulated in response to temperature adaptation, as compared to the ancestor DD3. 
Number 
Systematic 
namea 
Gene namea Mean FCb Specificationc Functiond 
1 MS0966-67   2.2 
Dihydropteroate synthase and 
phosphoglucosamine mutase 
H, G 
2 MS1441-42   2.5 
Pseudouridine synthase and ribosome 
binding factor A 
J 
3 MS1444-46   3.3 
Translation initiation factor IF2, 
transcription elongation factor and 
ribosome maturation protein 
J, K 
4 MS16(66)-75   2.0 Peptidoglycan biosynthesis M, D 
5 
MS1(699)-
703 
  3.1 Threonine synthesis E, S 
6 MS1922-23   2.3 Lipid biosynthesis M 
7 MS2311-12   2.2 
Uncharacterized protein containing 
SH3 domain and tRNA nucleotidyl-
transferase 
T, J 
8 MS0549-51  - 10.6 Glycine betain/proline transport E 
9 MS0911-12  - 2.0 Lipopolysaccharide biosynthesis M 
10 MS1652-55  - 2.4 Fumarate reductase C 
11 MS16(83)-87  - 2.4 ABC-type amino acid transport E 
12 MS1786-87  - 2.0 
Na+/solute symporter (pantothenate, 
proline) and uncharacterized protein 
H, S 
13 MS17(91)-95  - 2.6 Menaquinone biosynthesis H, R 
14 MS1816-(19)  - 4.6 Formate dependent nitrite reductase P, C 
15 MS1821-22  - 2.5 
Pseudouridine synthase and 
uncharacterized protein 
J, S 
16 MS1824-25  - 2.2 
Dihydroneopterin synthase and 
uncharacterized transporter protein 
H, R 
17 MS2066-67  - 4.8 Maltose, maltodextrins uptake G 
18 MS20(68)-70  - 3.7 Maltose, maltodextrins transport G 
19 MS2073-74  - 3.1 Glycogen metabolism G 
a Gene entries and names are given by KEGG annotations for M. succiniciproducens MBELE55. 
b Mean fold change represents the mean value of gene expression of all operon involved genes. 
c The operon specifications were assigned using the databases of KEGG and BLAST. 
d Functional grouping was taken from literature (Hong et al. 2004). 
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9.3 Rational strain construction 
 
The plasmid used for metabolic engineering of B. succiniciproducens is given in Table 9.8. Rationally 
engineered strains are given in Table 9.9. Strains, referred to BASF SE, were constructed by BASF SE 
in the laboratories of Dr. Joanna-Martyna Krawczyk. The applied site-specific primers for plasmid 
construction and nucleotide validation are given in Table 9.10. 
 
Table 9.8 Plasmids used for genetic modifications of B. succiniciproducens. 
Plasmid Modification(s) Reference 
pSUC-1 
pJFF224-XN + rpoC (MS0213) gene with nucleotide exchange 
692C>A  resulting in the amino acid exchange T231K under the 
native promoter 
This work 
 
Table 9.9 Basfia succiniciproducens strains genetically engineered for phenotype studies regarding succinate production 
improvement. 
Strain Modification(s) Reference 
DD3 pJFF224-XN DD3 + empty expression vector pJFF224-XN This work 
DD3 pSUC-1 DD3 + expression of plasmid pSUC-1 This work 
DD3 Δrfe DD3 + deletion of the rfe (MS0911) gene BASF SE 
DD3 rfeT18P 
DD3 + nucleotide exchange 46A>C resulting in the amino acid 
exchange T18P in the rfe (MS0911) gene  
BASF SE 
DD3 wcaJY27fs 
DD3 + nucleotide insertion 80_81insC resulting in the frame shift 
mutation Y27fs in the wcaJ (MS1494) gene 
BASF SE 
DD5 lysAG307C DD5 + nucleotide exchange 919G>T resulting in the amino acid 
exchange G307C in the lysA (MS2084) gene 
BASF SE 
DD1Δldh pta
V666I
 
DD1 + deletion of the ldh gene encoding for lactate dehydrogenase  
+ nucleotide exchange 1996G>A resulting in the amino acid 
exchange V666I in the pta (MS0998) gene 
BASF SE 
 
Table 9.10 Sequences of site-specific primers used for construction of transformation vector (Table 9.8) and validation of 
strain specific nucleotide exchanges (Table 9.9). 
Name Sequence (5’  3’) Plasmid Control 
RSt01 AGGTCATTCAAAAGGTCATC pJFF224-XN  
RSt02 AAGTGTCATAGCACCAACTG pJFF224-XN  
RSt03 GACTAGTTGATAAAATGCACGCTCGTT pJFF224-XN  
RSt04 CACTCGAGTTATTCCGCATCATCCGCCA pJFF224-XN  
RSt05 TTATTATTGGATATGCCGTT  rpoC for 
RSt06 GCCAAAGATTTTAACGGACG  rpoC rev 
RSt07 TATCGTCGGTGTCCCAAATA  rfe for 
RSt08 TCCAGTAAACCGATGACCAA  rfe rev 
RSt09 AATTGGTCGGTCGTAGGAGA  wcaJ for 
RSt10 TTCAACATACCAGGCATCCA  wcaJ rev 
RSt11 GCCACCGATCGATTATTCT  lysA for 
RSt11 GAAGACATGCTTGCTCCGTA  lysA rev 
RSt11 TAATCGACGGTCCGTTACAA  pta for 
RSt12 GCTTTCCGAGTAGTGCCTTT  pta rev 
 
 
